"AHC","PY","nTotDoc","meanAUPerArt","meanAU_IN_PerArt","meanArtAU_IN","meanArtPer_AU_IN_FIRST","meanArtPer_AU_IN_LAST","meanArtPer_AU_IN_CORR","ArtOA","singleAuArt","Q1_nSJR","Q2_nSJR","Q3_nSJR","Q4_nSJR","Q1_percSJR","Q2_percSJR","Q3_percSJR","Q4_percSJR","meanTCperArt","mean_NTC","InternCoauthorship","AffCoauthorship","meanCitationTrend","GC_AUIN_wFractional","GC_AUIN_FIRSTname","GC_AUIN_LASTname","GC_AUIN_CORRESP","top_AU","top_AU_freq","top_AU_wFract","top_AU_freq_wFract","top_AUIN","top_AUIN_freq","top_AUIN_wFract","top_AUIN_freq_wFract","topAUbyCit","topAUbyCit_TC","topAUINbyCit","topAUINbyCit_TC","topAUINbyCit_norm_byYear","topAUINbyCit_TC_norm_byYear","topConcept_L0","topFreq_L0","topConcept_L1","topFreq_L1","topConcept_L2","topFreq_L2","topConcept_L3","topFreq_L3","topConcept_L4","topFreq_L4","topMESH","topMESH_n","topprimary_topic.display_name","topprimary_topic.display_name_n","topDE","topDE_n","topTI_TM","topTI_TM_n","topAB_TM","topAB_TM_n","nDoc_wALTM","percDoc_wALTM","altmetric_score_thirdQu","cited_by_accounts_count_thirdQu","cited_by_fbwalls_count_thirdQu","cited_by_feeds_count_thirdQu","cited_by_gplus_count_thirdQu","cited_by_msm_count_thirdQu","cited_by_patents_count_thirdQu","cited_by_peer_review_sites_count_thirdQu","cited_by_policies_count_thirdQu","cited_by_posts_count_thirdQu","cited_by_rdts_count_thirdQu","cited_by_rh_count_thirdQu","cited_by_tweeters_count_thirdQu","cited_by_videos_count_thirdQu","cited_by_wikipedia_count_thirdQu","cohorts.com_thirdQu","cohorts.doc_thirdQu","cohorts.pub_thirdQu","cohorts.sci_thirdQu","readers.citeulike_thirdQu","readers.connotea_thirdQu","readers.mendeley_thirdQu","readers_count_thirdQu","n_patentsDistinct","nPatentStatus_Abandoned","nPatentStatus_Granted","nPatentStatus_N/A","nPatentStatus_Pending","nPatentStatus_Active","nPatentStatus_Not-in-force","nPatentStatus_Expired - Fee Related","nPatentStatus_Withdrawn","nPatentStatus_Ceased","nPatentStatus_Revoked","nPatentStatus_Expired - Lifetime","nPatentPubType_Application","nPatentPubType_Grant","nPatentPubType_N/A","avg_citations_Patent","avg_Inventors_Patent","inventor_per_AUIN_100","avg_InstitutesInvolved_Patent","nPatent_singleInventor","n_Patents_CoAff","n_Jurisdiction_distinct","nJurisd_AU","nJurisd_CA","nJurisd_EP","nJurisd_IN","nJurisd_CN","nJurisd_US","nJurisd_DE","nJurisd_ES","nJurisd_IT","nJurisd_AT","nJurisd_BR","nJurisd_WO","nJurisd_JP","nJurisd_DK","nJurisd_IL","nJurisd_PT","nJurisd_PL","nJurisd_FR","nJurisd_SA","nJurisd_MY","nJurisd_KR","nJurisd_NL","nJurisd_CO","nJurisd_SM","nJurisd_SI","nJurisd_HR","nJurisd_RU","nJurisd_EA","nJurisd_MX","nJurisd_HK","nPatentKC_A1","nPatentKC_A","nPatentKC_A2","nPatentKC_B1","nPatentKC_D1","nPatentKC_T3","nPatentKC_B2","nPatentKC_T1","nPatentKC_A3","nPatentKC_C","nPatentKC_B","nPatentKC_C2","nPatentKC_C0","nPatentKC_A8","nPatentKC_E","nPatentKC_T4","nPatentKC_D0","nPatentKC_T2","nPatentKC_A0","nPatentKC_B8","nPatentKC_A4","nPatentKC_T8","nPatentKC_C1","nPatentKC_U1","nPatentKC_T5","nPatentKC_B3","nPatentKC_T7","nPatentKC_A9","top_Inventor names_Patent","top_Inventor names_Patent_n","top_Original assignee names_Patent","top_Original assignee names_Patent_n","top_Fields of Research (ANZSRC 2020)_Patent","top_Fields of Research (ANZSRC 2020)_Patent_n","top_RCDC Categories_Patent","top_RCDC Categories_Patent_n","top_HRCS RAC Categories_Patent","top_HRCS RAC Categories_Patent_n","top_IPCR_Patent","top_IPCR_Patent_n","top_CPC_Patent","top_CPC_Patent_n","n_clTrial","avg_durationYear_clTrial","avg_participants_clTrial","clTrial_perAUIN_100","nClTrial_w_AltmScore","cl_AltmS_rel","avg_sponsor_clTrial","nclTrialPhase_Phase 1","nclTrialPhase_Phase 1/2","nclTrialPhase_Phase 2","nclTrialPhase_Phase 2/3","nclTrialPhase_Phase 3","nclTrialPhase_Phase 3/4","nclTrialPhase_Phase 4","nclTrialPhase_N/A","nclTrialPhase_Post Authorisation Studies","nclTrial_StudyType_Interventional","nclTrial_StudyType_Observational","nclTrial_StudyType_Other","nclTrial_StudyType_Expanded access","nclTrial_StudyType_Active surveillance","nclTrial_StudyType_Non-interventional","nclTrial_StudyType_RCT","nclTrial_StudyType_CCT","nclTrial_Gender_All","nclTrial_Gender_Female","nclTrial_Gender_Male","nclTrial_Registry_ClinicalTrials.gov","nclTrial_Registry_EU-CTR","nclTrial_Registry_ENCePP","nclTrial_Registry_ISRCTN","nclTrial_Registry_ANZCTR","nclTrial_Registry_GCTR","nclTrial_Registry_PACTR","nclTrial_Registry_CTRI","nclTrial_Registry_ReBEC","nclTrial_Registry_UMIN-CTR","top_funder_country","top_funder_country_n","top_Fields of Research (ANZSRC 2020)_clTrial","top_Fields of Research (ANZSRC 2020)_clTrial_n","top_RCDC Categories_clTrial","top_RCDC Categories_clTrial_n","top_HRCS HC Categories_clTrial","top_HRCS HC Categories_clTrial_n","top_HRCS RAC Categories_clTrial","top_HRCS RAC Categories_clTrial_n","top_Cancer Types_clTrial","top_Cancer Types_clTrial_n","top_CSO Categories_clTrial","top_CSO Categories_clTrial_n","n_grants","avg_funding_EUR","avg_funding_EUR_perOrganization","avg_durationYear_grant","avg_Organization_per_grant","avg_countries_per_grant","perc_grant_internationalColl","avg_ResultingPublications_per_grant","totFundingOrgbyActivedGrant","avgPubByActivedFundingGrant_1000","top_Research Organization - standardized_Grants","top_Research Organization - standardized_n_Grants","top_Funder_Grants","top_Funder_n_Grants","top_Funder Group_Grants","top_Funder Group_n_Grants","top_Program_Grants","top_Program_n_Grants","top_Fields of Research (ANZSRC 2020)_Grants","top_Fields of Research (ANZSRC 2020)_n_Grants","top_RCDC Categories_Grants","top_RCDC Categories_n_Grants","top_HRCS HC Categories_Grants","top_HRCS HC Categories_n_Grants","top_HRCS RAC Categories_Grants","top_HRCS RAC Categories_n_Grants","top_Cancer Types_Grants","top_Cancer Types_n_Grants","top_CSO Categories_Grants","top_CSO Categories_n_Grants","top_Units of Assessment_Grants","top_Units of Assessment_n_Grants","top_Sustainable Development Goals_Grants","top_Sustainable Development Goals_n_Grants","n_dataset","top_Repository_Dataset","top_Repository_Dataset_n","top_Fields of Research (ANZSRC 2020)_Dataset","top_Fields of Research (ANZSRC 2020)_Dataset_n","top_RCDC Categories_Dataset","top_RCDC Categories_Dataset_n","top_HRCS HC Categories_Dataset","top_HRCS HC Categories_Dataset_n","top_HRCS RAC Categories_Dataset","top_HRCS RAC Categories_Dataset_n","top_Health Research Areas_Dataset","top_Health Research Areas_Dataset_n","top_Broad Research Areas_Dataset","top_Broad Research Areas_Dataset_n","top_Cancer Types_Dataset","top_Cancer Types_Dataset_n","top_Sustainable Development Goals_Dataset","top_Sustainable Development Goals_Dataset_n"
"IRCCS_AUSLREGGIOEMILIA",2000,6,6,2.16666666666667,0.461538461538462,0.166666666666667,0.5,0,0.166666666666667,0,3,1,1,1,0.5,0.17,0.17,0.17,23.17,0.511055968404095,0.5,0.833333333333333,NA,0.371299151363004,0,0.166666666666667,0,"ADOLFO ZAVARONI;PAOLO AGOSTINI;ISABEL PRADA DE CASTRO;CARLO MARCHESI;GIAMPIERO GALLETTI;C. ROBERT CLONINGER;DONATA GUIDETTI;ENRICA BELLESIA;CARLO MAGGINI;ROBERTO VIVOLI;ERMANNO ROSSI;MIGUEL TORRES;JOHN MARSDEN;BRUNO CASALI;G. PADOAN;TERESA M. CASSINADRI;GRAZIA NACCI;ALFONSO IORIO;DÉSIRÉE COEN HERAK;UMBERTO NIZZOLI","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ADOLFO ZAVARONI;PAOLO AGOSTINI;ERMANNO ROSSI;DÉSIRÉE COEN HERAK;G RESTORI;CARLO MARCHESI;C. ROBERT CLONINGER;CARLO MAGGINI;S. GARIBOLDI;PAOLO AMPOLLINI;ROBERTO VIVOLI;TERESA M. CASSINADRI;GRAZIA NACCI;C. MARCHESI;MARCO VINCETI;MARGHERITA BERGOMI;ENRICO ROCCHI;ISABEL PRADA DE CASTRO;MIGUEL TORRES;JOHN MARSDEN","1;1;0.33;0.33;0.33;0.2;0.2;0.2;0.2;0.2;0.14;0.14;0.14;0.14;0.14;0.14;0.14;0.12;0.12;0.12","ADOLFO ZAVARONI;CARLO MARCHESI;C. ROBERT CLONINGER;ENRICA BELLESIA;CARLO MAGGINI;ERMANNO ROSSI;TERESA M. CASSINADRI;ALFONSO IORIO;UMBERTO NIZZOLI;S. GARIBOLDI;C. MARCHESI;PAOLO AMPOLLINI;CLAUDIA CORBELLI","2;1;1;1;1;1;1;1;1;1;1;1;1","ADOLFO ZAVARONI;ERMANNO ROSSI;CARLO MARCHESI;C. ROBERT CLONINGER;CARLO MAGGINI;S. GARIBOLDI;PAOLO AMPOLLINI;TERESA M. CASSINADRI;C. MARCHESI;UMBERTO NIZZOLI;CLAUDIA CORBELLI;ENRICA BELLESIA;ALFONSO IORIO","1;0.33;0.2;0.2;0.2;0.2;0.2;0.14;0.14;0.12;0.12;0.09;0.09","CLAUDIA CORBELLI;DUNCAN STEWART;HENRI MARGARON;ISABEL PRADA DE CASTRO;JOHN MARSDEN;MICHAEL GOSSOP;MIGUEL TORRES;UMBERTO NIZZOLI;C. MARCHESI;ENRICO ROCCHI;GRAZIA NACCI;MARCO VINCETI;MARGHERITA BERGOMI;ROBERTO VIVOLI;TERESA M. CASSINADRI;C. ROBERT CLONINGER;CARLO MAGGINI;CARLO MARCHESI;PAOLO AMPOLLINI;S. GARIBOLDI","50;50;50;50;50;50;50;50;48;48;48;48;48;48;48;36;36;36;36;36","CLAUDIA CORBELLI;UMBERTO NIZZOLI;C. MARCHESI;TERESA M. CASSINADRI;C. ROBERT CLONINGER;CARLO MAGGINI;CARLO MARCHESI;PAOLO AMPOLLINI;S. GARIBOLDI;ADOLFO ZAVARONI;ALFONSO IORIO;ENRICA BELLESIA;ERMANNO ROSSI","50;50;48;48;36;36;36;36;36;5;0;0;0","ADOLFO ZAVARONI;C. MARCHESI;C. ROBERT CLONINGER;CARLO MAGGINI;CARLO MARCHESI;CLAUDIA CORBELLI;PAOLO AMPOLLINI;S. GARIBOLDI;TERESA M. CASSINADRI;UMBERTO NIZZOLI;ALFONSO IORIO;ENRICA BELLESIA;ERMANNO ROSSI","1;1;1;1;1;1;1;1;1;1;0;0;0","MEDICINE;ENGINEERING;PHYSICS;PSYCHOLOGY;ART;BIOLOGY;BUSINESS;COMPUTER SCIENCE;GEOGRAPHY;HISTORY;PHILOSOPHY;SOCIOLOGY","4;2;2;2;1;1;1;1;1;1;1;1","INTERNAL MEDICINE;CARDIOLOGY;CLINICAL PSYCHOLOGY;ENVIRONMENTAL HEALTH;NEUROSCIENCE;PSYCHIATRY;ANCIENT HISTORY;ARCHAEOLOGY;DEMOGRAPHY;DEVELOPMENTAL PSYCHOLOGY;ECONOMIC POLICY;GEOTECHNICAL ENGINEERING;LINGUISTICS;MECHANICAL ENGINEERING;NATURAL LANGUAGE PROCESSING;PALEONTOLOGY;QUANTUM MECHANICS;SOCIAL PSYCHOLOGY;SURGERY","3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","POPULATION;ADDICTION;AMBULATORY;ATRIAL FIBRILLATION;BLOOD PRESSURE;CIRCADIAN RHYTHM;COHORT;COHORT STUDY;CONFIDENCE INTERVAL;CONFOUNDING;CONTEXT (ARCHAEOLOGY);EPIDEMIOLOGY;EUROPEAN UNION;MORTALITY RATE;NEUROCHEMICAL;NEUROLOGY;NEUROSURGERY;NOCTURNAL;PERCEPTION;PERSISTENCE (DISCONTINUITY);PERSONALITY;PHOENICIAN;POWER (PHYSICS);STROKE (ENGINE);TEST (BIOLOGY)","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","AMBULATORY BLOOD PRESSURE;BIG FIVE PERSONALITY TRAITS;DIASTOLE;EXCESS MORTALITY;HEART RATE;ISCHAEMIC STROKE;NEURORADIOLOGY;PERSONALITY DISORDERS;RELIABILITY (SEMICONDUCTOR);STANDARDIZED MORTALITY RATIO","1;1;1;1;1;1;1;1;1;1","HARM AVOIDANCE;NOVELTY SEEKING;PERSONALITY PATHOLOGY","1;1;1","ITALY;PERSONALITY DISORDERS;;FEMALE;HUMANS;MALE;ADULT;FRESH WATER;MORTALITY;OUTCOME ASSESSMENT, HEALTH CARE;SELENIUM;SUBSTANCE-RELATED DISORDERS;WATER POLLUTANTS, CHEMICAL;ADOLESCENT;AGED;AGED, 80 AND OVER;CAUSE OF DEATH;COHORT STUDIES;CROSS-CULTURAL COMPARISON;HEALTH SERVICES RESEARCH","5;4;3;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1","BLOOD PRESSURE AND HYPERTENSION STUDIES;LINGUISTICS AND LANGUAGE EVOLUTION;PERSONALITY DISORDERS AND PSYCHOPATHOLOGY;SCHIZOPHRENIA RESEARCH AND TREATMENT;SELENIUM IN BIOLOGICAL SYSTEMS;STROKE REHABILITATION AND RECOVERY","1;1;1;1;1;1",";EXCESS MORTALITY;ISCHAEMIC STROKE;NEUROCHEMICAL;NEURORADIOLOGY;PERSISTENCE (DISCONTINUITY);PERSONALITY PATHOLOGY;PHOENICIAN;REWARD DEPENDENCE;STANDARDIZED MORTALITY RATIO;STROKE","2;1;1;1;1;1;1;1;1;1;1","ABPM LEVELS;ADDICTION PROFILE;AMBULATORY BLOOD;BILINGUAL PHOENICIAN-ETRUSCAN;BLOOD PRESSURE;DRINKING WATER;DSM-III-R PERSONALITY;ESSENTIAL HYPERTENSION;EUROPEAN INSTRUMENTS;GOLDEN PLATES;HEART RATE;HOURS ABPM;HOURS HT;INORGANIC SELENIUM;ISCHAEMIC STROKE;ITALIAN ADOLESCENTS;ITALY SPAIN;LONG-TERM EXPOSURE;MAUDSLEY ADDICTION;MONITORING HOURS;OUTCOME RESEARCH;PERCEPTIONS QUESTIONNAIRE;PERSONALITY QUESTIONNAIRE;PERSONALITY TRAITS;PHOENICIAN-ETRUSCAN TEXT;PRESSURE MONITORING;PROTHROMBOTIC RISK;QUESTIONNAIRE DIMENSIONS;RATE HOURS;RESEARCH RELIABILITY","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","STANDARD DEVIATION;ASBPM HOURS;HOURS STANDARD;ADBPM HOURS;BLOOD PRESSURE;ABPM HOURS;ADBP MMHG;ASBP MMHG;DIURNAL ASBPM;FEMALES HR;MALE SEX;NOCTURNAL ASBPM;VALUES MMHG;ABPM ABOVEALL;ADBP HOURS;ADBPM DIASTOLIC;AGE LENGTH;AGE LH;AMBULATORY DIASTOLIC;AMBULATORY SYSTOLIC;ASBPM SYSTOLIC;ATHEROSCLEROSIS DEVELOPMENT;AUTONOMIC NERVOUS;AUTONOMIC REGULATOR;BMI ASBP;BMI FEMALES;CHOSE ESSENTIAL;D-ADBPM DIURNAL-ADBP;D-ASBPM DIURNAL;DEVIATION ADBPM","6;5;5;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_AUSLREGGIOEMILIA",2001,6,10.1666666666667,1.16666666666667,0.857142857142857,0.333333333333333,0,0,0.166666666666667,0,3,1,0,2,0.5,0.17,0,0.33,28.17,0.616440562900572,0,1,NA,0.252962515114873,0,0,0,"LUIGI BOIARDI;FABRIZIO CANTINI;CARLO SALVARANI;IGNAZIO OLIVIERI;FABRIZIO SALVI;MARCELLO GOVONI;GIOVANNI CIANCÌO;DAVIDE FILIPPINI;RENATO MALATESTA;FRANCESCO TROTTA;GIOVANNI PAOLAZZI;MARIA I. SCARANO;BARBARA GARAVAGLIA;SERGIO ROVESTI;MAURIZIO PONZ DE LEÒN;BRUNO CASALI;CARMELA DI GREGORIO;FEDERICA INVERNIZZI;VIVIANA GISMONDI;CARLA MOLINOTTI","3;3;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","LUIGI BOIARDI;FABRIZIO CANTINI;CARLO SALVARANI;IGNAZIO OLIVIERI;BARBARA GARAVAGLIA;FEDERICA INVERNIZZI;ALBERTO BURLINA;A. DONADIO;ANGELA PADULA;LAURA NICCOLI;FRANCO TARONI;GIUSEPPE GIORDANO;FABRIZIO SALVI;MARCELLO GOVONI;GIOVANNI CIANCÌO;DAVIDE FILIPPINI;RENATO MALATESTA;FRANCESCO TROTTA;SERGIO ROVESTI;ELISA CALZOLARI","0.3;0.3;0.3;0.3;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.14;0.14;0.14;0.14;0.14;0.14;0.12;0.12","LUIGI BOIARDI;CARLO SALVARANI;A. DONADIO;ROMANO SASSATELLI;SILVIA CANDELA","3;3;1;1;1","LUIGI BOIARDI;CARLO SALVARANI;A. DONADIO;SILVIA CANDELA;ROMANO SASSATELLI","0.3;0.3;0.17;0.12;0.08","CARLO SALVARANI;DAVIDE FILIPPINI;FABRIZIO CANTINI;FABRIZIO SALVI;FRANCESCO TROTTA;GIOVANNI CIANCÌO;IGNAZIO OLIVIERI;LUIGI BOIARDI;MARCELLO GOVONI;RENATO MALATESTA;BRUNO CASALI;DAVIDE NICOLI;ENRICO FARNETTI;GIOVANNI PAOLAZZI;LUIGI MACCHIONI;ANSELMO CAMPAGNA;ELISA CALZOLARI;GIANFRANCO VIVOLI;MARCO VINCETI;MARGHERITA BERGOMI","94;94;94;94;94;94;94;94;94;94;56;56;56;56;56;52;52;52;52;52","LUIGI BOIARDI;SILVIA CANDELA;CARLO SALVARANI;ROMANO SASSATELLI;A. DONADIO","56;52;38;12;11","CARLO SALVARANI;LUIGI BOIARDI;A. DONADIO;ROMANO SASSATELLI;SILVIA CANDELA","2;2;1;1;1","MEDICINE;BIOLOGY;PHYSICS;SOCIOLOGY","6;4;1;1","INTERNAL MEDICINE;GENETICS;GASTROENTEROLOGY;IMMUNOLOGY;SURGERY;CANCER RESEARCH;DEMOGRAPHY;ENDOCRINOLOGY;ENVIRONMENTAL HEALTH;PALEONTOLOGY;PATHOLOGY;PEDIATRICS;THERMODYNAMICS","5;4;3;2;2;1;1;1;1;1;1;1;1","GENE;CONFIDENCE INTERVAL;DISEASE;RHEUMATOLOGY;ADVERSE EFFECT;ANTIGEN;BLOOD PRESSURE;CANCER;CARNITINE;CATS;CELL ADHESION MOLECULE;HOMOGENEOUS;LEAD (GEOLOGY);METABOLISM;POPULATION;PREGNANCY;PRESENTATION (OBSTETRICS);RISK FACTOR;TUMOR NECROSIS FACTOR ALPHA","3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ALLELE;EXON;GENOTYPE;BEHCET'S DISEASE;BETA OXIDATION;COLORECTAL CANCER;FETUS;GENETIC PREDISPOSITION;HEART RATE;HUMAN LEUKOCYTE ANTIGEN;ICAM-1;INFLIXIMAB;INTERCELLULAR ADHESION MOLECULE-1;LEAD EXPOSURE;MUTATION;PHENOTYPE;POLYMERASE CHAIN REACTION;RELATIVE RISK;VASCULITIS","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ADENOMATOUS POLYPOSIS COLI;BRADYCARDIA;CARNITINE O-PALMITOYLTRANSFERASE;FAMILIAL ADENOMATOUS POLYPOSIS;GENE MUTATION;GIANT CELL ARTERITIS;HAPLOTYPE;HLA-C;NEURAL TUBE DEFECT;PENETRANCE","1;1;1;1;1;1;1;1;1;1","BEHCET SYNDROME;HUMANS;MALE;FEMALE;ITALY;ADENOMATOUS POLYPOSIS COLI;ADULT;CONGENITAL ABNORMALITIES;FIBROMA;LIPID METABOLISM, INBORN ERRORS;ACETYLCARNITINE;BRADYCARDIA;CARNITINE O-PALMITOYLTRANSFERASE;GENETIC PREDISPOSITION TO DISEASE;GENOTYPE;HEART ARREST;HISTOCOMPATIBILITY ANTIGENS CLASS I;HLA-B ANTIGENS;INFANT, NEWBORN;INTERCELLULAR ADHESION MOLECULE-1","5;5;5;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2","HEAVY METAL EXPOSURE AND TOXICITY;METABOLISM AND GENETIC DISORDERS;OCULAR DISEASES AND BEHÇET’S SYNDROME;OTITIS MEDIA AND RELAPSING POLYCHONDRITIS;SOFT TISSUE TUMOR CASE STUDIES;VASCULITIS AND RELATED CONDITIONS","1;1;1;1;1;1",";ADENOMATOUS POLYPOSIS COLI;CARNITINE O-PALMITOYLTRANSFERASE;GENETIC PREDISPOSITION;HLA-C;LEAD (GEOLOGY);LINKAGE DISEQUILIBRIUM;NEURAL TUBE DEFECT;PENETRANCE;PRESENTATION (OBSTETRICS)","1;1;1;1;1;1;1;1;1;1","BEHÇETS DISEASE;ACTIVE GIANT;ADENOMATOSIS COLI;ADHESION MOLECULE-;APC GENE;ARTERITIS GCA;BIRTH DEFECTS;CARNITINE PALMITOYLTRANSFERASE;CELL ARTERITIS;ENVIRONMENTAL LEAD;EXTENDED FAMILY;FRI LONGSTANDING;GCA TREATED;GENE MUTATION;GENE POLYMORPHISMS;GIANT CELL;INFLIXIMAB REPORT;INTERCELLULAR ADHESION;ITALIAN PATIENTS;LEAD POLLUTION;LETHAL NEONATAL;LONGSTANDING ACTIVE;MICA ALLELES;MOLECULE- GENE;NEONATAL PRESENTATION;PHENOTYPE-GENOTYPE CORRELATIONS;POPULATION EXPOSED;UNUSUAL APC","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ADVERSE EVENTS;REQUIRING CS;ACTIVE GCA;AGE YS;ALTERNATIVE THERAPEUTIC;ANTI-TNF-ALPHA DEMONSTRATED;BIOPSY PROVEN;CHIMERIC MONOCLONAL;CHRONIC INFLAMMATORY;CLINICAL SIGNSSYMPTOMS;COMPLETE REMISSION;CONCLUSIVE CONSIDERATIONS;CORTICOSTEROIDS CS;CS GCA;CS-RELATED ADVERSE;DEMONSTRATED REMARKABLE;DISEASE DURATION;DURATION YS;ENCOURAGING RESULTS;FM MEDIAN;FOURTH PATIENT;GCA HMETHODSH;GCA SUGGESTING;HBACKGROUNDH TNF-ALPHA;HUMORAL REMISSION;INFLAMED ARTERIES;INFLAMMATORY PROCESS;INFLAMMATORY RESPONSE;INFLIXIMAB INFUSIONS;INFLIXIMAB MGKG","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_AUSLREGGIOEMILIA",2002,10,11,3.1,0.32258064516129,0.4,0.2,0,0.3,0,5,1,1,2,0.5,0.1,0.1,0.2,45.4,0.822930236630988,0.1,0.9,NA,0.434231077640707,0.133333333333333,0.166666666666667,0,"ANTONIO ROMANELLI;LUIGI BOIARDI;FABRIZIO CANTINI;CARLO SALVARANI;BRUNO CASALI;PIERLUIGI MACCHIONI;ENRICO FARNETTI;LUCÌA MANGONE;DAVIDE NICOLI;SILVIA CANDELA;A GANZI;RENKE MAAS;FRANCESCO RAPISARDA;LORENZO MALATINO;GIOVANNI TRIPEPI;PASQUALE FATUZZO;MARCO MASSARI;L. CAMELLINI;ANDRZEJ CHAMIENIA;ERALDO OCCHETTA","2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","ANTONIO ROMANELLI;LUCÌA MANGONE;SILVIA CANDELA;CINZIA CAMPARI;ADRIANO FERRARI;FRANCO GEMIGNANI;A MARBINI;GIOVANNI CIONI;CARLO FUSCO;MARIA FEDERICA BELLANOVA;LUIGI BOIARDI;FABRIZIO CANTINI;CARLO SALVARANI;BRUNO CASALI;PIERLUIGI MACCHIONI;ENRICO FARNETTI;DAVIDE NICOLI;MARCO MASSARI;MARISA BRINI;ANDREW BENEDICT F. CLAUDIO","0.58;0.58;0.58;0.25;0.17;0.17;0.17;0.17;0.17;0.17;0.16;0.16;0.16;0.16;0.16;0.16;0.16;0.12;0.12;0.12","ANTONIO ROMANELLI;LUIGI BOIARDI;CARLO SALVARANI;BRUNO CASALI;PIERLUIGI MACCHIONI;ENRICO FARNETTI;LUCÌA MANGONE;DAVIDE NICOLI;SILVIA CANDELA;A GANZI;GIOVANNI TRIPEPI;MARCO MASSARI;ANDRZEJ CHAMIENIA;ADRIANO FERRARI;MARISA BRINI;GIOVANNI LO SCOCCO;FRANCESCA MALLAMACI;ALICJA DĘBSKA‐ŚLIZIEŃ;C. MENOZZI;STEFANO GUAZZETTI","2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","ANTONIO ROMANELLI;LUCÌA MANGONE;SILVIA CANDELA;ADRIANO FERRARI;LUIGI BOIARDI;CARLO SALVARANI;BRUNO CASALI;PIERLUIGI MACCHIONI;ENRICO FARNETTI;DAVIDE NICOLI;MARCO MASSARI;MARISA BRINI;G. ERMANNO;STEFANO GUAZZETTI;A GANZI;GIOVANNI LO SCOCCO;MARIA GRAZIA CATANOSO;GIANLUIGI BAJOCCHI;WENLAN LIU;C. MENOZZI","0.58;0.58;0.58;0.17;0.16;0.16;0.16;0.16;0.16;0.16;0.12;0.12;0.12;0.11;0.09;0.09;0.09;0.09;0.09;0.08","BRUNO CASALI;CARLO SALVARANI;DAVIDE NICOLI;ENRICO FARNETTI;FABRIZIO CANTINI;LUIGI BOIARDI;PIERLUIGI MACCHIONI;A MARBINI;ADRIANO FERRARI;CARLO FUSCO;FRANCO GEMIGNANI;GIOVANNI CIONI;MARIA FEDERICA BELLANOVA;A. MERIGHI;A. SCARCELLI;FLAVIO MANENTI;FRANCESCO AZZOLINI;G.P. RIGO;GIORGIO BEDOGNI;L. CAMELLINI","111;111;111;111;111;111;111;103;103;103;103;103;103;71;71;71;71;71;71;71","CARLO SALVARANI;ADRIANO FERRARI;STEFANO GUAZZETTI;A GANZI;BRUNO CASALI;DAVIDE NICOLI;ENRICO FARNETTI;GIANLUIGI BAJOCCHI;GIOVANNI LO SCOCCO;LUIGI BOIARDI;MARIA GRAZIA CATANOSO;PIERLUIGI MACCHIONI;WENLAN LIU;G. ERMANNO;MARCO MASSARI;MARISA BRINI;C. MENOZZI;L GUGLIOTTA;ANTONIO ROMANELLI;LUCÌA MANGONE","111;103;71;60;49;49;49;49;49;49;49;49;49;47;47;47;40;15;7;7","CARLO SALVARANI;A GANZI;ADRIANO FERRARI;ANTONIO ROMANELLI;BRUNO CASALI;C. MENOZZI;DAVIDE NICOLI;ENRICO FARNETTI;G. ERMANNO;GIANLUIGI BAJOCCHI;GIOVANNI LO SCOCCO;L GUGLIOTTA;LUCÌA MANGONE;LUIGI BOIARDI;MARCO MASSARI;MARIA GRAZIA CATANOSO;MARISA BRINI;PIERLUIGI MACCHIONI;SILVIA CANDELA;STEFANO GUAZZETTI","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;COMPUTER SCIENCE;ENVIRONMENTAL SCIENCE;MATERIALS SCIENCE;PHILOSOPHY;PHYSICS;SOCIOLOGY","9;4;2;1;1;1;1;1","INTERNAL MEDICINE;GENETICS;PATHOLOGY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;IMMUNOLOGY;MOLECULAR BIOLOGY;SURGERY;ANATOMY;CANCER RESEARCH;CARDIOLOGY;CELL BIOLOGY;COMPUTER SECURITY;EMERGENCY MEDICINE;ENDOCRINOLOGY;ENVIRONMENTAL PROTECTION;FAMILY MEDICINE;HUMANITIES;INTENSIVE CARE MEDICINE;METALLURGY;OPTICS;PALEONTOLOGY;PEDIATRICS;PHYSICAL MEDICINE AND REHABILITATION;PROGRAMMING LANGUAGE;SOCIOECONOMICS;VIROLOGY","5;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","DISEASE;BIOPSY;GENE;ARTERITIS;ASBESTOS;ATRIAL FIBRILLATION;CELL;CELL CULTURE;CEREBRAL PALSY;CLUSTER (SPACECRAFT);CONFIDENCE INTERVAL;DENERVATION;DIALYSIS;ENDOSCOPY;HEMODIALYSIS;IMMUNOHISTOCHEMISTRY;INCIDENCE (GEOMETRY);INGESTION;LEAD (GEOLOGY);MESOTHELIOMA;MULTIVARIATE ANALYSIS;NITRIC OXIDE;ODDS RATIO;OUTBREAK;POLYCYTHEMIA VERA;POPULATION;QRS COMPLEX;RISK ASSESSMENT;SPASTICITY;STEM CELL;SUDDEN DEATH;TANZANIA;TRIAGE;TRYPANOSOMIASIS;TUNICA VAGINALIS;VACCINATION;VIRUS","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","AFRICAN TRYPANOSOMIASIS;ALLELE;BEHCET'S DISEASE;BLOT;CD34;CELL ADHESION;ESOPHAGOGASTRODUODENOSCOPY;ESSENTIAL THROMBOCYTHEMIA;EXON;FRAMINGHAM RISK SCORE;GENE ISOFORM;GENOTYPE;HAEMATOPOIESIS;INTRON;MESSENGER RNA;MUSCLE BIOPSY;NITRIC OXIDE SYNTHASE;PARVOVIRUS;SINUS RHYTHM;TRANSCRIPTION FACTOR;UNIVARIATE ANALYSIS;VASCULITIS","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ALLELE FREQUENCY;ENOS;GIANT CELL ARTERITIS;MEGAKARYOCYTE;NEURAL CELL ADHESION MOLECULE;POLYARTERITIS NODOSA;POLYMORPHISM (COMPUTER SCIENCE);SYSTEMIC VASCULITIS","1;1;1;1;1;1;1;1","HUMANS;MALE;FEMALE;ADULT;ITALY;MIDDLE AGED;BURNS, CHEMICAL;CEREBRAL PALSY;THROMBOCYTOPENIA;ADOLESCENT;AGED;BEHCET SYNDROME;DNA-BINDING PROTEINS;GASTRECTOMY;MESOTHELIOMA;MUSCLE FIBERS, FAST-TWITCH;MUSCLE FIBERS, SLOW-TWITCH;MUSCLE, SKELETAL;NUCLEAR PROTEINS;OCCUPATIONAL DISEASES","9;8;7;6;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3","CEREBRAL PALSY AND MOVEMENT DISORDERS;DIALYSIS AND RENAL DISEASE MANAGEMENT;ECG MONITORING AND ANALYSIS;ESOPHAGEAL AND GI PATHOLOGY;HEAVY METAL EXPOSURE AND TOXICITY;MYELOPROLIFERATIVE NEOPLASMS: DIAGNOSIS AND TREATMENT;OCCUPATIONAL AND ENVIRONMENTAL LUNG DISEASES;OCULAR DISEASES AND BEHÇET’S SYNDROME;PARVOVIRUS B19 INFECTION STUDIES;TRYPANOSOMA SPECIES RESEARCH AND IMPLICATIONS","1;1;1;1;1;1;1;1;1;1",";ARTERITIS;ESOPHAGOGASTRODUODENOSCOPY;LEAD (GEOLOGY);MEGAKARYOCYTOPOIESIS;POLYARTERITIS NODOSA;POLYMYALGIA RHEUMATICA;SUDDEN DEATH;SYSTEMIC VASCULITIS;TRIAGE;TUNICA VAGINALIS;UNIVARIATE ANALYSIS","4;1;1;1;1;1;1;1;1;1;1;1","AFRICAN SLEEPING;ASBESTOS EXPOSURE;BEHÇETS DISEASE;BLOOD LEAD;CARDIOVERTER DEFIBRILLATORS;CASECONTROL STUDY;CAUSTIC INGESTION;CELL ARTERITIS;CEREBRAL PALSY;CHAIN REACTION;CHAMBER CARDIOVERTER;DIALYSIS CARDIOVASCULAR;DISCRIMINATING ALGORITHMS;DISCRIMINATION SUDDEN;EMILIA-ROMAGNA INCIDENCE;ENDOSCOPIC PARAMETERS;ENDOTHELIAL NITRIC;EUROPEAN TRAVELERS;FACTOR-ERYTHROID NF-E;GENE POLYMORPHISMS;GIANT CELL;III T-T;IMMUNOHISTOCHEMICAL STUDY;ITALIAN POLYCENTRIC;LEAD REFERENCE;MALIGNANT MEGAKARYOCYTOPOIESIS;MALIGNANT MESOTHELIOMA;MORPHOLOGY DISCRIMINATION;MUSCLE BIOPSY;NF-E EXPRESSION","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","TAB SPECIMENS;AGE-MATCHED CONTROLS;BIOPSY-PROVEN GCA;NUCLEOTIDE POSITIONS;HISTOLOGIC EVIDENCE;AORTA SPECIMENS;ATHEROSCLEROTIC DISEASE;CONSECUTIVE PATIENTS;MAYO CLINIC;PURE PMR;AGE-MATCHED PATIENTS;DNA EXTRACTION;FETAL AORTA;GENOME CODING;NEGATIVE CONTROL;NESTED PCR;SPECIMENS OBTAINED;TAB TISSUE;AMPLIFICATION ROUND;AMPLIFICATION ROUNDS;BYSTANDER COMMONLY;CAROTID ARTERY;CLINIC STUDY;ELDERLY PATIENTS;ELDERLY PEOPLE;EMILIA HOSPITAL;FALSE-POSITIVE RESULTS;FORWARD PRIMER;FRESH FROZEN;FRESH SAMPLES","7;6;6;6;5;4;4;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2",1,0.1,6,2,0,0,0,0,0,0,2,2,0,0,0,0,0,0,0,0,0,0,0,18,18,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_AUSLREGGIOEMILIA",2003,10,9.4,3.5,0.285714285714286,0.4,0.3,0.1,0.4,0,5,1,2,2,0.5,0.1,0.2,0.2,31.1,0.587591780386792,0.2,0.8,NA,0.278535389829218,0.228571428571429,0.166666666666667,0,"ALBERTO CAVAZZA;GIULIO ROSSI;PAMELA SIGHINOLFI;RICCARDO VALLI;FEDERICA BERTOLINI;GABRIELE LUPPI;FRANCESCO RIVASI;LUISA LOSI;LUCIA LONGO;VINCENZO DE GIORGI;D SESTI;FILIPPO DE MARINIS;MARIAELENA GAMBINI;GRAZIELLA BRUNO;ALBERTA BETTACCHI;ROBERTO SABBATINI;ALBERTO MATTEELLI;SYLVIE ZUCCA;M. DOTTORI;GIOVANNI GUARALDI","3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","ALBERTO CAVAZZA;GIULIO ROSSI;PAMELA SIGHINOLFI;RICCARDO VALLI;FEDERICA BERTOLINI;GABRIELE LUPPI;FRANCESCO RIVASI;LUISA LOSI;GRAZIELLA BRUNO;M. DOTTORI;S. PERINI;C COSCELLI;L BEDOGNI;VALERIA MANICARDI;ROSSELLA RODOLFI;FERDINANDO LUBERTO;FULVIO FERRI;M. LIGABUE;ALBERTO MATTEELLI;GIOVANNI GUARALDI","0.35;0.35;0.25;0.25;0.25;0.25;0.25;0.25;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.2;0.11;0.11","ALBERTO CAVAZZA;GIULIO ROSSI;PAMELA SIGHINOLFI;RICCARDO VALLI;FEDERICA BERTOLINI;GABRIELE LUPPI;FRANCESCO RIVASI;LUISA LOSI;FILIPPO DE MARINIS;VALTER TORRI;G. MAGNANI;CARLO E. NEUMAIER;GIOVANNI LO SCOCCO;NICOLA FACCIOLONGO;L. RICCI;ANDREA ARDIZZONI;C. BONI;ANNALISA BARONI;E. CASALI;L. DELL’ANNA","3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","ALBERTO CAVAZZA;GIULIO ROSSI;PAMELA SIGHINOLFI;RICCARDO VALLI;FEDERICA BERTOLINI;GABRIELE LUPPI;FRANCESCO RIVASI;LUISA LOSI;VALERIA MANICARDI;FULVIO FERRI;G. MAGNANI;NICOLA FACCIOLONGO;ANNALISA BARONI;MANUELA BEDESCHI;FILIPPO DE MARINIS;VALTER TORRI;CARLO E. NEUMAIER;ANDREA ARDIZZONI;C. BONI;E. CASALI","0.35;0.35;0.25;0.25;0.25;0.25;0.25;0.25;0.2;0.2;0.11;0.1;0.1;0.1;0.09;0.09;0.09;0.09;0.09;0.09","ALBERTO CAVAZZA;GIULIO ROSSI;FEDERICA BERTOLINI;FRANCESCO RIVASI;GABRIELE LUPPI;LUISA LOSI;PAMELA SIGHINOLFI;RICCARDO VALLI;ALBERTO ROSA BIAN;ANGELO SIDONI;ANNA MARIA MOSCONI;BRUNO MAZZOCCHI;CARMELINA RODINÒ;E BUCCIARELLI;GIANCARLO BISAGNI;GUIDO BELLEZZA;LORENZA PISTOLA;MARIANTONIETTA COLOZZA;MAURIZIO TONATO;ROBERTA CHERUBINI","151;151;96;96;96;96;96;96;95;95;95;95;95;95;95;95;95;95;95;95","ALBERTO CAVAZZA;FEDERICA BERTOLINI;FRANCESCO RIVASI;GABRIELE LUPPI;LUISA LOSI;PAMELA SIGHINOLFI;RICCARDO VALLI;GIANCARLO BISAGNI;NICOLA FACCIOLONGO;GIULIO ROSSI;GIOVANNI LO SCOCCO;ANNALISA BARONI;MANUELA BEDESCHI;G. MAGNANI;ALBERTO ZANIBONI;ANDREA ARDIZZONI;C. BONI;CARLO E. NEUMAIER;FAUSTO MERIGGI;FILIPPO DE MARINIS","151;96;96;96;96;96;96;95;55;47;23;19;19;10;8;8;8;8;8;8","ALBERTO CAVAZZA;FEDERICA BERTOLINI;FRANCESCO RIVASI;GABRIELE LUPPI;LUISA LOSI;PAMELA SIGHINOLFI;RICCARDO VALLI;ALBERTO ZANIBONI;ANDREA ARDIZZONI;ANNALISA BARONI;C. BONI;CARLO E. NEUMAIER;FAUSTO MERIGGI;FILIPPO DE MARINIS;FULVIO FERRI;G. MAGNANI;GIANCARLO BISAGNI;GIOVANNI LO SCOCCO;GIULIO ROSSI;L PORTALONE","3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;PHYSICS;ART;CHEMISTRY;COMPUTER SCIENCE;GEOGRAPHY;SOCIOLOGY","11;5;3;1;1;1;1;1","INTERNAL MEDICINE;PATHOLOGY;GASTROENTEROLOGY;CANCER RESEARCH;CELL BIOLOGY;ENVIRONMENTAL HEALTH;GENETICS;IMMUNOLOGY;ONCOLOGY;PALEONTOLOGY;SURGERY;THERMODYNAMICS;AGRONOMY;ANIMAL SCIENCE;ARCHAEOLOGY;ASTRONOMY;DEMOGRAPHY;DERMATOLOGY;ENDOCRINOLOGY;FAMILY MEDICINE;HUMANITIES;INTENSIVE CARE MEDICINE;ORGANIC CHEMISTRY;PEDIATRICS;PROGRAMMING LANGUAGE;SOCIOECONOMICS;UROLOGY;VETERINARY MEDICINE","6;5;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","IMMUNOHISTOCHEMISTRY;APPENDIX;CHEMOTHERAPY;INFILTRATION (HVAC);MITOSIS;NEUROENDOCRINE TUMORS;STEM CELL;AIR POLLUTION;ALLERGY;ALTERNATIVE MEDICINE;ASTHMA;CANCER;CARCINOMA;CLINICAL SIGNIFICANCE;CLUSTER (SPACECRAFT);DIABETES MELLITUS;EPIDEMIOLOGY;EVENING;FAMILY HISTORY;FORAGE;GRAZING;HAY;IMMIGRATION;LESION;LUNG;LUNG CANCER;MALARIA;MELANOMA;MORNING;MULTIVARIATE ANALYSIS;PASSIVE SMOKING;PROPORTIONAL HAZARDS MODEL;REFERRAL;REGIMEN;RESPIRATORY SYSTEM;SURVIVAL RATE;TOXICITY;VEGF RECEPTORS","3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CD34;IMMUNOSTAINING;MITOTIC INDEX;ATOPY;BREAST CANCER;CISPLATIN;FARMER'S LUNG;HAY FEVER;LOG-RANK TEST;PACLITAXEL;SMALL-CELL CARCINOMA;TRADITIONAL CHINESE MEDICINE;UNIVARIATE ANALYSIS;VASCULAR ENDOTHELIAL GROWTH FACTOR","2;2;2;1;1;1;1;1;1;1;1;1;1;1","CARBOPLATIN;CD117;EPIRUBICIN;IFOSFAMIDE;PHLEGM;SMALL CELL LUNG CARCINOMA","1;1;1;1;1;1","HUMANS;FEMALE;LUNG NEOPLASMS;ADULT;ITALY;MALE;AIR POLLUTION;MIDDLE AGED;AGED;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;ASTHMA;CARBOPLATIN;CARCINOMA, SMALL CELL;DIABETES MELLITUS;FARMER'S LUNG;MALARIA;APPENDICEAL NEOPLASMS;BREAST NEOPLASMS;CARCINOMA, DUCTAL, BREAST;CARCINOMA, NON-SMALL-CELL LUNG","9;7;7;6;6;6;5;5;4;4;4;4;4;4;4;4;3;3;3;3","INTRAPERITONEAL AND APPENDICEAL MALIGNANCIES;AIR QUALITY AND HEALTH IMPACTS;ANGIOGENESIS AND VEGF IN CANCER;CUTANEOUS MELANOMA DETECTION AND MANAGEMENT;LUNG CANCER TREATMENTS AND MUTATIONS;MALARIA RESEARCH AND CONTROL;NEUROENDOCRINE TUMOR RESEARCH ADVANCES;OCCUPATIONAL EXPOSURE AND ASTHMA;URBAN PLANNING AND VALUATION","2;1;1;1;1;1;1;1;1",";IMMUNOSTAINING;INFILTRATION (HVAC);MITOTIC INDEX;ATOPY;CARBOPLATIN;CD117;CLINICAL SIGNIFICANCE;EPIRUBICIN;FARMER'S LUNG;HAY FEVER;LOG-RANK TEST;MESNA;PASSIVE SMOKING;PHLEGM;REGIMEN;UNIVARIATE ANALYSIS","3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","INCIDENTAL NEUROENDOCRINE;INFILTRATION PREDICT;MESOAPPENDIX INFILTRATION;NEUROENDOCRINE TUMORS;REGGIO EMILIA;WORSE PROGNOSIS;AIR POLLUTION;AIRE STUDY;ALLERGIC ALVEOLITIS;ALVEOLITIS FARMERS;ASTHMATIC CHILDREN;BASED PREVENTIVE;BREAST CANCER;CANCER PATIENTS;CATTLE BREEDERS;CELL CARCINOMAS;CHILDREN HINTS;CHINESE IMMIGRANTS;DIAGNOSTIC OUTCOME;EMILIA ITALY;ENDOTHELIAL GROWTH;EXTRINSIC ALLERGIC;FARMERS LUNG;FEASIBILITY STUDY;GROWTH FACTOR;II BREAST;II STUDY;IIIBIV NON-SMALL-CELL;ILLEGAL CHINESE;IMMUNOHISTOCHEMICAL STUDY","2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MONTHS RANGE;APPENDICEAL NEUROENDOCRINE;NEUROENDOCRINE TUMORS;RESPONSE RATE;SIMPLE APPENDECTOMY;STAGE IIIB-IV;ABSENT MITOTIC;ACTIVE SAFE;ACUTE RESPIRATORY;ADVANCED NSCLC;BIOLOGIC SIGNIFICANCE;CANCER NSCLC;CHINESE IMMIGRANTS;CLOSELY INTERMINGLED;COMPLETE REMISSIONS;CYTOPLASMIC DENDRITIC;DENDRITIC PROCESSES;DISCLOSED POSITIVE;EXCELLENT PROGNOSIS;EXCEPTIONALLY MILD;FOUND INCIDENTALLY;GASTROINTESTINAL SITES;GRADE III;HEMATOLOGIC TOXICITY;HOURS IFOSFAMIDE;IIIB-IV NON-SMALL-CELL;IIIB-IV NSCLC;ILLEGAL CHINESE;ILLEGAL IMMIGRATIONS;IMMIGRANTS TRAVELED","3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",2,0.2,7.5,2.5,0,0,0,0,0,0,2.5,4,0,0,0,0,0,0,0,0,0,0,0,31.5,31.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_AUSLREGGIOEMILIA",2004,20,10.8,1.85,0.540540540540541,0.3,0.2,0.2,0.05,1,10,7,2,0,0.5,0.35,0.1,0,47.25,1.00417368473199,0.35,0.85,NA,0.473936817208041,0.233766233766234,0.166666666666667,0,"VINCENZO DE GIORGI;ELISA PERFETTI;R. BOIARDI;GIOVANNI LO SCOCCO;ROBERTO BETTI;ANDREA MAURICHI;UGO BOTTONI;PIERFRANCO SOMA;IGNAZIO STANGANELLI;D. DIOGUARDI;DOMENICO PALLI;CATERINA CATRICALÀ;M.V. BALDELLI;MASSIMILIANO SCALVENZI;PAOLO CARLI;P. MULAS;C. ORLANDI;ALBERTO CAVAZZA;ANTONIO PONTI;GIANLORENZO IMBERTI","3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2","GADDOMARIA GRASSI;R. BOIARDI;M.V. BALDELLI;P. FERRARI;FRANCESCA MASINO;FABIO CHINNICI;ANDREA ANTONELLI;ROSSANA STANCHI;WILFRIED STEFFENS;G. ROSSI;AMEDEO ORLANDINI;ALBERTO CAVAZZA;GIULIO ROSSI;ALESSANDRO ULRICI;SAMANTHA A. BIANCHI;PIETRO FERRARI;CINZIA CAMPARI;ERIKA BASILE;GIANCARLO FRANCHINI;M. HUNSCOTT BIANCHI","1;0.73;0.73;0.53;0.53;0.53;0.53;0.5;0.5;0.5;0.5;0.24;0.24;0.2;0.2;0.2;0.2;0.2;0.2;0.2","R. BOIARDI;GIOVANNI LO SCOCCO;ALBERTO CAVAZZA;P. FERRARI;C. MARCHESI;FRANCESCA MASINO;ANDREA ANTONELLI;MARCO CIOTTI;ALESSANDRO ULRICI;PAOLO AVANZINI;MAURO SILINGARDI;LUIGI BOIARDI;G. ROSSI;CARLO SALVARANI;CARTESIO FAVALLI;STEFANO GUAZZETTI;PIETRO FERRARI;M BRANCA;M. IERAN;ERIKA BASILE","3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","GADDOMARIA GRASSI;R. BOIARDI;P. FERRARI;FRANCESCA MASINO;ANDREA ANTONELLI;G. ROSSI;AMEDEO ORLANDINI;ALBERTO CAVAZZA;ALESSANDRO ULRICI;PIETRO FERRARI;ERIKA BASILE;GIANCARLO FRANCHINI;GIOVANNI LO SCOCCO;MARCO CIOTTI;CARTESIO FAVALLI;M BRANCA;MARIA TERESA CASSINADRI;LUCIA MONICI;ANTONIO POETA;STEFANO GUAZZETTI","1;0.73;0.53;0.53;0.53;0.5;0.5;0.24;0.2;0.2;0.2;0.2;0.18;0.17;0.17;0.17;0.17;0.17;0.14;0.12","A.W.A. LENSING;ANDREA PICCIOLI;ANNA FALANGA;ANTONIO GIROLAMI;G.L. SCANNAPIECO;GB AMBROSIO;M. CIGOLINI;M. IERAN;MANUEL MONRÉAL;MARTIN H. PRINS;PAOLO PRANDONI;ALBERTO CAVAZZA;GIULIO ROSSI;ALESSANDRO MARCHIONI;BRUNO MURER;GIOVANNI CAPITANIO;LORENA LOSI;MARIO MIGALDI;PAMELA NATALI;ÉLISABETH BRAMBILLA","315;315;315;315;315;315;315;315;315;315;315;212;212;176;176;176;176;176;176;176","M. IERAN;ALBERTO CAVAZZA;GIOVANNI LO SCOCCO;ANDREA ANTONELLI;FRANCESCA MASINO;STEFANO GUAZZETTI;ANGELO GHIRARDUZZI;CARLO SALVARANI;IDO IORI;LUIGI BOIARDI;MAURO SILINGARDI;P ACCARDO;ALESSANDRO ULRICI;GIANCARLO FRANCHINI;MASSIMILIANO PACI;LUCIA MONICI;MARIA TERESA CASSINADRI;R. BOIARDI;C. MARCHESI;ERIKA BASILE","315;176;104;96;96;83;45;45;45;45;45;45;39;39;36;34;34;20;15;11","GIOVANNI LO SCOCCO;R. BOIARDI;ANDREA ANTONELLI;C. MARCHESI;FRANCESCA MASINO;P. FERRARI;ALBERTO CAVAZZA;ALESSANDRO BONINI;ALESSANDRO ULRICI;ANGELO GHIRARDUZZI;ANTONIO POETA;CARLO LABERTO MORI;CARLO SALVARANI;ERIKA BASILE;G. ROSSI;GADDOMARIA GRASSI;GIANCARLO FRANCHINI;IDO IORI;LUCIA MONICI;LUIGI BOIARDI","3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;CHEMISTRY;COMPUTER SCIENCE;ART;MATHEMATICS;POLITICAL SCIENCE;BUSINESS;ECONOMICS;ENGINEERING;GEOLOGY;PHILOSOPHY;PSYCHOLOGY;SOCIOLOGY","18;4;3;3;2;2;2;1;1;1;1;1;1;1","INTERNAL MEDICINE;PATHOLOGY;SURGERY;CANCER RESEARCH;ENVIRONMENTAL HEALTH;FAMILY MEDICINE;DERMATOLOGY;FOOD SCIENCE;GASTROENTEROLOGY;NURSING;PALEONTOLOGY;CHROMATOGRAPHY;GERONTOLOGY;GYNECOLOGY;LAW;ORGANIC CHEMISTRY;PHYSICAL MEDICINE AND REHABILITATION;PHYSICAL THERAPY;ALGORITHM;ANATOMY;ANTHROPOLOGY;ARTIFICIAL INTELLIGENCE;BUSINESS ADMINISTRATION;COMBINATORICS;COMPUTER SECURITY;ECOLOGY;EPISTEMOLOGY;GENERAL SURGERY;GENETICS;HORTICULTURE;HUMANITIES;INTENSIVE CARE MEDICINE;LIBRARY SCIENCE;MANAGEMENT;MEDICAL EDUCATION;MICROBIOLOGY;OBSTETRICS;OCEANOGRAPHY;ONCOLOGY;OPERATING SYSTEM;PSYCHIATRY;STATISTICS;TRADITIONAL MEDICINE;VIROLOGY;WASTE MANAGEMENT","12;8;5;4;4;4;3;3;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CANCER;POPULATION;DISEASE;MELANOMA;CATALYSIS;CONFIDENCE INTERVAL;FRUCTOSE;HIGH-PERFORMANCE LIQUID CHROMATOGRAPHY;IMMUNOHISTOCHEMISTRY;LUNG;NURSING HOMES;PSYCHOLOGICAL INTERVENTION;RANDOMIZED CONTROLLED TRIAL;SUGAR;THROMBOSIS;ABSORBANCE;ACCREDITATION;ACTIVITIES OF DAILY LIVING;ALTERNATIVE MEDICINE;AREA UNDER THE CURVE;ATYPIA;AUDIT;BACTERIA;BASELINE (SEA);BODY MASS INDEX;CHEMOTHERAPY;CLINICAL TRIAL;COGNITION;COHORT;COHORT STUDY;CONE (FORMAL LANGUAGES);CONTAMINATION;CONTEXT (ARCHAEOLOGY);DISCRIMINATIVE MODEL;ENDOSCOPY;EPITHELIUM;FURAN;HOMOGENEOUS;HUMAN PAPILLOMAVIRUS;INOCULATION;LESION;LOCALE (COMPUTER SOFTWARE);MALNUTRITION;MEDLINE;MUCIN;NODULE (GEOLOGY);NORMATIVE;OBESITY;OBSERVATIONAL STUDY;OCCUPATIONAL THERAPY;ODDS RATIO;PREDICTIVE VALUE OF TESTS;PRINCIPAL COMPONENT ANALYSIS;PROSPECTIVE COHORT STUDY;PSYCHOMOTOR AGITATION;QUALITY (PHILOSOPHY);RECEIVER OPERATING CHARACTERISTIC;REFERRAL;REGIMEN;REHABILITATION;RESEARCH OBJECT;RISK ASSESSMENT;RISK FACTOR;RISK OF MORTALITY;SCORING SYSTEM;SEROTYPE;SPOUSE;STAGE (STRATIGRAPHY);TEST (BIOLOGY);ULTRASTRUCTURE;VIRUS;WATER TREATMENT","5;4;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","5-HYDROXYMETHYLFURFURAL;BREAST CANCER;FURFURAL;NODULAR MELANOMA;ADENOCARCINOMA;BARTHEL INDEX;BEHCET'S DISEASE;BRIX;CERVICAL CANCER;CYTARABINE;CYTOKERATIN;FACTOR V;FRAMINGHAM RISK SCORE;GOBLET CELL;INDUCTION CHEMOTHERAPY;LISTERIA MONOCYTOGENES;MINIMUM DATA SET;MITOXANTRONE;MULTICENTER STUDY;OCCULT;PSYCHOMOTOR LEARNING;STOMACH CANCER;SUPERFICIAL SPREADING MELANOMA;THROMBOPHILIA;TRIHALOMETHANE;UPPER GASTROINTESTINAL BLEEDING;VENOUS THROMBOEMBOLISM;VENOUS THROMBOSIS;WEIGHT LOSS","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BREAST DISEASE;CERVICAL INTRAEPITHELIAL NEOPLASIA;DUCTAL CARCINOMA;FACTOR V LEIDEN;HYDROXYMETHYLFURFURAL;IDARUBICIN;MAMMOGRAPHY;SIGNET RING CELL","1;1;1;1;1;1;1;1","HUMANS;FEMALE;MALE;ITALY;AGED;MIDDLE AGED;ADULT;MELANOMA;SKIN NEOPLASMS;BREAST NEOPLASMS;MASS SCREENING;NEOPLASMS;;AGED, 80 AND OVER;VENOUS THROMBOSIS;ACCREDITATION;DERMATITIS, ALLERGIC CONTACT;LUNG DISEASES;MENTAL HEALTH SERVICES;NUTRITION DISORDERS","15;13;11;10;9;9;8;7;7;6;6;6;5;5;5;4;4;4;4;4","CUTANEOUS MELANOMA DETECTION AND MANAGEMENT;FERMENTATION AND SENSORY ANALYSIS;ACUTE MYELOID LEUKEMIA RESEARCH;BLOOD COAGULATION AND THROMBOSIS MECHANISMS;BREAST CANCER TREATMENT STUDIES;CONGENITAL DIAPHRAGMATIC HERNIA STUDIES;CONTACT DERMATITIS AND ALLERGIES;DEMENTIA AND COGNITIVE IMPAIRMENT RESEARCH;GASTROINTESTINAL BLEEDING DIAGNOSIS AND TREATMENT;GERIATRIC CARE AND NURSING HOMES;GLOBAL CANCER INCIDENCE AND SCREENING;HEALTHCARE QUALITY AND MANAGEMENT;LISTERIA MONOCYTOGENES IN FOOD SAFETY;METASTASIS AND CARCINOMA CASE STUDIES;NUTRITION AND HEALTH IN AGING;VENOUS THROMBOEMBOLISM DIAGNOSIS AND MANAGEMENT;WATER TREATMENT AND DISINFECTION","3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";5-HYDROXYMETHYLFURFURAL;NODULAR MELANOMA;ABSORBANCE;ATYPIA;BARTHEL INDEX;BASELINE (SEA);BREAST CANCER SCREENING;BREAST DISEASE;BRIX;DISCRIMINATIVE MODEL;FACTOR V;FURAN;GOBLET CELL;HYDROXYMETHYLFURFURAL;IDARUBICIN;INDUCTION CHEMOTHERAPY;LOCALE (COMPUTER SOFTWARE);MINIMUM DATA SET;MITOXANTRONE","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CARE NURSING;ITALIAN PATIENTS;NODULAR-TYPE MELANOMA;NURSING HOME;SUBACUTE CARE;SUPERFICIAL SPREADING;ACCREDITATION CLASSIFICATION;ACETO BALSAMICO;ACIDITY SUGAR;ALLERGIC CONTACT;AML PATIENTS;ASSESSMENT CRITERIA;AUTANSUPSUP SPRAY;BALSAMIC VINEGAR;BALSAMICO TRADIZIONALE;BEHÇETS DISEASE;BENIGN BREAST;BREAST CANCER;BREAST DISEASES;BREAST LESIONS;CANCER MORTALITY;CANCER SCREENING;CHEMICAL MODIFICATION;CLINICAL TRIAL;CLINICOPATHOLOGIC IMMUNOHISTOCHEMICAL;COHORT STUDY;COLLOID CARCINOMAS;COMPOUND CONCENTRATIONS;CONTACT DERMATITIS;CUTANEOUS MELANOMAS","2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BD PATIENTS;GENE GA;PROTHROMBIN GENE;GA MUTATION;ITALIAN BD;LEIDEN POLYMORPHISMS;VASCULAR LESIONS;ALLELE-SPECIFIC RESTRICTION;BEHÇETS DISEASE;BLOOD DONORS;CARRIAGE RATES;CHAIN REACTION;CLINICAL DIFFERENCES;COMMON LESIONS;CONSECUTIVE ITALIAN;DEEP VEIN;DISEASE BDINCLUDED;ENZYME TECHNIQUES;GA LEIDEN;GA POLYMORPHISMS;GA POLYMORPHISMSVASCULAR;GENOTYPE FREQUENCIES;HEALTHY CONTROLS;HEALTHY ITALIAN;INTERNATIONAL STUDY;ITALIAN BLOOD;ITALIAN PATIENTS;LEIDEN MUTATION;OCULAR DISEASE;OCULAR INVOLVEMENT","6;6;6;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",3,0.15,6,2,0,0,0,0,0,0,2.5,3.5,0,0,0,0,1,0,0,0,0,0.5,0.5,65,66,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_AUSLREGGIOEMILIA",2005,22,10.2727272727273,1.45454545454545,0.6875,0.318181818181818,0.181818181818182,0.181818181818182,0.272727272727273,1,10,3,2,5,0.45,0.14,0.09,0.23,38.68,0.730621344187609,0.318181818181818,0.863636363636364,NA,0.433003822772455,0.240740740740741,0.133333333333333,0.1875,"ANNA CANDONI;GABRIELE TONNI;LUIGI GUGLIOTTA;MONICA BOCCHIA;GIANCARLA PRICOLO;FRANCESCA PERANDIN;ELIANA ZUFFA;PAOLO AVANZINI;MICHELA RONDONI;CARLO MAGGINI;DANIELA DAMIANI;EMANUELA OTTAVIANI;M FIACCHINI;GIUSEPPE VISANI;L. RICCI;MICHELE MALAGOLA;DONATELLA RASPADORI;ADRIANA CALDERARO;MAURIZIO CASTELLI;PIER PAOLO PICCALUGA","3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","GABRIELE TONNI;ELENA DEGOLI;CARLO MAGGINI;GABRIELE CENTINI;ALESSANDRO VENTURA;ANDREA RABALLO;L. ROSIGNOLI;FRANCESCA PERANDIN;L. RICCI;ADRIANA CALDERARO;GIOVANNA PICCOLO;G. DETTORI;N. MANCA;C. CHEZZI;C. DEFELICE;MILTON CARLOS FARINA;MARCO POLETTI;G VEZZOSI;G MORINI;BRUNO FERRARI","1.08;1;0.67;0.58;0.5;0.5;0.33;0.25;0.25;0.25;0.25;0.25;0.25;0.25;0.25;0.25;0.25;0.25;0.25;0.25","GABRIELE TONNI;LUIGI GUGLIOTTA;PAOLO AVANZINI;L. RICCI;ADRIANA CALDERARO;N. MANCA;ALESSANDRO BONINI;C. CHEZZI;S. LEONI;DENIS SACCANI;G. MAGNANI;GIOVANNI TORTORELLA;LIVIA GARAVELLI;MAURO SILINGARDI;ANTONIO ROMANELLI;CARLO SALVARANI;C. ZUELLI;ALESSANDRO VENTURA;ELENA DEGOLI;MARCO POLETTI","3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1","GABRIELE TONNI;ELENA DEGOLI;ALESSANDRO VENTURA;ANDREA RABALLO;L. RICCI;ADRIANA CALDERARO;N. MANCA;C. CHEZZI;MARCO POLETTI;MAURO SILINGARDI;ANGELA GERHARD;PIETRO RAGNI;GIOVANNI MALFERRARI;S. LEONI;CARLO SALVARANI;LUIGI MACCHIONI;ANDREA LORETO;S. SPATAFORA;FERDINANDO LUBERTO;MIRCO LUSUARDI","1.08;1;0.5;0.5;0.25;0.25;0.25;0.25;0.25;0.17;0.17;0.17;0.17;0.14;0.14;0.14;0.14;0.14;0.14;0.14","CARLO MAGGINI;A.M.A. LACHMEIJER;ANCA MANNHARDT;ANDREA BIER;ANDREAS DUFKE;ANITA RAUCH;BARUCH YERUSHALMI;BOYAN DIMITROV;CHRISTIAN T. THIEL;CHRISTIANE ZWEIER;CORNELIA KRAUS;FRITS A. BEEMER;GABRIELE GILLESSEN‐KAESBACH;HEIDE SEIDEL;HELEN V. FIRTH;HELENA KÄÄRIÄINEN;I. KAREN TEMPLE;IAN D. KRANTZ;JÜRGEN MÜCKE;KOENRAAD DEVRIENDT","155;140;140;140;140;140;140;140;140;140;140;140;140;140;140;140;140;140;140;140","LIVIA GARAVELLI;DENIS SACCANI;MAURO SILINGARDI;ANGELA GERHARD;GABRIELE TONNI;ANDREA RABALLO;GIOVANNI MALFERRARI;G. MAGNANI;ALESSANDRO BONINI;LUIGI GUGLIOTTA;PAOLO AVANZINI;PIETRO RAGNI;MIRCO LUSUARDI;FERDINANDO LUBERTO;LUCA CIMINO;ALESSANDRO VENTURA;CARLO SALVARANI;LUIGI MACCHIONI;A. CARRIERO;ALINE GONÇALVES MORA","140;137;120;104;60;51;49;47;44;44;44;44;39;11;3;2;2;2;0;0","GABRIELE TONNI;ALESSANDRO BONINI;LUIGI GUGLIOTTA;PAOLO AVANZINI;ALESSANDRO VENTURA;ANDREA RABALLO;ANGELA GERHARD;CARLO SALVARANI;DENIS SACCANI;FERDINANDO LUBERTO;G. MAGNANI;GIOVANNI MALFERRARI;LIVIA GARAVELLI;LUCA CIMINO;LUIGI MACCHIONI;MAURO SILINGARDI;MIRCO LUSUARDI;PIETRO RAGNI;A. CARRIERO;ALINE GONÇALVES MORA","3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;0;0","MEDICINE;BIOLOGY;BUSINESS;PHYSICS;PSYCHOLOGY;COMPUTER SCIENCE;ENGINEERING;MATERIALS SCIENCE;PHILOSOPHY;ART;CHEMISTRY;ECONOMICS;MATHEMATICS;POLITICAL SCIENCE","22;4;3;3;3;2;2;2;2;1;1;1;1;1","INTERNAL MEDICINE;SURGERY;ENVIRONMENTAL HEALTH;RADIOLOGY;GASTROENTEROLOGY;PATHOLOGY;PSYCHIATRY;GENETICS;EMERGENCY MEDICINE;HUMANITIES;IMMUNOLOGY;MARKETING;OBSTETRICS;OPTICS;ACCOUNTING;AESTHETICS;ANESTHESIA;ARITHMETIC;ATOMIC PHYSICS;CARDIOLOGY;CLINICAL PSYCHOLOGY;COMPOSITE MATERIAL;COMPUTATIONAL CHEMISTRY;DENTISTRY;EMBEDDED SYSTEM;GYNECOLOGY;LAW;MACROECONOMICS;MECHANICAL ENGINEERING;METALLURGY;MOLECULAR PHYSICS;NANOTECHNOLOGY;OPERATIONS MANAGEMENT;OPHTHALMOLOGY;OPTOELECTRONICS;OPTOMETRY;ORGANIC CHEMISTRY;PALEONTOLOGY;PEDIATRICS;PHYSICAL THERAPY;PSYCHOTHERAPIST;QUANTUM MECHANICS;RISK ANALYSIS (ENGINEERING);SOCIAL PSYCHOLOGY;UROLOGY;VIROLOGY","14;8;5;5;4;4;4;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","POPULATION;CANCER;COHORT;PROSPECTIVE COHORT STUDY;CHEMOTHERAPY;INCIDENCE (GEOMETRY);PATHOLOGICAL;PREGNANCY;REGIMEN;AB INITIO;ABSORPTION (ACOUSTICS);ADVERSE EFFECT;AGENESIS;ALTERNATIVE MEDICINE;ANALGESIC;ANGIOGRAPHY;ANOREXIA;ASBESTOS;ASYMPTOMATIC;ATOM (SYSTEM ON CHIP);ATRIAL FIBRILLATION;BENCHMARKING;CALCIUM;CAMPTODACTYLY;CEREBRAL PALSY;COGNITION;COHORT STUDY;CONCOMITANT;CONFIDENCE INTERVAL;CONGENITAL DISORDER;CONSTIPATION;CONTEXT (ARCHAEOLOGY);COPD;CORPUS CALLOSUM;DEPRESSION (ECONOMICS);DIFFERENTIAL DIAGNOSIS;DISCONTINUATION;DISEASE;DISTRESS;DIVISION (MATHEMATICS);ECHOENCEPHALOGRAPHY;ELECTRONIC STRUCTURE;ENDOMETRIOSIS;EXACERBATION;EXCITATION;EXCITED STATE;GENE;GLAUCOMA;GROUND STATE;HEART FAILURE;HEPATITIS C;HYPOSPADIAS;INDIRECT COSTS;INFERIOR VENA CAVA;INSTITUTION;KIDNEY;LAYER (ELECTRONICS);LEIOMYOMA;LEUKEMIA;LITHIUM (MEDICATION);LUMINESCENCE;LUNG;MAGNETIC RESONANCE IMAGING;MANIC DEPRESSIVE;METHOTREXATE;MIGRAINE;MOLECULE;MORTALITY RATE;MOVEMENT (MUSIC);MYELOID LEUKEMIA;MYOCARDIAL INFARCTION;NANOCRYSTAL;NEUROLOGY;OBSERVATIONAL STUDY;OCCUPATIONAL EXPOSURE;PELVIC PAIN;PLATELET;PORENCEPHALY;PREDNISOLONE;PREDNISONE;PSYCHOPATHOLOGY;PULMONARY DISEASE;RANDOMIZED CONTROLLED TRIAL;RELAXATION (PSYCHOLOGY);RESPIRATORY SYSTEM;SCHIZOPHRENIA (OBJECT-ORIENTED PROGRAMMING);SERVICE (BUSINESS);SILICON;STROKE (ENGINE);SURGICAL SITE INFECTION;THROMBOSIS;ULTRASONOGRAPHY;ULTRASOUND;URETER;URETHRA;URINARY SYSTEM;UTERUS;VIRUS","4;3;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CYCLOPHOSPHAMIDE;CYTARABINE;ETOPOSIDE;3D ULTRASOUND;AB INITIO QUANTUM CHEMISTRY METHODS;ADENOMYOSIS;AGENESIS OF THE CORPUS CALLOSUM;ANTIMETABOLITE;ASBESTOS CEMENT;ASBESTOSIS;AURA;BIPOLAR DISORDER;CANCER PAIN;COINFECTION;CONTRAINDICATION;CUMULATIVE INCIDENCE;DAUNORUBICIN;DEEP VEIN;ESSENTIAL THROMBOCYTHEMIA;EXCESS MORTALITY;FETUS;FLUNARIZINE;GESTATION;GESTATIONAL AGE;HEALTH SERVICES;HEPATITIS C VIRUS;INDUCTION CHEMOTHERAPY;MICROPENIS;MICROPHTHALMIA;MITOXANTRONE;MUCOSITIS;MYOMETRIUM;NEUROPSYCHOLOGY;OPEN ANGLE GLAUCOMA;PASSIVATION;PATENT FORAMEN OVALE;PHENOTYPE;POWER DOPPLER;PROSTATE;RENAL PELVIS;RESPIRATORY TRACT;STANDARDIZED MORTALITY RATIO;STOKES SHIFT;THROMBOCYTOSIS;TOLERABILITY;TRABECULECTOMY;UPPER URINARY TRACT;VASCULITIS;VENOUS THROMBOSIS;VIRAL DISEASE;VIRAL LOAD;VIREMIA;WARFARIN","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","FLUDARABINE;ANAGRELIDE;GIANT CELL ARTERITIS;IDARUBICIN;INTRAVENTRICULAR HEMORRHAGE;MIGRAINE WITH AURA;MISSENSE MUTATION;PERIVENTRICULAR LEUKOMALACIA;PRENATAL DIAGNOSIS;PROSTATIC URETHRA;SIDA","2;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;ITALY;MALE;;ADULT;MIDDLE AGED;ANALGESICS, OPIOID;ANTICOAGULANTS;BRAIN DISEASES;HEART SEPTAL DEFECTS, ATRIAL;HIV INFECTIONS;HTLV-II INFECTIONS;LEUKEMIA, MYELOID;MIGRAINE WITH AURA;PROSPECTIVE STUDIES;ACID-BASE IMBALANCE;AGED;ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;BIPOLAR DISORDER","13;11;10;10;9;9;5;4;4;4;4;4;4;4;4;4;3;3;3;3","ACUTE MYELOID LEUKEMIA RESEARCH;ANORECTAL DISEASE TREATMENTS AND OUTCOMES;BLADDER AND UROTHELIAL CANCER TREATMENTS;CARDIOVASCULAR AND DIVING-RELATED COMPLICATIONS;CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) RESEARCH;CLEFT LIP AND PALATE RESEARCH;CONGENITAL GASTROINTESTINAL AND NEURAL ANOMALIES;ENDOMETRIOSIS RESEARCH AND TREATMENT;GLAUCOMA AND RETINAL DISORDERS;HEALTH, MEDICINE AND SOCIETY;HIV/AIDS DRUG DEVELOPMENT AND TREATMENT;MENTAL HEALTH AND PSYCHIATRY;MYELOPROLIFERATIVE NEOPLASMS: DIAGNOSIS AND TREATMENT;NEONATAL AND FETAL BRAIN PATHOLOGY;OCCUPATIONAL AND ENVIRONMENTAL LUNG DISEASES;PAIN MANAGEMENT AND OPIOID USE;SCHIZOPHRENIA RESEARCH AND TREATMENT;SILICON NANOSTRUCTURES AND PHOTOLUMINESCENCE;SURGICAL SITE INFECTION PREVENTION;T-CELL AND RETROVIRUS STUDIES","1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";REGIMEN;3D ULTRASOUND;ADENOMYOSIS;AGENESIS;ANAGRELIDE;ANOREXIA;ASBESTOS CEMENT;ASBESTOSIS;BENCHMARKING;CAMPTODACTYLY;CONCOMITANT;CONGENITAL DISORDER;CONTRAINDICATION;CUMULATIVE INCIDENCE;DAUNORUBICIN;DEPRESSION;DISCONTINUATION;ECHOENCEPHALOGRAPHY;EXCESS MORTALITY","3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ACUTE MYELOID;AB-INITIO CALCULATIONS;ABSORPTION EMISSION;ANAGRELIDE TREATMENT;ANALGESIC LADDER;ANGLE GLAUCOMA;ASBESTOS CEMENT;ASPHYXIAL INJURY;AUTHORS REPLY;BASED REGIMEN;BILATERAL PYELOCUTANEOUS;BIRTH WEIGHT;BRONCOPNEUMOPATIA CRONICA;CARDIOVASCULAR EVALUATION;CAVA FILTERS;CEMENT WORKERS;CLINICAL EXPERIENCE;CLINICAL TRIAL;COSTI DELLA;CRONICA OSTRUTTIVA;CYTARABINE ARAC;DEEP SCLERECTOMY;DELAYED PROGRESSION;DELLA BRONCOPNEUMOPATIA;DELLO STUDIO;DETECTION RATE;DIAGNOSED ACUTE;DIFFUSE NEOPLASIA;DIMENSIONAL ULTRASOUND;DRUG USERS","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MTX-TREATED PATIENTS;POWER DOPPLER;HTLV-II INFECTION;NEWLY DIAGNOSED;TRANSVAGINAL POWER;AML PATIENTS;CELL COUNTS;CUMULATIVE DOSE;DIAGNOSED AML;DOPPLER SONOGRAPHY;FLAI ARM;HTLV-II PROVIRAL;ICE ARM;ORIGINAL PATIENTS;PATIENTS RECEIVED;PMR PATIENTS;PROVIRAL LOAD;STEROID TREATMENT;STUDY PATIENTS;VASCULAR TREE;ACCIDENT MYOCARDIAL;ACETYLSALICYLIC ACID;ACUTE MYELOID;AGE DISEASE;AID CLINICIANS;AIDS PROGRESSION;ALLOGENEIC ALLO-SCT;ANALOGUE SCALE;ANTI-LEUKAEMIC EFFECT;ANTIRETROVIRAL THERAPY","8;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1",4,0.18,3,1,0,0,0,0,0,0,1,1.25,0,0,0,0,1,0,0,0,0,0,0.25,64.5,64.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_AUSLREGGIOEMILIA",2006,19,7.26315789473684,1.52631578947368,0.655172413793103,0.31578947368421,0.157894736842105,0.0526315789473684,0.31578947368421,0,8,5,0,4,0.42,0.26,0,0.21,38.84,0.760443786250262,0.263157894736842,0.894736842105263,NA,0.316721034454224,0.1875,0.25,0,"ISABELLA CAMPANINI;LUCÌA MANGONE;P. DEGOLA;A CAMPAGNA;MANUEL ZORZI;CARLOTTA MALAGOLI;GABRIELE TONNI;STEFANO FERRETTI;VINCENZO DE LISI;­ROSARIO ­TUMINO;ROBERTO MERLETTI;GABRIELE CENTINI;FABIO FALCINI;ANDREA RABALLO;DARIO FARINA;M MUZII;ROSSELLA RODOLFI;DONELLA PULITI;MARCO VINCETI;EUǴENIO PACI","3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","GABRIELE TONNI;GABRIELE CENTINI;ISABELLA CAMPANINI;ANDREA RABALLO;GIOVANNI TANI;LEONARDO ORAZI;P. DEGOLA;GIOVANNI STANGHELLINI;ROBERTO MERLETTI;MARCO O. BERTELLI;DARIO FARINA;G VEZZOSI;LUCÌA MANGONE;M. CRIVELLINI;VERÔNICA CIMOLIN;MARCO TERRENI;MANUELA GALLI;STEFANO GUAZZETTI;P. MARTELLI;S. CAVIRANI","0.67;0.67;0.58;0.53;0.5;0.5;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.25;0.25;0.25;0.25;0.25;0.25;0.25","ISABELLA CAMPANINI;LUCÌA MANGONE;P. DEGOLA;GABRIELE TONNI;ANDREA RABALLO;ROSSELLA RODOLFI;G VEZZOSI;GIAN LUCA GIOVANARDI;G CASTELLANI;PIERPAOLO PATTACINI;A. MERLO;E. DALPASSO;STEFANO GUAZZETTI;ALESSANDRO VENTURA;GIUSEPPE REGOLISTI;VALERIO MISELLI;LEONARDO ORAZI;L. TAMAGNINI;FRANCESCO MERLI;MARCO PANTEGHINI","3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","GABRIELE TONNI;ISABELLA CAMPANINI;ANDREA RABALLO;LEONARDO ORAZI;P. DEGOLA;G VEZZOSI;LUCÌA MANGONE;STEFANO GUAZZETTI;ROSSELLA RODOLFI;GIAN LUCA GIOVANARDI;L. TAMAGNINI;SILVIA CANDELA;G CASTELLANI;PIERPAOLO PATTACINI;A. MERLO;E. DALPASSO;ALESSANDRO VENTURA;MARCO PANTEGHINI;ANDREA MERLO;VALERIO MISELLI","0.67;0.58;0.53;0.5;0.33;0.33;0.33;0.25;0.22;0.2;0.2;0.2;0.17;0.17;0.17;0.17;0.17;0.17;0.17;0.12","ALBERTO MILAN;CARLOS FARDELLA;FRANCESCA PIZZOLO;FRANCESCO FALLO;FRANCO VEGLIO;GIUSEPPE REGOLISTI;LISA MARAFETTI;LORENA MOSSO;MAURO MACCARIO;PAOLO MULATERO;ACHILLE VENCO;ANGELO GHIRARDUZZI;ERICA ROMUALDI;FRANCESCO DENTALI;MARK CROWTHER;PAOLO PRANDONI;RAFFAELE PESAVENTO;WALTER AGENO;DONELLA PULITI;EUǴENIO PACI","192;192;192;192;192;192;192;192;192;192;150;150;150;150;150;150;150;150;129;129","GIUSEPPE REGOLISTI;ANGELO GHIRARDUZZI;LUCÌA MANGONE;ISABELLA CAMPANINI;ANDREA MERLO;G VEZZOSI;P. DEGOLA;STEFANO GUAZZETTI;ANDREA RABALLO;GABRIELE TONNI;LEONARDO ORAZI;L. TAMAGNINI;VALERIO MISELLI;ALESSANDRO VENTURA;MARCO PANTEGHINI;PIERPAOLO PATTACINI;ROSSELLA RODOLFI;A. MERLO;E. DALPASSO;FRANCESCO MERLI","192;150;129;128;126;126;126;50;48;15;12;7;4;3;3;3;3;0;0;0","ISABELLA CAMPANINI;ANDREA RABALLO;G VEZZOSI;GABRIELE TONNI;LUCÌA MANGONE;P. DEGOLA;ROSSELLA RODOLFI;ALESSANDRO VENTURA;ANDREA MERLO;ANGELO GHIRARDUZZI;GIUSEPPE REGOLISTI;L. TAMAGNINI;LEONARDO ORAZI;MARCO PANTEGHINI;PIERPAOLO PATTACINI;STEFANO GUAZZETTI;VALERIO MISELLI;A. MERLO;E. DALPASSO;FRANCESCO MERLI","3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;0;0;0","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PHYSICS;MATHEMATICS;CHEMISTRY;ENGINEERING;PSYCHOLOGY;SOCIOLOGY;MATERIALS SCIENCE;PHILOSOPHY","16;7;5;5;4;2;2;2;2;1;1","INTERNAL MEDICINE;ANATOMY;GENETICS;SURGERY;ENVIRONMENTAL HEALTH;PHYSICAL MEDICINE AND REHABILITATION;PROGRAMMING LANGUAGE;ARTIFICIAL INTELLIGENCE;BIOMEDICAL ENGINEERING;CLASSICAL MECHANICS;CLINICAL PSYCHOLOGY;DEMOGRAPHY;ENDOCRINOLOGY;GASTROENTEROLOGY;GYNECOLOGY;IMMUNOLOGY;OPTICS;PATHOLOGY;PHYSICAL CHEMISTRY;PSYCHIATRY;RADIOLOGY;SOCIAL PSYCHOLOGY","8;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CONFIDENCE INTERVAL;PREGNANCY;POPULATION;CANCER;ELECTRODE;ELECTROMYOGRAPHY;GAIT;INCIDENCE (GEOMETRY);INCINERATION;KINEMATICS;PERSONALITY;ABDOMINAL CAVITY;ABDOMINAL WALL;ACTUATOR;ADENOMA;ALDOSTERONE;ALTERNATIVE MEDICINE;ANTIBODY;ASYMPTOMATIC;BLOOD PRESSURE;BODY MASS INDEX;CADENCE;CASE-CONTROL STUDY;CENTRALITY;CHEMOTHERAPY;COHORT;COHORT STUDY;CONTEXT (ARCHAEOLOGY);CONTROL SYSTEM;CURVATURE;DC MOTOR;DIABETES MELLITUS;DIATHESIS;ENUCLEATION;FEATURE (LINGUISTICS);FIELD-PROGRAMMABLE GATE ARRAY;HARD PALATE;HERD;HERNIA;HYDROCORTISONE;IMMUNE SYSTEM;IMPLANT;INSULIN;LYMPHOMA;MAGNETIC RESONANCE IMAGING;MICROCONTROLLER;MODULAR DESIGN;MOOD;MOTOR CONTROL;MOTOR DRIVE;MULTIVARIATE ANALYSIS;MYCOPLASMA HYOPNEUMONIAE;OBESITY;ODDS RATIO;ORIENTATION (VECTOR SPACE);OVERDIAGNOSIS;PATTERN RECOGNITION (PSYCHOLOGY);POWER (PHYSICS);PSYCHOPATHOLOGY;PSYCHOSIS;RADAR;RECEIVER OPERATING CHARACTERISTIC;REDUNDANCY (ENGINEERING);RISK FACTOR;SECONDARY PALATE;SEGMENTATION;SET (ABSTRACT DATA TYPE);SIMPLE (PHILOSOPHY);SOFTWARE;THROMBOSIS;TRAIT;VACCINATION;VOLTAGE","4;4;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BREAST CANCER;FETUS;GAIT ANALYSIS;GAIT CYCLE;RELATIVE RISK;ABDOMINAL WALL DEFECT;ABORTION;ALVEOLAR RIDGE;ANTIBODY RESPONSE;CANCER SCREENING;CONGENITAL MALFORMATIONS;CYCLOPHOSPHAMIDE;DEEP VEIN;ENVELOPE (RADAR);EVISCERATION (OPHTHALMOLOGY);FLUDROCORTISONE;FOLLICULAR LYMPHOMA;GAUSSIAN CURVATURE;HERD IMMUNITY;HYPERALDOSTERONISM;IMMUNITY;MAJOR DEPRESSIVE EPISODE;METABOLIC SYNDROME;MISCARRIAGE;MOTOR CONTROLLER;OFFSPRING;PERONEUS LONGUS;POSTPRANDIAL;PRIMARY ALDOSTERONISM;PULSE-WIDTH MODULATION;RITUXIMAB;SCHIZOTYPY;SECONDARY HYPERTENSION;SOCIOECONOMIC STATUS;TRIPLE MODULAR REDUNDANCY;TYPE 1 DIABETES;UNIVARIATE ANALYSIS;VENOUS THROMBOSIS","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CHEMOIMMUNOTHERAPY;FLUDARABINE;HOLOPROSENCEPHALY;INSULIN ASPART;INSULIN LISPRO;INSULIN PUMP;MAMMOGRAPHY;MASTECTOMY;NATIONAL CHOLESTEROL EDUCATION PROGRAM;OMPHALOCELE;PRENATAL DIAGNOSIS","1;1;1;1;1;1;1;1;1;1;1",";HUMANS;BREAST NEOPLASMS;FEMALE;MIDDLE AGED;ADULT;AGED;ITALY;PNEUMONIA OF SWINE, MYCOPLASMAL;ADENOMA;ADRENAL GLAND NEOPLASMS;ALDOSTERONE;ANIMALS, SUCKLING;CARCINOMA IN SITU;CARCINOMA, DUCTAL, BREAST;COLOSTRUM;DEPRESSIVE DISORDER, MAJOR;ELECTROMYOGRAPHY;ENZYME-LINKED IMMUNOSORBENT ASSAY;HYPERALDOSTERONISM","10;8;6;6;6;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3","CLEFT LIP AND PALATE RESEARCH;ENVIRONMENTAL JUSTICE AND HEALTH DISPARITIES;GLOBAL CANCER INCIDENCE AND SCREENING;MUSCLE ACTIVATION AND ELECTROMYOGRAPHY STUDIES;CEREBRAL PALSY AND MOVEMENT DISORDERS;DIABETES MANAGEMENT AND RESEARCH;HORMONAL REGULATION AND HYPERTENSION;LYMPHOMA DIAGNOSIS AND TREATMENT;MENTAL HEALTH AND PSYCHIATRY;MICROBIAL INFECTIONS AND DISEASE RESEARCH;OCULAR DISORDERS AND TREATMENTS;OPTICAL MEASUREMENT AND INTERFERENCE TECHNIQUES;PERSONALITY DISORDERS AND PSYCHOPATHOLOGY;REAL-TIME SIMULATION AND CONTROL SYSTEMS;VENOUS THROMBOEMBOLISM DIAGNOSIS AND MANAGEMENT","2;2;2;2;1;1;1;1;1;1;1;1;1;1;1",";GAIT CYCLE;ABDOMINAL CAVITY;ABDOMINAL WALL DEFECT;ALVEOLAR RIDGE;ANTIBODY RESPONSE;BREAST CANCER SCREENING;CADENCE;CANCER SCREENING;CHEMOIMMUNOTHERAPY;CONGENITAL MALFORMATIONS;DIATHESIS;ENVELOPE (RADAR);EVISCERATION (OPHTHALMOLOGY);FEATURE (LINGUISTICS);FLUDROCORTISONE;FOLLICULAR LYMPHOMA;GAUSSIAN CURVATURE;HARD PALATE;HERD IMMUNITY","4;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ELECTRODE LOCATION;EMG SIGNAL;LEG MUSCLES;MODERN MUNICIPAL;MUNICIPAL SOLID;SERVICE SCREENING;SIGNAL ENVELOPE;SOLID WASTE;ACQUIRED SURFACES;ALOBAR HOLOPROSENCEPHALY;ANTIBODIES INDUCED;ANTIBODY RESPONSE;BREAST CANCER;BRUSHLESS MOTOR;CANCER DUE;CASECONTROL STUDY;CLEFT LIP;CLEFT PALATE;CONCEPTUAL REVIEW;CONFIRMATORY TESTS;CONGENITAL ANOMALIES;CONTROL SYSTEM;DEPRESSIVE EPISODE;EXPERIMENTAL SET;FIRST-TRIMESTER TRANSVAGINAL;FL PATIENTS;FOLLICULAR LYMPHOMA;GEOMETRICAL INSPECTION;HARDWARE-IN-THE-LOOP APPROACH;HYOPNEUMONIAEI INFECTION","2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BIRTH DEFECTS;BREAST CANCER;INTERMEDIATE EXPOSURE;REMAINING MUNICIPAL;WASTE INCINERATOR;CONGENITAL ANOMALIES;MUNICIPAL POPULATION;MUNICIPAL WASTE;SECONDARY PALATE;SOCIOECONOMIC STATUS;WOMEN AGED;AGED RESIDING;CONFIDENCE INTERVAL;CONFIDENCE LIMITS;EXCESS RATIO;EXPOSED COHORTS;EXPOSURE COHORT;HOSPITAL DISCHARGE;HYPERTENSIVE PATIENTS;ITALIAN CITY;IV SLT;LEAD TIME;MASTECTOMY RATES;MODERN INCINERATOR;MODERN MUNICIPAL;P- INTRODUCTION;POSITIVE SCREENING;PREGNANCIES OCCURRING;REGISTRY OFFICE;REPRODUCTIVE HEALTH","4;4;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",4,0.21,5.35,1.5,0,1,0,1,3,0,0,1.5,0,0,0,0,0,0,0,0,0,1,0.25,61,61.75,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_AUSLREGGIOEMILIA",2007,34,7.76470588235294,1.64705882352941,0.607142857142857,0.441176470588235,0.294117647058824,0.176470588235294,0.176470588235294,2,18,4,1,7,0.53,0.12,0.03,0.21,83.74,1.5866171838039,0.176470588235294,0.823529411764706,NA,0.493219353587384,0.344444444444444,0.325,0.348484848484849,"GABRIELE TONNI;CLAUDIO DE FELICE;ALESSANDRO VENTURA;ANDREA RABALLO;LUCÌA MANGONE;PATRIZIO PALANDRI;GIOVANNA TAGLIABUE;DANIELA AZZONI;O. SECHI;ENRICO AMENTA;GIUSEPPE VISANI;MASSIMO FEDERICO;STEFANO FERRETTI;L. DI COSMO;A CAMINITI;ALBERTO DELLA VALLE;MARINA VERCELLI;STEFANO CARIANI;TIZIANA CASSETTI;VINCENZO DE LISI","5;4;4;4;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ANDREA RABALLO;GABRIELE TONNI;ANTÔNIO ROSSI;ELISA MOTOLESE;ALESSANDRO VENTURA;G. CASTIGNOLI;CLAUDIO DE FELICE;ISABELLA CAMPANINI;DARIO FARINA;ANDREA MERLO;GIOVANNI STANGHELLINI;E. SEMROV;DANIELA AZZONI;ALESSANDRO TACCHINI;I. MONTANARI;CARMEN CATTANEO;V. AVANZI;PATRIZIO PALANDRI;M. CRIVELLINI;SOFIA ASIOLI","1.83;1;1;1;0.9;0.83;0.8;0.58;0.53;0.53;0.5;0.5;0.4;0.33;0.33;0.33;0.33;0.25;0.25;0.25","GABRIELE TONNI;ALESSANDRO VENTURA;ANDREA RABALLO;LUCÌA MANGONE;DANIELA AZZONI;ISABELLA CAMPANINI;ANDREA MERLO;LUIGI GUGLIOTTA;E DELLA VALLE;FRANCESCO LOMBARDI;M. DOTTORI;P BONATI;O. PATTACINI;GIORGIA COLLINI;PAOLO BONILAURI;R. BOIARDI;MAURO SILINGARDI;P. FERRARI;MELINDA DINCĂ;ANTÔNIO ROSSI","5;4;4;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","ANDREA RABALLO;GABRIELE TONNI;ANTÔNIO ROSSI;ELISA MOTOLESE;ALESSANDRO VENTURA;ISABELLA CAMPANINI;ANDREA MERLO;E. SEMROV;DANIELA AZZONI;ALESSANDRO TACCHINI;V. AVANZI;STEFANO GUAZZETTI;E DELLA VALLE;LUCÌA MANGONE;FRANCESCO LOMBARDI;R. BOIARDI;P. FERRARI;GIUSEPPE MONTEVECCHI;MARTA PUTZU;GIANCARLO GARUTI","1.83;1;1;1;0.9;0.58;0.53;0.5;0.4;0.33;0.33;0.25;0.25;0.23;0.2;0.2;0.2;0.2;0.2;0.2","LUCÌA MANGONE;ANDREA MICHELI;ARDUINO VERDECCHIA;GEMMA GATTA;HERMANN BRENNER;IAN KUNKLER;SILVIA FRANCISCI;ANTONIO RAVIELE;C. MENOZZI;ERALDO OCCHETTA;FRANCESCO CROCI;FRANCO GIADA;LUCIO SANTANGELO;MAURA FRANCESE;MAURIZIO SANTOMAURO;MICHELE MASSIMO GULIZIA;ISABELLA CAMPANINI;M. CRIVELLINI;MANUELA GALLI;VERÔNICA CIMOLIN","1817;1800;1800;1800;1800;1800;1800;156;156;156;156;156;156;156;156;156;131;115;115;115","LUCÌA MANGONE;C. MENOZZI;ISABELLA CAMPANINI;MARTA PUTZU;FRANCESCO LOMBARDI;ANDREA MERLO;RITA CONIGLIARO;ANDREA ANTONELLI;FRANCESCA MASINO;GIUSEPPE MONTEVECCHI;STEFANO GUAZZETTI;GABRIELE TONNI;CINZIA CAMPARI;EMANUELA BEDESCHI;GIORGIA COLLINI;SILVIA CANDELA;MAURO SILINGARDI;ALESSANDRO VENTURA;ANDREA RABALLO;MELINDA DINCĂ","1817;156;131;106;92;84;81;77;77;77;68;49;48;48;48;48;42;40;27;26","GABRIELE TONNI;ANDREA RABALLO;ALESSANDRO VENTURA;LUCÌA MANGONE;ANDREA MERLO;DANIELA AZZONI;E DELLA VALLE;ISABELLA CAMPANINI;LUIGI GUGLIOTTA;ANDREA ANTONELLI;ANTÔNIO ROSSI;C. MENOZZI;CINZIA CAMPARI;EMANUELA BEDESCHI;FRANCESCA MASINO;FRANCESCO LOMBARDI;GIORGIA COLLINI;GIUSEPPE MONTEVECCHI;MARCO PANTEGHINI;MARTA PUTZU","5;4;4;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;PSYCHOLOGY;BIOLOGY;PHYSICS;SOCIOLOGY;CHEMISTRY;COMPUTER SCIENCE;MATERIALS SCIENCE;PHILOSOPHY;MATHEMATICS;POLITICAL SCIENCE;ART;ECONOMICS;ENGINEERING;GEOGRAPHY","29;9;8;8;5;4;3;3;3;2;2;1;1;1;1","INTERNAL MEDICINE;SURGERY;GENETICS;ANATOMY;CLINICAL PSYCHOLOGY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;PEDIATRICS;PSYCHIATRY;ANESTHESIA;DEMOGRAPHY;OBSTETRICS;OPTICS;PHYSICAL MEDICINE AND REHABILITATION;IMMUNOLOGY;ORGANIC CHEMISTRY;PHYSICAL THERAPY;BIOCHEMISTRY;CARDIOLOGY;DERMATOLOGY;DEVELOPMENTAL PSYCHOLOGY;EPISTEMOLOGY;GEOMETRY;LAW;MACHINE LEARNING;METALLURGY;ONCOLOGY;PATHOLOGY;QUANTUM MECHANICS;RADIOLOGY","18;8;7;6;5;5;5;5;5;4;4;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","INCIDENCE (GEOMETRY);POPULATION;PREGNANCY;CANCER;DISEASE;LUNG CANCER;BACTERIA;COGNITION;ELECTROMYOGRAPHY;OBESITY;PLATELET;PROSPECTIVE COHORT STUDY;PUNCHING;STOMACH;TRISOMY;ACETIC ACID;ADMINISTRATION (PROBATE LAW);AIR POLLUTION;ALLERGY;AMBULATORY;ANASTOMOSIS;ANTIFUNGAL;ANTIOXIDANT;ASPERGILLOSIS;ASYMPTOMATIC;ATRIAL FIBRILLATION;BASE EXCESS;BICEPS;BLOOD PRESSURE;BODY MASS INDEX;BOLUS (DIGESTION);CATS;CEREBELLUM;CHEMOTHERAPY;CLOTTING FACTOR;COHORT STUDY;COMA (OPTICS);CONFIDENCE INTERVAL;CONFOUNDING;DEXAMETHASONE;DISTRESS;DISTRIBUTED LAG;DYSPHAGIA;EMBRYO;EMERGENCY DEPARTMENT;ENCEPHALOCELE;ENDOMETRIOSIS;ENDOSCOPY;EPIDEMIOLOGY;ESOPHAGUS;ETIOLOGY;FOREHEAD;FOURTH VENTRICLE;FUNCTIONAL MOVEMENT;GENE;GLASGOW COMA SCALE;GOLD STANDARD (TEST);HAEMOPHILIA;HERD;HYPERSENSITIVITY REACTION;HYPOTHERMIA;IMMUNOSUPPRESSION;IN SITU;IN VITRO;INGESTION;INHALATION;KINEMATICS;LAPAROSCOPY;LIABILITY;LOGISTIC REGRESSION;LYMPHOMA;MACROCEPHALY;MASSETER MUSCLE;MASTICATION;MASTICATORY FORCE;MEDICAL RECORD;MOOD;MOTOR CONTROL;MOTOR SKILL;MOTOR UNIT;MOVEMENT (MUSIC);MOVEMENT CONTROL;MYELOID LEUKEMIA;NARRATIVE;NASAL BONE;NATURALISM;NERVE CONDUCTION VELOCITY;NORMATIVE;NUT;OCCLUSION;OCCUPATIONAL THERAPY;OXYGEN;OXYGENATION;PALPITATIONS;PATHOLOGICAL;PERIOPERATIVE;PERSONAL HYGIENE;PERSONALITY;PHENOLS;POWER (PHYSICS);PSYCHOPATHOLOGY;PULMONARY EMBOLISM;QUALITATIVE RESEARCH;RADIOGRAPHY;RANDOMIZED CONTROLLED TRIAL;RECEIVER OPERATING CHARACTERISTIC;REFRACTORY (PLANETARY SCIENCE);RESPITE CARE;RETROSPECTIVE COHORT STUDY;SCALE (RATIO);SELF;SEPSIS;SET (ABSTRACT DATA TYPE);SPECTRUM (FUNCTIONAL ANALYSIS);SPECTRUM DISORDER;SPINA BIFIDA;SPINAL ANESTHESIA;STABILITY (LEARNING THEORY);STENT;STRESS (LINGUISTICS);SURVIVAL ANALYSIS;SURVIVAL RATE;SWALLOWING;TASK (PROJECT MANAGEMENT);THROMBOSIS;TRUNK;UMBILICAL CORD","5;5;5;4;4;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","FETUS;CANCER REGISTRY;BREAST CANCER;CANCER INCIDENCE;COLORECTAL CANCER;DEMENTIA;PERFORATION;PROSTATE CANCER;STOMACH CANCER;WEIGHT LOSS;ADENOCARCINOMA;AERODYNAMIC DIAMETER;AIR POLLUTANTS;ALLERGEN;ALLERGIC REACTION;AMPHOTERICIN B;ANAPHYLAXIS;BIPOLAR DISORDER;CEREBELLAR VERMIS;CYCLOPHOSPHAMIDE;DPPH;EFFECT MODIFICATION;ELECTIVE CESAREAN SECTION;ESOPHAGEAL DISEASE;ETOPOSIDE;GENETIC PREDISPOSITION;GESTATION;GESTATIONAL AGE;HAEMOPHILIA A;IMMUNE THROMBOCYTOPENIA;IMPLANTABLE LOOP RECORDER;INDUCTION CHEMOTHERAPY;INFECTIOUS DISEASE (MEDICAL SPECIALTY);INTERIM ANALYSIS;LACTIC ACID;MESSENGER RNA;NEURAL TUBE;OXYGEN SATURATION;RELIABILITY (SEMICONDUCTOR);RITUXIMAB;SALMONELLA;SCHIZOTYPY;STRESS MEASURES;SYSTEMIC REACTION;TEMPERAMENT;THROMBOCYTOPENIC PURPURA;UMBILICAL VEIN;VENOUS THROMBOSIS;VON WILLEBRAND FACTOR","4;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","GASTRIC BYPASS;PRENATAL DIAGNOSIS;ABTS;CAREGIVER STRESS;CORONAVIRUS DISEASE 2019 (COVID-19);CYSTIC HYGROMA;DUCTUS VENOSUS;FIRST TRIMESTER;FLUDARABINE;GROWTH RESTRICTION;HAEMOPHILIA B;INTRAUTERINE GROWTH RESTRICTION;NEURAL TUBE DEFECT;OMPHALOCELE;POSACONAZOLE;RELATIVE SURVIVAL;SMALL FOR GESTATIONAL AGE;TRANSLATION (BIOLOGY);UMBILICAL ARTERY;VASCULAR DEMENTIA;VON WILLEBRAND DISEASE","2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;ADULT;ITALY;;MALE;MIDDLE AGED;AGED;PREGNANCY;AIR POLLUTION;ANESTHESIA, GENERAL;BRAIN DAMAGE, CHRONIC;COMA;DEMENTIA;FELINE INFECTIOUS PERITONITIS;FETUS;HEART VENTRICLES;HEMORRHAGIC DISORDERS;HIP FRACTURES;HYPOTHERMIA","23;14;12;11;10;9;8;7;5;4;4;4;4;4;4;4;4;4;4;4","DEMENTIA AND COGNITIVE IMPAIRMENT RESEARCH;GLOBAL CANCER INCIDENCE AND SCREENING;PRENATAL SCREENING AND DIAGNOSTICS;AIR QUALITY AND HEALTH IMPACTS;ANESTHESIA AND PAIN MANAGEMENT;ANIMAL VIRUS INFECTIONS STUDIES;BALANCE, GAIT, AND FALLS PREVENTION;BARIATRIC SURGERY AND OUTCOMES;BIPOLAR DISORDER AND TREATMENT;CARDIOVASCULAR SYNCOPE AND AUTONOMIC DISORDERS;CONTACT DERMATITIS AND ALLERGIES;ESOPHAGEAL AND GI PATHOLOGY;FERMENTATION AND SENSORY ANALYSIS;FOLATE AND B VITAMINS RESEARCH;FUNCTIONAL BRAIN CONNECTIVITY STUDIES;GENETIC FACTORS IN COLORECTAL CANCER;HEMOPHILIA TREATMENT AND RESEARCH;IDENTITY, MEMORY, AND THERAPY;MENTAL HEALTH AND PSYCHIATRY;METASTASIS AND CARCINOMA CASE STUDIES","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";CANCER INCIDENCE;NUCHAL TRANSLUCENCY MEASUREMENT;PERFORATION;STOMACH CANCER;TRISOMY;ABTS;AERODYNAMIC DIAMETER;ALLERGIC REACTION;BASE EXCESS;BOLUS (DIGESTION);CAREGIVER STRESS;CEREBELLAR VERMIS;CHORIONIC VILLUS SAMPLING;CLOTTING FACTOR;COMA (OPTICS);CROWN-RUMP LENGTH;CYSTIC HYGROMA;DISTRIBUTED LAG;DUCTUS VENOSUS","6;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","ANOMALOUS SUBJECTIVE;CANCER INCIDENCE;OBSERVED CANCER;SUBJECTIVE EXPERIENCES;VALIDATION STUDY;ABSENT NASAL;ACUTE MYELOID;AGE-RELATED DISEASE;AIR POLLUTION;ANESTHESIOLOGICAL FEATURES;ANOMALOUS INCIPIENCY;ATRIOVENTRICULAR CANAL;BACTERIAL INFECTIONS;BALSAMIC VINEGAR;BANDED GASTROPLASTY;BILIARY TRACT;BIOLOGICAL PSYCHOLOGICAL;BIPOLAR SPECTRUM;BLEEDING DISORDERS;BOLUS HARDNESS;BYPASSED STOMACH;CANCER SURVIVAL;CAREGIVERS STRESS;CEREBROFRONTOFACIAL SYNDROME;CESAREAN SECTION;CHEMICAL PHYSICAL;CHEWING PATTERN;CLINICAL COMPLICATIONS;CLINICAL MARKERS;COHORT STUDY","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","NASAL BONES;SERUM AGP;AGP LEVELS;FETAL MALFORMATIONS;PRETEST PROBABILITY;ABSENT NASAL;BLOOD SAMPLES;LYMPH NODES;MESENTERIC LYMPH;NUCHAL TRANSLUCENCY;WEEKS GESTATION;BAYESIAN APPROACH;CHORIONIC VILLUS;CHROMOSOMAL ABNORMALITIES;CYSTIC HYGROMA;DIAGNOSTIC POTENTIAL;DUCTUS VENOSUS;EAR TAGGED;ENTERICA INFECTION;EXAMINATION CONFIRMED;FAECAL SAMPLES;FETAL KARYOTYPE;LONGITUDINAL STUDY;ROC CURVE;SALMONELLA ENTERICA;SEPTATED CYSTIC;SWINE HERDS;VILLUS SAMPLING;ABNORMAL DUCTUS;ABNORMALITIES INFLUENCE","7;7;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1",6,0.18,6,7.25,0,1,0,6,5,0,1,7.25,0,0,0,0,4,0,0,0,0,0,0,72.5,72.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_AUSLREGGIOEMILIA",2008,28,11.8571428571429,1.35714285714286,0.736842105263158,0.178571428571429,0.142857142857143,0.0714285714285714,0.214285714285714,0,13,7,4,2,0.46,0.25,0.14,0.07,20.14,0.367088945397998,0.321428571428571,0.821428571428571,NA,0.415673789074107,0.3125,0.15,0.166666666666667,"GABRIELE TONNI;STEFANO FERRETTI;CLAUDIO DE FELICE;VINCENZO DE LISI;LUCÌA MANGONE;MANUEL ZORZI;­ROSARIO ­TUMINO;FIORELLA ILARIUCCI;CATERINA STELITANO;DONELLA PULITI;EUǴENIO PACI;LUIGI RIGACCI;UMBERTO VITOLO;OMAR BARTOLI;MONICA BOCCHIA;ANTONIO PONTI;GIUSEPPE VISANI;ALESSANDRA RAVAIOLI;MARCO ZAPPA;MASSIMO FEDERICO","4;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2","ADOLFO ZAVARONI;GABRIELE TONNI;CLAUDIO DE FELICE;ANDREA MERLO;OMAR BARTOLI;GIOVANNI MARTINELLI;ISABELLA CAMPANINI;ANNA MERLO;FEDERICA ZACCARINI;DIMITRA RAPTI;MAURIZIO SCACCHETTI;GIORGIO GARUTI;ALESSANDRO VENTURA;P. PRATI;LUCA CAPRILI;DAVIDE MAZZOLI;CARMINE CARBONE;ANTONIO FRANCESCO AMICO;B FERRARI;STEFANO FERRETTI","1;0.64;0.64;0.53;0.5;0.5;0.5;0.5;0.5;0.5;0.5;0.5;0.45;0.33;0.33;0.33;0.33;0.33;0.25;0.21","GABRIELE TONNI;CLAUDIO DE FELICE;LUCÌA MANGONE;FIORELLA ILARIUCCI;OMAR BARTOLI;ALESSANDRO VENTURA;FRANCESCO MERLI;ANDREA MERLO;MAURIZIO SCACCHETTI;LUIGI GUGLIOTTA;MARGHERITA GAMBINI;DANIELA AZZONI;ALESSIA TIEGHI;GIOVANNI MARTINELLI;BIANCA RIMINI;ISABELLA CAMPANINI;LUCA CAPRILI;VALERIO MISELLI;ANNA MERLO;ADOLFO ZAVARONI","4;4;4;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1","ADOLFO ZAVARONI;GABRIELE TONNI;CLAUDIO DE FELICE;ANDREA MERLO;OMAR BARTOLI;GIOVANNI MARTINELLI;ISABELLA CAMPANINI;ANNA MERLO;MAURIZIO SCACCHETTI;ALESSANDRO VENTURA;LUCA CAPRILI;B FERRARI;LUCÌA MANGONE;MARGHERITA GAMBINI;DANIELA AZZONI;BIANCA RIMINI;ROSSELLA RODOLFI;F. SINISI;A. PRATISSOLI;FRANCESCO MERLI","1;0.64;0.64;0.53;0.5;0.5;0.5;0.5;0.5;0.45;0.33;0.25;0.21;0.2;0.2;0.2;0.2;0.17;0.17;0.14","FRANCESCO LAURIA;EMANUELE ZUCCA;FIORELLA ILARIUCCI;LUCÌA MANGONE;STEFANO FERRETTI;VINCENZO DE LISI;ANTONELLA ZUCCHETTO;DANIELA CAPELLO;DAVIDE ROSSI;DIMITAR G. EFREMOV;ELISA SOZZI;FRANCESCA MARIA ROSSI;FRANCESCO BERTONI;FRANCESCO FORCONI;GIANLUCA GAÏDANO;GIOVANNI DEL POETA;ILARIA CATTAROSSI;LUCA LAURENTI;MARIA ILARIA DEL PRINCIPE;MASSIMO DEGAN","153;126;126;120;120;120;119;119;119;119;119;119;119;119;119;119;119;119;119;119","FIORELLA ILARIUCCI;LUCÌA MANGONE;MARGHERITA GAMBINI;LUIGI GUGLIOTTA;GABRIELE TONNI;ALESSANDRO BONINI;GIOVANNI MARTINELLI;ROBERTO VALCAVI;ROSSELLA RODOLFI;ALESSIA TIEGHI;MAURIZIO SCACCHETTI;OMAR BARTOLI;BIANCA RIMINI;ALESSANDRO VENTURA;F. SINISI;DANIELA AZZONI;FRANCESCO MERLI;IDA CAPODANNO;MARIACATERINA MACONI;ANDREA MERLO","126;120;75;60;42;34;29;28;27;26;22;22;16;6;6;4;4;4;4;3","LUCÌA MANGONE;GABRIELE TONNI;FIORELLA ILARIUCCI;ALESSANDRO VENTURA;ANDREA MERLO;FRANCESCO MERLI;LUIGI GUGLIOTTA;A. PRATISSOLI;ALESSANDRO BONINI;ALESSIA TIEGHI;B FERRARI;BIANCA RIMINI;CLAUDIO DE FELICE;DANIELA AZZONI;F. SINISI;GIOVANNI MARTINELLI;IDA CAPODANNO;MARGHERITA GAMBINI;MARIACATERINA MACONI;MAURIZIO SCACCHETTI","4;4;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PHYSICS;ENGINEERING;SOCIOLOGY;BUSINESS;GEOLOGY;ART;ECONOMICS;MATHEMATICS;PHILOSOPHY;CHEMISTRY;GEOGRAPHY;HISTORY;POLITICAL SCIENCE","23;10;6;6;4;4;3;3;2;2;2;2;1;1;1;1","INTERNAL MEDICINE;GASTROENTEROLOGY;SURGERY;GENETICS;DEMOGRAPHY;PALEONTOLOGY;PEDIATRICS;OBSTETRICS;ONCOLOGY;OPTICS;PHYSICAL MEDICINE AND REHABILITATION;CARDIOLOGY;CLASSICAL MECHANICS;ELECTRICAL ENGINEERING;ENDOCRINOLOGY;ENVIRONMENTAL ECONOMICS;ENVIRONMENTAL HEALTH;EPISTEMOLOGY;GEOCHEMISTRY;HUMANITIES;IMMUNOLOGY;WORLD WIDE WEB","18;8;8;5;4;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2","CHEMOTHERAPY;CANCER;LYMPHOMA;PREGNANCY;CONFIDENCE INTERVAL;INCIDENCE (GEOMETRY);EPIDEMIOLOGY;GAIT;HORMONE;KINEMATICS;LOGISTIC REGRESSION;ODDS RATIO;POPULATION;RANDOMIZED CONTROLLED TRIAL;STRUCTURAL BASIN;ACCELERATION;ADVERSE EFFECT;AGENCY (PHILOSOPHY);AGENESIS;ANKLE;ANTIBODY;AORTA;CASE-CONTROL STUDY;CERTIFICATION;CHEESEMAKING;CLAMPING;COHORT;COHORT STUDY;CONFOUNDING;CONSCIOUSNESS;CONTEXT (ARCHAEOLOGY);CORPUS CALLOSUM;CORTICOSTEROID;CROSSTALK;DAIRY INDUSTRY;DEXAMETHASONE;DIRECTIVE;DISEASE;DOWNLOAD;EFFICIENT ENERGY USE;EFFUSION;ELECTROMYOGRAPHY;ELECTRONIC EQUIPMENT;ENERGY CONSUMPTION;ESTROGEN;EUROPEAN UNION;FEMINISM;FOLLICULAR PHASE;FORCE PLATFORM;GENE;GREENHOUSE GAS;GROUNDWATER;HAZARD;HERD;HYDROGEOLOGY;HYDROLOGY (AGRICULTURE);HYDROTHERMAL CIRCULATION;IMMUNE SYSTEM;IMPULSE (PHYSICS);INCENTIVE;JAVASCRIPT;KIDNEY;KNEE FLEXION;LEUKEMIA;LYMPH NODE;MALDEVELOPMENT;MEDICAL PRESCRIPTION;METHOTREXATE;MILK PRODUCTS;MULTIPLE SCLEROSIS;MULTIVARIATE ANALYSIS;MULTIVARIATE STATISTICS;NEUROLOGY;NODULE (GEOLOGY);OTITIS;PERMISSION;PLATELET;PREDNISONE;PROPORTIONAL HAZARDS MODEL;RADIATION THERAPY;REFRACTORY (PLANETARY SCIENCE);REGIMEN;REMANUFACTURING;RENEWABLE ENERGY;SEAFLOOR SPREADING;SECTION (TYPOGRAPHY);STAGE (STRATIGRAPHY);STROKE (ENGINE);TECTONICS;THE INTERNET;THESAURUS;THYROID;TONSILLECTOMY;URINARY SYSTEM;VOLCANO","6;4;4;4;3;3;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CYCLOPHOSPHAMIDE;BREAST CANCER;FETUS;RITUXIMAB;BIRTH WEIGHT;CYTARABINE;FOLLICULAR LYMPHOMA;ADENOIDECTOMY;ADRENOCORTICOTROPIC HORMONE;AGENESIS OF THE CORPUS CALLOSUM;AMYOTROPHIC LATERAL SCLEROSIS;AORTIC DISSECTION;AQUIFER;B SYMPTOMS;BRACHIORADIALIS;BREAKPOINT CLUSTER REGION;BULK TANK;CASE FATALITY RATE;CHEMOTHERAPY REGIMEN;CHRONIC LYMPHOCYTIC LEUKEMIA;CLINICAL ENDPOINT;COHORT EFFECT;DACARBAZINE;ELECTIVE CESAREAN SECTION;ENERGY PERFORMANCE;ENERGY POLICY;ETOPOSIDE;GENE REARRANGEMENT;GESTATION;GESTATIONAL AGE;GROUND REACTION FORCE;HAZARD RATIO;HODGKIN'S LYMPHOMA;IMMUNOGLOBULIN HEAVY CHAIN;IMMUNOGLOBULIN LIGHT CHAIN;INDUCTION CHEMOTHERAPY;INVOLUTION (ESOTERISM);KYOTO PROTOCOL;LIVER CANCER;MAINTENANCE THERAPY;MESONEPHRIC DUCT;MESOZOIC;MITOXANTRONE;MULTICYSTIC DYSPLASTIC KIDNEY;NEURORADIOLOGY;NEUTROPENIA;ODDS;OPHIOLITE;PHASES OF CLINICAL RESEARCH;PHILOLOGY;PRIMARY CENTRAL NERVOUS SYSTEM LYMPHOMA;PROGRESSION-FREE SURVIVAL;RENAL AGENESIS;SALVAGE THERAPY;SEDIMENTARY DEPOSITIONAL ENVIRONMENT;T CELL;THROMBOCYTOPENIC PURPURA;THYROID NODULES;THYROID-STIMULATING HORMONE;TOLERABILITY;UNIVARIATE;UNIVARIATE ANALYSIS","4;3;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","FLUDARABINE;MAMMOGRAPHY;VINCRISTINE;ADENOID HYPERTROPHY;ARTESIAN AQUIFER;BENDAMUSTINE;CHORIOAMNIONITIS;COMPLEMENTARITY DETERMINING REGION;GROUNDWATER FLOW;GROUNDWATER RECHARGE;IDARUBICIN;IGHV@;IN UTERO;THYMIC INVOLUTION","3;2;2;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;FEMALE;ITALY;BREAST NEOPLASMS;MIDDLE AGED;MALE;ADULT;AGED;MAMMOGRAPHY;MASS SCREENING;INCIDENCE;LEUKEMIA, LYMPHOCYTIC, CHRONIC, B-CELL;MULTIPLE SCLEROSIS;VIDARABINE;ABNORMALITIES, MULTIPLE;AMYOTROPHIC LATERAL SCLEROSIS;ANEURYSM, DISSECTING;ANTINEOPLASTIC AGENTS;BACTEREMIA","14;13;12;10;8;8;7;6;6;5;5;4;4;4;4;3;3;3;3;3","CHRONIC LYMPHOCYTIC LEUKEMIA RESEARCH;GLOBAL CANCER INCIDENCE AND SCREENING;LYMPHOMA DIAGNOSIS AND TREATMENT;AMYOTROPHIC LATERAL SCLEROSIS RESEARCH;ANESTHESIA AND PAIN MANAGEMENT;ANTIFUNGAL RESISTANCE AND SUSCEPTIBILITY;BALANCE, GAIT, AND FALLS PREVENTION;BREAST CANCER TREATMENT STUDIES;BUILDING ENERGY AND COMFORT OPTIMIZATION;CARDIAC, ANESTHESIA AND SURGICAL OUTCOMES;CLINICAL LABORATORY PRACTICES AND QUALITY CONTROL;CNS LYMPHOMA DIAGNOSIS AND TREATMENT;EAR SURGERY AND OTITIS MEDIA;FETAL AND PEDIATRIC NEUROLOGICAL DISORDERS;GEOLOGICAL AND GEOCHEMICAL ANALYSIS;GROUNDWATER AND ISOTOPE GEOCHEMISTRY;LIVER DISEASE DIAGNOSIS AND TREATMENT;MEAT AND ANIMAL PRODUCT QUALITY;MULTIPLE SCLEROSIS RESEARCH STUDIES;MUSCLE ACTIVATION AND ELECTROMYOGRAPHY STUDIES","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";FOLLICULAR LYMPHOMA;ABVD;ADENOID HYPERTROPHY;AGENESIS;B SYMPTOMS;BENDAMUSTINE;BRACHIORADIALIS;BREAKPOINT CLUSTER REGION;BREAST CANCER SCREENING;BREAST SCREENING;BULK TANK;CASE FATALITY RATE;CHEESEMAKING;CHEMOTHERAPY REGIMEN;CHORIOAMNIONITIS;CLINICAL ENDPOINT;COHORT EFFECT;CROSSTALK;DACARBAZINE","3;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","FOLLICULAR LYMPHOMA;LYMPHOMA PATIENTS;REGGIO EMILIA;ABVD TREATED;ACUTE MYELOID;ACUTE TYPE-A;ADVANCED FOLLICULAR;ADVANCED STAGE;AGEPERIODCOHORT ANALYSIS;AMYOTROPHIC LATERAL;AORTIC CROSS-CLAMPING;AORTIC DISSECTION;APENNINES ITALY;AQUIFER SYSTEMS;ASSESS BREAST;AXILLARY LYMPH;BASED LABORATORY;BIOCHEMICAL DIAGNOSTIC;BRACHIORADIALIS MUSCLE;BREAST CANCER;BREAST SCREENING;CALLOSUM ACC;CANCER MORTALITY;CASECONTROL STUDY;CELL RECEPTORS;CESAREAN SECTION;CHEESEMAKING LOSSES;CHEMO-IMMUNOTHERAPY RITUXIMAB-FC;CHRONIC LYMPHOCYTIC;CLINICAL FEATURES","2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","BREAST CANCER;IGHV GENES;INTERVAL CANCERS;ODDS RATIO;SCREENING PROGRAMMES;STEREOTYPED BCR;TUMOUR SIZE;VOLCANIC PILE;CANCER DEATHS;CANCER MORTALITY;CLL EXPRESSING;CONFIDENCE INTERVAL;EXCESS RISK;HISTOLOGIC TYPE;HYDROTHERMAL ACTIVITY;IG REARRANGEMENTS;MONTHS NA;ORE BODIES;SD CANCERS;SEAFL OOR-STRATIFORM;SERVICE SCREENING;TUMOUR GRADE;UM CLL;ACTIVE SERVER;ACTIVITY CONTINUED;ACTIVITY FORMED;ADDITIONAL IMPACT;ADDITIONAL MOLECULAR;ADJUSTED DEMOGRAPHICS;ADJUSTING NA","6;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1",2,0.07,23.25,4.25,0,0,0,3,0,0,2,4.25,0,0,0,0,0,0,0,0,0,0,0,50,50,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,13,927,3.7,0,0,53,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,NA,NA,"42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","1;1","BASIC BEHAVIORAL AND SOCIAL SCIENCE;BEHAVIORAL AND SOCIAL SCIENCE;CLINICAL RESEARCH;PATIENT SAFETY;PREVENTION;RARE DISEASES","1;1;1;1;1;1",NA,NA,"7.3 MANAGEMENT AND DECISION MAKING","1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_AUSLREGGIOEMILIA",2009,46,9.19565217391304,1.56521739130435,0.638888888888889,0.369565217391304,0.195652173913043,0.130434782608696,0.326086956521739,2,19,11,7,6,0.41,0.24,0.15,0.13,46.61,1.00759823900067,0.304347826086957,0.826086956521739,NA,0.522849613443586,0.351851851851852,0.308333333333333,0.25,"GABRIELE TONNI;ANDREA MERLO;STEFANO FERRETTI;VINCENZO DE LISI;GABRIELE CENTINI;ALESSANDRO VENTURA;LUCÌA MANGONE;G. ROSSI;MARINA VERCELLI;ROBERTO ZANETTI;­ROSARIO ­TUMINO;ANTONIO RUSSO;FABIO FALCINI;ANDREA RABALLO;SUSANNA VITARELLI;CORRADO SINIGAGLIA;ANTONIETTA MELCHIORRE;LUISA BOMMARITO;ROBERTO LATAGLIATA;A. ARENA","7;5;4;4;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2","ANDREA MERLO;ANDREA RABALLO;GABRIELE TONNI;LORENZO PELIZZA;GABRIELE CENTINI;ALESSANDRO VENTURA;ISABELLA CAMPANINI;ALBERTO FERRARI;FEDERICA BONAZZI;MARIA PAOLA BONASONI;FRANK LARØI;L. ROSIGNOLI;G. ROSSI;CLAUDIO DE FELICE;STEFANO GUAZZETTI;DITTE SÆBYE;GIANNI MISTRELLO;K. TAILA;B. MONICA;ANDREA PRATI","2.23;1.83;1.68;1;0.98;0.95;0.83;0.5;0.5;0.5;0.5;0.45;0.41;0.4;0.39;0.33;0.33;0.33;0.33;0.33","GABRIELE TONNI;ANDREA MERLO;ALESSANDRO VENTURA;LUCÌA MANGONE;G. ROSSI;ANDREA RABALLO;B. MONICA;LORENZO PELIZZA;M. GRANDE;ERICA SANTELLI;STEFANO GUAZZETTI;FIORELLA ILARIUCCI;ISABELLA CAMPANINI;MICHELANGELO LAROSA;MARIA PAOLA BONASONI;FRANCESCO FACCHINI;MARCO LEONE;G. POZZOLI;DANIELA AZZONI;M. DOTTORI","7;5;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;1;1","ANDREA MERLO;ANDREA RABALLO;GABRIELE TONNI;LORENZO PELIZZA;ALESSANDRO VENTURA;ISABELLA CAMPANINI;ALBERTO FERRARI;MARIA PAOLA BONASONI;G. ROSSI;STEFANO GUAZZETTI;K. TAILA;B. MONICA;ANDREA PRATI;M. GRANDE;LORENZO CAVAZZUTI;MICHELANGELO LAROSA;MARIA TERESA VILLANI;FRANCESCO FACCHINI;MARCO LEONE;G. POZZOLI","2.23;1.83;1.68;1;0.95;0.83;0.5;0.5;0.41;0.39;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33;0.33","CATERINA STELITANO;FIORELLA ILARIUCCI;ALBA A. BRANDES;ALBERTO FABBRI;ANDRÉS JM FERRERI;ATTILIO GUARINI;CATRINA UHLMANN;DANIELE VALLISA;EMANUELE ZUCCA;FEDERICO CALIGARIS‐CAPPIO;FRANCESCO ZAJA;FRANCO CAVALLI;GAETANO CORAZZELLI;GERASIMUS A PANGALIS;GIAN MARCO AONDIO;GIUSEPPE AVVISATI;GIUSEPPE ROSSI;GRAZIELLA PINOTTI;HENRY GÓMEZ;JOSÉ FAJARDO","645;645;638;638;638;638;638;638;638;638;638;638;638;638;638;638;638;638;638;638","FIORELLA ILARIUCCI;G. ROSSI;ALBERTO FERRARI;LORENZO PELIZZA;ANDREA RABALLO;LUCÌA MANGONE;ERICA SANTELLI;ALESSIA TIEGHI;GIUSEPPINA COMITINI;LUIGI GUGLIOTTA;ANDREA MERLO;G. MAGNANI;ISABELLA CAMPANINI;STEFANO GUAZZETTI;ROSSELLA RODOLFI;GABRIELE TONNI;ROMANO SASSATELLI;PAOLO TERENZIANI;ALESSANDRO VENTURA;DONATA GUIDETTI","645;286;237;237;229;186;157;87;87;87;58;58;56;52;41;33;19;14;11;11","GABRIELE TONNI;ANDREA MERLO;LUCÌA MANGONE;ALESSANDRO VENTURA;ANDREA RABALLO;G. ROSSI;ERICA SANTELLI;FIORELLA ILARIUCCI;ISABELLA CAMPANINI;LORENZO PELIZZA;STEFANO GUAZZETTI;ALBERTO FERRARI;ALESSIA TIEGHI;ANDREA PRATI;CARLO SALVARANI;DANIELA AZZONI;DONATA GUIDETTI;G. MAGNANI;GIUSEPPINA COMITINI;ISOTTA COLORETTI","6;5;4;3;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PSYCHOLOGY;PHYSICS;ENGINEERING;MATHEMATICS;SOCIOLOGY;ECONOMICS;ENVIRONMENTAL SCIENCE;GEOGRAPHY;PHILOSOPHY;ART;CHEMISTRY;MATERIALS SCIENCE","38;20;10;8;6;3;3;3;2;2;2;2;1;1;1","INTERNAL MEDICINE;GENETICS;PSYCHIATRY;SURGERY;ENVIRONMENTAL HEALTH;IMMUNOLOGY;PATHOLOGY;PHYSICAL MEDICINE AND REHABILITATION;RADIOLOGY;CLINICAL PSYCHOLOGY;OBSTETRICS;ARTIFICIAL INTELLIGENCE;GASTROENTEROLOGY;PALEONTOLOGY;PEDIATRICS;PHYSICAL THERAPY;ALGORITHM;ANATOMY;CARDIOLOGY;DERMATOLOGY;ECOLOGY;ONCOLOGY","25;10;8;8;6;6;6;6;6;5;5;4;4;4;4;4;3;3;3;3;3;3","PREGNANCY;CANCER;PSYCHOSIS;SCHIZOPHRENIA (OBJECT-ORIENTED PROGRAMMING);ULTRASOUND;ANTIBODY;POPULATION;ALLERGY;GAIT;LYMPHOMA;OBJECT (GRAMMAR);PSYCHOPATHOLOGY;RANDOMIZED CONTROLLED TRIAL;ABDOMEN;AUTISM;CHEMOTHERAPY;CONFIDENCE INTERVAL;DISEASE;EPIDEMIOLOGY;GENE;HEAD AND NECK;INCIDENCE (GEOMETRY);KINEMATICS;LOGISTIC REGRESSION;MELANOMA;METABOLIC ACIDOSIS;SEASONALITY;URINARY SYSTEM;VIRUS","9;7;5;5;5;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","FETUS;IMMUNOGLOBULIN E;ABORTION;ALLERGEN;CANCER REGISTRY;CYSTOGRAPHY;FOOD ALLERGY;GAIT ANALYSIS;SCHIZOAFFECTIVE DISORDER;SKIN CANCER;3D ULTRASOUND;AMPLIFIER;ANAL CANCER;ANAPHYLAXIS;ANHEDONIA;ANTIMETABOLITE;ANTIPHOSPHOLIPID SYNDROME;AUDITORY HALLUCINATION;AUTISM SPECTRUM DISORDER;AUTOANTIBODY;AUTOIMMUNE DISEASE;BREAST CANCER;BRIEF PSYCHIATRIC RATING SCALE;CERVICAL CANCER;CERVIX;CHROMOSOME;CLINICAL ENDPOINT;COINFECTION;COLORECTAL CANCER;COMPUTED TOMOGRAPHIC;CORONARY ARTERIES;CULPRIT;CYCLOPHOSPHAMIDE;CYTARABINE;DELUSIONAL DISORDER;DEMENTIA PRAECOX;DIPLEGIA;DYSURIA;ESSENTIAL THROMBOCYTHEMIA;FOLLICULAR LYMPHOMA;GAIT CYCLE;GESTATION;GESTATIONAL AGE;GLOBAL ASSESSMENT OF FUNCTIONING;GLUTEN FREE;GROSS MOTOR FUNCTION CLASSIFICATION SYSTEM;GROUND REACTION FORCE;GROUNDED THEORY;HEPATITIS C VIRUS;HODGKIN LYMPHOMA;HYPOPLASTIC LEFT HEART SYNDROME;IMATINIB;INTERNAL CONSISTENCY;INTRACLASS CORRELATION;LIVE BIRTH;MAJOR DEPRESSIVE DISORDER;MISCARRIAGE;MUTATION;PHASES OF CLINICAL RESEARCH;PORCINE CIRCOVIRUS;PREVALENCE;PRODROME;PROJECTIVE SPACE;PSORIATIC ARTHRITIS;PULMONARY ATRESIA;RANSAC;RELATIVE RISK;RELIABILITY (SEMICONDUCTOR);RITUXIMAB;SCALE-INVARIANT FEATURE TRANSFORM;SCHIZOPHRENIA SPECTRUM;SCHIZOTYPAL PERSONALITY DISORDER;SCHIZOTYPY;SONOGRAPHER;SPASTIC;SPASTIC DIPLEGIA;STUNNING;TETRALOGY OF FALLOT;THROMBOCYTOSIS;TRICUSPID ATRESIA;TURNER'S SYNDROME;TYPICALLY DEVELOPING;TYROSINE-KINASE INHIBITOR;ULCERATIVE COLITIS;VASTUS MEDIALIS;WASTING SYNDROME;WINE TASTING;X-RAY FLUORESCENCE","6;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PRENATAL DIAGNOSIS;ADENOMATOUS POLYPOSIS COLI;ANTHRACYCLINE;ANTI-NUCLEAR ANTIBODY;BRONCHOPULMONARY DYSPLASIA;CONCURRENT VALIDITY;DASATINIB;DUCTUS VENOSUS;ENTHESITIS;FAMILIAL ADENOMATOUS POLYPOSIS;FETAL POSITION;FIRST TRIMESTER;FLUDARABINE;GERMLINE MUTATION;HOMOGRAPHY;IMATINIB MESYLATE;KARYOTYPE;NILOTINIB;ORAL ALLERGY SYNDROME;PEANUT ALLERGY;PROCTOCOLECTOMY;PRODUCTS OF CONCEPTION;SCALE FOR THE ASSESSMENT OF NEGATIVE SYMPTOMS;TERATOLOGY;TRUNCUS ARTERIOSUS","3;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;ITALY;;ADULT;MALE;FOOD HYPERSENSITIVITY;MIDDLE AGED;AGED;ULTRASONOGRAPHY, PRENATAL;MELANOMA;SKIN NEOPLASMS;ACQUIRED IMMUNODEFICIENCY SYNDROME;ADOLESCENT;PREGNANCY;PREGNANCY COMPLICATIONS;THROMBOCYTHEMIA, ESSENTIAL;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;ENVIRONMENTAL EXPOSURE;IMMUNOGLOBULIN E","26;22;22;17;16;14;12;12;9;9;8;8;7;7;7;6;6;5;5;5","MENTAL HEALTH AND PSYCHIATRY;FOOD ALLERGY AND ANAPHYLAXIS RESEARCH;PRENATAL SCREENING AND DIAGNOSTICS;AUTISM SPECTRUM DISORDER RESEARCH;CONGENITAL HEART DISEASE STUDIES;CUTANEOUS MELANOMA DETECTION AND MANAGEMENT;LOWER EXTREMITY BIOMECHANICS AND PATHOLOGIES;LYMPHOMA DIAGNOSIS AND TREATMENT;UROLOGICAL DISORDERS AND TREATMENTS;ADVANCED IMAGE AND VIDEO RETRIEVAL TECHNIQUES;ANIMAL VIRUS INFECTIONS STUDIES;CARDIOVASCULAR CONDITIONS AND TREATMENTS;CARDIOVASCULAR ISSUES IN PREGNANCY;CEREBRAL PALSY AND MOVEMENT DISORDERS;CHRONIC MYELOID LEUKEMIA TREATMENTS;CLEFT LIP AND PALATE RESEARCH;CNS LYMPHOMA DIAGNOSIS AND TREATMENT;ELECTROMAGNETIC COMPATIBILITY AND NOISE SUPPRESSION;ENVIRONMENTAL JUSTICE AND HEALTH DISPARITIES;GENETIC FACTORS IN COLORECTAL CANCER","4;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1",";CYSTOGRAPHY;SEASONALITY;3D ULTRASOUND;ADENOMATOUS POLYPOSIS COLI;AMNIOCENTESIS;ANHEDONIA;AUDITORY HALLUCINATION;BIOMECHANICS;BRONCHOPULMONARY DYSPLASIA;CLINICAL ENDPOINT;COEFFICIENT OF VARIATION;COMBINATION THERAPY;CONCORDANCE;CONCURRENT VALIDITY;CORONARY ARTERIES;CORRECT NAME;CULPRIT;DACTYLITIS;DELUSIONAL DISORDER","5;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","AIRTUM STUDY;BLADDER SPONTANEOUS;CANCER REGISTRIES;FEMALE BLADDER;HIGH-DOSE METHOTREXATE;INTENTION UNDERSTANDING;ITALIAN ADULTS;ITALIAN NETWORK;PRENATAL DIAGNOSIS;REGISTRIES AIRTUM;SKIN MELANOMA;SPONTANEOUS RUPTURE;STRONG SEASONALITY;ABSTRACT ACS;ACRANIAENCEPHALOCELE SEQUENCE;ADENOMATOUS POLYPOSIS;ADULTS ATTENDING;ADVANCED FOLLICULAR;AGED GT;AIDSDEFINING ILLNESSES;ALLERGEN LUPINE;ALLERGY CLINICS;ANTERIOR KNEE;ANTHRACYCLINEFLUDARABINECONTAINING REGIMENS;ANTISMOKING STUDY;AORTO-SEPTAL ANGLE;ARTERIOSUS COMMUNIS;ATTENDING ALLERGY;AUDIO AMPLIFIER;AUDITORY HALLUCINATIONS","2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","INFORMATION DERIVED;MOTOR ACT;SAMPLE ANHEDONIA;TD CHILDREN;BIRTH RATE;CONGENITAL ANOMALIES;IFN TREATMENT;JAK VF;LIVE BIRTH;NEGATIVE SYMPTOMS;NORTHERN ITALY;PREVALENCE RATE;SCHIZOPHRENIA SPECTRUM;ANHEDONIA REACHED;ANHEDONIA SCALE;ANHEDONIC SUBGROUP;ASD PERFORMED;AUTISTIC SPECTRUM;BIRTH DEFECTS;CHILDREN CORRECTLY;CONSECUTIVELY OBSERVED;CONSTRUCT VALIDITY;CONTEXT SUGGESTING;CONTROL POPULATION;CONTROLLED TRIALS;CORRECTLY INDICATING;CUTANEOUS PSORIASIS;CYTOGENETIC ANALYSIS;DELUSIONAL DISORDER;DEPRESSED SAMPLE","4;4;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2",7,0.15,7.68,2.5,1,0,0,1,2,0,1,3,0,1,9.5,0,1,1,1.75,6.25,1,0.5,0,253,253.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_AUSLREGGIOEMILIA",2010,38,9.1578947368421,2.36842105263158,0.422222222222222,0.552631578947368,0.31578947368421,0.236842105263158,0.394736842105263,1,19,10,4,4,0.5,0.26,0.11,0.11,26.55,0.587569877931466,0.236842105263158,0.763157894736842,NA,0.494615334715528,0.348484848484849,0.2625,0.333333333333333,"ANDREA RABALLO;LORENZO PELIZZA;GABRIELE TONNI;ANDREA PICCIN;IVANA PIERRI;FEDERICA BONACINI;ALBERTO FERRARI;B. MONICA;CARLOTTA MALAGOLI;M. GRANDE;ALESSANDRO VENTURA;GIOVANNI MARTINELLI;MARCO VINCETI;FRANCESCO FACCHINI;MARCO LEONE;G. POZZOLI;LUCIANO MASINI;MARCO GOBBI;FILÍPPO GHERLINZONI;ROBIN FOÀ","5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2","ANDREA RABALLO;LORENZO PELIZZA;JOSEF PARNAS;ISABELLA CAMPANINI;ANDREA MERLO;FRANK LARØI;FEDERICA BONACINI;ALBERTO FERRARI;GABRIELE TONNI;FEDERICA BONAZZI;ALESSANDRO VENTURA;B. MONICA;M. GRANDE;FRANCESCO FACCHINI;MARCO LEONE;G. POZZOLI;IDA VITO;R. LOSI;B. WELSCH;CARLOTTA MALAGOLI","2.75;1.23;1;0.75;0.75;0.75;0.73;0.73;0.73;0.5;0.48;0.45;0.45;0.45;0.45;0.45;0.42;0.4;0.4;0.38","ANDREA RABALLO;LORENZO PELIZZA;GABRIELE TONNI;FEDERICA BONACINI;ALBERTO FERRARI;B. MONICA;M. GRANDE;ALESSANDRO VENTURA;FRANCESCO FACCHINI;MARCO LEONE;G. POZZOLI;LUCIANO MASINI;IDA VITO;R. LOSI;ISABELLA CAMPANINI;B. WELSCH;ANDREA MERLO;ROSSELLA RODOLFI;C. IOTTI;MARCO MAMEI","5;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;1;1","ANDREA RABALLO;LORENZO PELIZZA;ISABELLA CAMPANINI;ANDREA MERLO;FEDERICA BONACINI;ALBERTO FERRARI;GABRIELE TONNI;ALESSANDRO VENTURA;B. MONICA;M. GRANDE;FRANCESCO FACCHINI;MARCO LEONE;G. POZZOLI;IDA VITO;R. LOSI;B. WELSCH;MARCO MAMEI;B. AUDONE;ALESSANDRO TACCHINI;FRANCO ZAMBONELLI","2.75;1.23;0.75;0.75;0.73;0.73;0.73;0.48;0.45;0.45;0.45;0.45;0.45;0.42;0.4;0.4;0.33;0.33;0.33;0.33","ANDREA RABALLO;ANDREA MERLO;ISABELLA CAMPANINI;ALESSANDRO CORSINI;FEDERICA MANENTI;FEDERICO CERVI;FRANCESCO RONCHETTI;LISA BORGATTI;MATTEO BERTI;JOSEF PARNAS;ANTONIO CALEFFI;ELENA DE ANGELIS;LUCA FERRARI;MARINA MORGANTI;P. MARTELLI;PAOLO BONILAURI;PAOLO BORGHETTI;STEFANO GUAZZETTI;ALESSANDRO MARCHIONI;CHRISTIAN CASALI","222;148;148;146;146;146;146;146;146;143;114;114;114;114;114;114;114;114;91;91","ANDREA RABALLO;ANDREA MERLO;ISABELLA CAMPANINI;FEDERICA MANENTI;STEFANO GUAZZETTI;FEDERICA MASELLI;FABIANA DE SOUZA ORLANDI;LORENZO CAVAZZUTI;LUCÌA MANGONE;MARIAGIULIA CALZARI;ALBERTO ROSI;FRANCO ZAMBONELLI;MARCO MAMEI;NICOLA BOTTONI;MELINDA DINCĂ;ALBERTO FERRARI;FEDERICA BONACINI;LORENZO PELIZZA;ALESSANDRO VENTURA;B. MONICA","222;148;148;146;114;91;69;69;63;46;41;41;41;29;21;17;17;17;14;14","ANDREA RABALLO;GABRIELE TONNI;LORENZO PELIZZA;ALBERTO FERRARI;B. MONICA;FEDERICA BONACINI;FRANCESCO FACCHINI;G. POZZOLI;M. GRANDE;MARCO LEONE;ALESSANDRO VENTURA;ANDREA MERLO;B. WELSCH;IDA VITO;ISABELLA CAMPANINI;LUCIANO MASINI;R. LOSI;ROSSELLA RODOLFI;A. CUCCURESE;ALBERTO ROSI","5;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;1;1","MEDICINE;BIOLOGY;PSYCHOLOGY;COMPUTER SCIENCE;SOCIOLOGY;PHILOSOPHY;ENGINEERING;CHEMISTRY;GEOGRAPHY;GEOLOGY;PHYSICS;BUSINESS;ENVIRONMENTAL SCIENCE;MATERIALS SCIENCE;MATHEMATICS","26;11;8;7;6;4;3;2;2;2;2;1;1;1;1","INTERNAL MEDICINE;SURGERY;PSYCHIATRY;GENETICS;ENVIRONMENTAL HEALTH;OBSTETRICS;CLINICAL PSYCHOLOGY;DEMOGRAPHY;PALEONTOLOGY;PEDIATRICS;PSYCHOTHERAPIST;EPISTEMOLOGY;GASTROENTEROLOGY;LINGUISTICS;ONCOLOGY;PATHOLOGY;RADIOLOGY;SOCIAL PSYCHOLOGY;COMMUNICATION;COMPUTER SECURITY;MATHEMATICS EDUCATION;ORGANIC CHEMISTRY;PHARMACOLOGY;PHYSICAL MEDICINE AND REHABILITATION;TELECOMMUNICATIONS;VETERINARY MEDICINE;WORLD WIDE WEB","17;10;8;6;5;5;4;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2","CANCER;PSYCHOSIS;SCHIZOPHRENIA (OBJECT-ORIENTED PROGRAMMING);GENE;POPULATION;PREGNANCY;LEUKEMIA;ADVERSE EFFECT;CASE-CONTROL STUDY;CLADRIBINE;CLINICAL TRIAL;CONFIDENCE INTERVAL;CONFOUNDING;DELUSION;DISEASE;ELECTROMYOGRAPHY;EXISTENTIALISM;EXPERIENTIAL LEARNING;LUNG CANCER;MAGNETIC RESONANCE IMAGING;MEDICAL PRESCRIPTION;PERSONALITY;PRESENTATION (OBSTETRICS);PSYCHOPATHOLOGY;RESIDENCE;STAGE (STRATIGRAPHY);ULTRASOUND;VOLITION (LINGUISTICS);VULNERABILITY (COMPUTING)","5;5;5;4;4;4;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","FETUS;DELUSIONAL DISORDER;DEMENTIA PRAECOX;HAIRY CELL LEUKEMIA;RELATIVE RISK;3D ULTRASOUND;ADENOCARCINOMA;AUTOIMMUNE DISEASE;CALCIPHYLAXIS;CANCER REGISTRY;CHROMOSOME;COLORECTAL CANCER;DEEP VEIN;DIAPHRAGMATIC HERNIA;DISGUST;EPIDERMAL GROWTH FACTOR RECEPTOR;ESSENTIAL THROMBOCYTHEMIA;EXON;FAST SPIN ECHO;GESTATION;GESTATIONAL AGE;GLANS;GLANS PENIS;HAEMOPHILIA A;HUMAN GENETICS;IMATINIB;IMMUNITY;INTERNET ACCESS;LAND COVER;LIFE EXPECTANCY;LIVE BIRTH;LOW MOLECULAR WEIGHT HEPARIN;LYMPHOBLASTIC LEUKEMIA;MENSTRUAL CYCLE;MUTATION;NEUTROPENIA;NEXT-GENERATION NETWORK;OPHIOLITE;PARANOID SCHIZOPHRENIA;PATELLOFEMORAL PAIN SYNDROME;POLYMERASE CHAIN REACTION;PORCINE CIRCOVIRUS;PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME VIRUS;POSITIVE AND NEGATIVE SYNDROME SCALE;PSYCHIATRIC MEDICATION;RARE DISEASE;SADNESS;SCHIZOAFFECTIVE DISORDER;SCHIZOTYPAL PERSONALITY DISORDER;SCHIZOTYPY;SEROLOGY;SOCIOECONOMIC STATUS;SOFT TISSUE SARCOMA;STANDARDIZED MORTALITY RATIO;STUNNING;TYROSINE-KINASE INHIBITOR;UNIVARIATE ANALYSIS;UTERINE CAVITY;VACCINE EFFICACY;VASTUS LATERALIS MUSCLE;VASTUS MEDIALIS;VIREMIA;WEIGHT GAIN;WIRELESS NETWORK","3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PRENATAL DIAGNOSIS;ABDOMINOPERINEAL RESECTION;ANENCEPHALY;CHILDHOOD LEUKEMIA;CIRCOVIRUS;CONGENITAL DIAPHRAGMATIC HERNIA;DASATINIB;GASTROSCHISIS;HAEMOPHILIA B;KARYOTYPE;MULTIPLEX POLYMERASE CHAIN REACTION;NILOTINIB;SJÖGREN SYNDROME;TERATOLOGY;TOTAL MESORECTAL EXCISION;VENTRICULOMEGALY;WIRELESS BROADBAND","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";HUMANS;FEMALE;MALE;ADULT;CALCIPHYLAXIS;ITALY;CIRCOVIRIDAE INFECTIONS;ADENOCARCINOMA;ADENOCARCINOMA, BRONCHIOLO-ALVEOLAR;LUNG NEOPLASMS;PARANOID DISORDERS;PENIS;PSYCHIATRIC STATUS RATING SCALES;SCHIZOPHRENIA;SCHIZOTYPAL PERSONALITY DISORDER;SKIN ULCER;SWINE DISEASES;VIREMIA;ANTIBODIES, VIRAL","23;13;9;8;6;6;6;5;4;4;4;4;4;4;4;4;4;4;4;3","MENTAL HEALTH AND PSYCHIATRY;CHRONIC LYMPHOCYTIC LEUKEMIA RESEARCH;ELECTROMAGNETIC FIELDS AND BIOLOGICAL EFFECTS;SALIVARY GLAND DISORDERS AND FUNCTIONS;;ADVANCED IMAGE AND VIDEO RETRIEVAL TECHNIQUES;ANIMAL VIRUS INFECTIONS STUDIES;ASSISTED REPRODUCTIVE TECHNOLOGY AND TWIN PREGNANCY;CARDIAC PACING AND DEFIBRILLATION STUDIES;CHRONIC MYELOID LEUKEMIA TREATMENTS;COLORECTAL CANCER SURGICAL TREATMENTS;CONGENITAL ANOMALIES AND FETAL SURGERY;DERMATOLOGICAL AND COVID-19 STUDIES;ELECTROMAGNETIC COMPATIBILITY AND MEASUREMENTS;ENDOMETRIOSIS RESEARCH AND TREATMENT;FETAL AND PEDIATRIC NEUROLOGICAL DISORDERS;FOLATE AND B VITAMINS RESEARCH;GEOLOGICAL AND GEOCHEMICAL ANALYSIS;HEMOPHILIA TREATMENT AND RESEARCH;LANDSLIDES AND RELATED HAZARDS","5;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";CLADRIBINE;DELUSIONAL DISORDER;DEMENTIA PRAECOX;PRESENTATION (OBSTETRICS);VOLITION (LINGUISTICS);VULNERABILITY;3D ULTRASOUND;ABDOMINAL CAVITY;ABDOMINOPERINEAL RESECTION;ACCESS NETWORK;AFFECT;ANENCEPHALY;BEDROCK;CALCIPHYLAXIS;CHILDHOOD LEUKEMIA;CIRCOVIRUS;CONJOINED TWINS;CONTEMPT;DEGRADATION","7;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","CASE-CONTROL STUDY;CELL LEUKEMIA;CLINICAL PRESENTATION;DELLA LETTERATURA;HAIRY CELL;ICGHCL PROTOCOL;ITALIAN COOPERATIVE;LEUKEMIA HCL;NECROSI PENIENA;POWER LINES;PRIMARY SJÖGRENS;PSYCHIATRIC DISORDER;REVISIONE DELLA;SJÖGRENS SYNDROME;SUBCUTANEOUS CLADRIBINE;VEIN THROMBOSIS;ACCESS NETWORKS;ADVERSE EVENTS;AETIOPATHOGENETIC BASIS;ANALYSIS MOLECULAR;ANENCEPHALY-EXENCEPHALY SEQUENCE;ANTENATAL SINGLE-SHOT;ANTICOAGULANT THERAPY;APENNINES REGGIO;AUTOMATIC ANALYSIS;BASIC EMOTION;BIRTH DEFECTS;BOCCASSUOLO OPHIOLITE;BORDERLINE VENTRICULOMEGALY;BRONCHIOLOALVEOLAR ADENOCARCINOMA","2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1","RELATIVE RISK;SOFT-TISSUE SARCOMA;IMPLANT RATES;POWER LINES;BORDERLINE VENTRICULOMEGALY;CONFIDENCE INTERVAL;NEURODEVELOPMENTAL OUTCOME;POSTNATAL MRI;ATRIAL WIDTH;BIRTH DEFECTS;DOSE-RESPONSE RELATION;ELECTROMAGNETIC FIELDS;FETAL BORDERLINE;HAART PERIOD;INCREASED RISK;ISOLATED FETAL;MAGNETIC FIELD;PRIMARY SJÖGRENS;REGGIO EMILIA;SJÖGRENS SYNDROME;SOLID WASTE;CANCERS INCREASED;CASE-CONTROL STUDY;CLINICAL PRACTICE;CONDITIONAL LOGISTIC;CONGENITAL MALFORMATIONS;CRUDE IR;DIAGNOSTIC CATEGORY;DIAGNOSTIC CRITERIA;EXPOSED CHILDREN","6;6;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2",8,0.21,9.12,3,0,1,0,2,25,0,2,3,0,0,1,0,1,0,1,1.5,0,0,0,98.75,99,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,4,206,1.75,0,0,4,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;40 ENGINEERING","1;1;1","DIGESTIVE DISEASES","1",NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_AUSLREGGIOEMILIA",2011,39,7.35897435897436,1.58974358974359,0.629032258064516,0.282051282051282,0.230769230769231,0.0256410256410256,0.307692307692308,0,16,10,2,7,0.41,0.26,0.05,0.18,33.03,0.776447505572926,0.307692307692308,0.871794871794872,NA,0.500658707269665,0.451724137931034,0.483695652173913,0,"ANDREA MERLO;ISABELLA CAMPANINI;ANDREA RABALLO;ALBERTO LEARDINI;SILVIA CANDELA;F. BIAGI;CARLO GAGLIOTTI;MERETE GLENNE ØIE;PAOLO LAURIOLA;SILVIA STORCHI INCERTI;MARIO SARTI;OLE A. ANDREASSEN;MICHELE CORDIOLI;ANDREA RANZI;FRANCESCO FORASTIERE;PAUL MØLLER;INGRID MELLE;ANTONIO PAOLO CIPOLLONI;ELISABETH HAUG;CARLA SABIA","10;5;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","ANDREA MERLO;ISABELLA CAMPANINI;UMBERTO NIZZOLI;ANDREA RABALLO;ALBERTO LEARDINI;F. BIAGI;GIACOMO PIETRANERA;B SOMMAVILLA;SILVIA CANDELA;CLAUDIO BELVEDERE;MARIA GRAZIA BENEDETTI;FRANCESCO LOMBARDI;ANTONIO DE ANGELI;GIOVANNI PASINI;LORENZO CAVAZZUTI;RITA STAGNI;ALESSANDRO GARASSINO;MERETE GLENNE ØIE;OLE A. ANDREASSEN;GABRIELE TONNI","2.66;1.75;1;0.67;0.6;0.6;0.5;0.5;0.49;0.4;0.4;0.33;0.33;0.33;0.33;0.33;0.33;0.25;0.25;0.25","ANDREA MERLO;ISABELLA CAMPANINI;ANDREA RABALLO;ALBERTO LEARDINI;SILVIA CANDELA;F. BIAGI;SILVIA STORCHI INCERTI;CINZIA CAMPARI;G. TORNATORE;FRANCESCO LOMBARDI;MIRKO BACCHIAVINI;PAOLO FANTINATI;IVANO MASSIRIO;GIACOMO PIETRANERA;LAURA BONVICINI;CLAUDIO ROTA;LISA BERTI;MAURO SILINGARDI;CLAUDIA SANVITO;GABRIELE TONNI","10;5;4;3;3;3;2;2;1;1;1;1;1;1;1;1;1;1;1;1","ANDREA MERLO;ISABELLA CAMPANINI;UMBERTO NIZZOLI;ANDREA RABALLO;ALBERTO LEARDINI;F. BIAGI;GIACOMO PIETRANERA;SILVIA CANDELA;FRANCESCO LOMBARDI;GIOVANNI PASINI;LORENZO CAVAZZUTI;ALESSANDRO GARASSINO;GABRIELE TONNI;LAURA BONVICINI;CINZIA CAMPARI;G. TORNATORE;LISA BERTI;M. CAZZAGON;D. RESTUCCIA;GUIDO R. ZANNI","2.66;1.75;1;0.67;0.6;0.6;0.5;0.49;0.33;0.33;0.33;0.33;0.25;0.25;0.24;0.2;0.2;0.2;0.2;0.2","ANDREA RABALLO;ANNE–MARIE BOUVIER;HERMANN BRENNER;INGER KRISTIN LARSEN;LUCÌA MANGONE;MONIKA HACKL;ROBERTO FOSCHI;SILVIA FRANCISCI;V.E.P.P. LEMMENS;ANDREA MERLO;ALBERTO LEARDINI;CLAUDIO BELVEDERE;F. BIAGI;MARIA GRAZIA BENEDETTI;ANNE VOLLMER-LARSEN;DITTE SÆBYE;JOSEF PARNAS;LENNART JANSSON;PETER HANDEST;CINZIA CAMPARI","295;250;250;250;250;250;250;250;250;207;199;199;199;199;162;162;162;162;162;110","ANDREA RABALLO;LUCÌA MANGONE;ANDREA MERLO;CINZIA CAMPARI;MAURO SILINGARDI;STEFANO GHIDINI;CARLO SALVARANI;CLAUDIO ROTA;GABRIELE TONNI;SILVIA STORCHI INCERTI;MIRKO BACCHIAVINI;GIUSEPPE ARGENZIANO;PAOLO FANTINATI;MARIELA IVANA ALVAREZ;ROSSELLA RODOLFI;MICHELANGELO LAROSA;LAURA BONVICINI;ISABELLA CAMPANINI;ALESSANDRO GARASSINO;GIOVANNI PASINI","295;250;207;110;55;53;50;50;45;30;27;22;21;17;17;14;8;7;6;6","ANDREA MERLO;ISABELLA CAMPANINI;ANDREA RABALLO;CINZIA CAMPARI;SILVIA STORCHI INCERTI;ALESSANDRO GARASSINO;CARLO SALVARANI;CLAUDIO ROTA;FRANCESCO LOMBARDI;GABRIELE TONNI;GIACOMO PIETRANERA;GIOVANNI PASINI;GIUSEPPE ARGENZIANO;IVANO MASSIRIO;LAURA BONVICINI;LORENZO CAVAZZUTI;LUCÌA MANGONE;MARIELA IVANA ALVAREZ;MAURO SILINGARDI;MICHELANGELO LAROSA","10;5;4;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;PSYCHOLOGY;MATHEMATICS;SOCIOLOGY;GEOGRAPHY;PHYSICS;COMPUTER SCIENCE;POLITICAL SCIENCE;PHILOSOPHY;CHEMISTRY;ECONOMICS;ENGINEERING;BUSINESS;ENVIRONMENTAL SCIENCE;MATERIALS SCIENCE","34;16;8;7;7;6;6;5;5;4;2;2;2;1;1;1","INTERNAL MEDICINE;PHYSICAL MEDICINE AND REHABILITATION;PSYCHIATRY;ENVIRONMENTAL HEALTH;GENETICS;PHYSICAL THERAPY;CLINICAL PSYCHOLOGY;DEMOGRAPHY;ECOLOGY;ANATOMY;PATHOLOGY;SURGERY;CLASSICAL MECHANICS;LAW;MICROBIOLOGY;ARTIFICIAL INTELLIGENCE;DEVELOPMENTAL PSYCHOLOGY;VETERINARY MEDICINE;ARCHAEOLOGY;DERMATOLOGY;FOOD SCIENCE;GEOMETRY;HUMANITIES;LINGUISTICS;MACROECONOMICS;OBSTETRICS;ORGANIC CHEMISTRY;PALEONTOLOGY;PEDIATRICS;PSYCHOTHERAPIST;RADIOLOGY;STATISTICS","16;9;9;7;7;7;6;6;6;5;5;5;4;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2","POPULATION;BACTERIA;COGNITION;GAIT;KINEMATICS;ALTERNATIVE MEDICINE;BIOMECHANICS;CANCER;COHORT;CONFIDENCE INTERVAL;GENE;MOTION (PHYSICS);POLITICS;SCHIZOPHRENIA (OBJECT-ORIENTED PROGRAMMING);TRUNK;ANKLE;ANTIBIOTICS;ANXIETY;COHORT STUDY;CONTEXT (ARCHAEOLOGY);DEPRESSION (ECONOMICS);DISEASE;EXPOSURE ASSESSMENT;INCIDENCE (GEOMETRY);MOTION ANALYSIS;POISON CONTROL;PREGNANCY;PSYCHOSIS;RANDOMIZED CONTROLLED TRIAL;RECTUM;REHABILITATION;RESIDENCE;TORSO","5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","COLORECTAL CANCER;CUMULATIVE INCIDENCE;GAIT ANALYSIS;PLACEBO;REPRESENTATION (POLITICS);ANTIDEPRESSANT;BERG BALANCE SCALE;BIPOLAR DISORDER;CANCER REGISTRY;CAUSE OF DEATH;CITIZENSHIP;COCHRANE LIBRARY;COGNITIVE IMPAIRMENT;CONGENITAL MALFORMATIONS;DECAPODA;DEMENTIA;ETEST;EUROPEAN POPULATION;EXECUTIVE FUNCTIONS;FETUS;FINE-NEEDLE ASPIRATION;GENE EXPRESSION;GENOME;HOLOTYPE;INOSITOL;INTRACLASS CORRELATION;LACTOBACILLUS;MAJOR DEPRESSIVE DISORDER;MENSTRUAL CYCLE;MODIFIED ASHWORTH SCALE;MOOD DISORDERS;MOTION CAPTURE;NEURAL TUBE;NEUROCOGNITIVE;NEUROPSYCHOLOGY;PHENOTYPE;POSITIVE AND NEGATIVE SYNDROME SCALE;POSTUROGRAPHY;PRODROME;PROTOCOL (SCIENCE);PSEUDOMONAS AERUGINOSA;PSORIATIC ARTHRITIS;PSYCHOEDUCATION;PSYCHOMOTOR LEARNING;RECOMBINANT DNA;RELATIVE RISK;SALMONELLA;SCHIZOPHRENIA SPECTRUM;SEROLOGY;STAPHYLOCOCCUS AUREUS;STUNNING;SUICIDE PREVENTION;SUPRACHIASMATIC NUCLEUS;TACROLIMUS;TINETTI TEST;UTERINE CAVITY;VENOUS THROMBOEMBOLISM;VENOUS THROMBOSIS;VERBAL MEMORY;VITICULTURE;WORKING MEMORY","2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CROSSOVER STUDY;ANENCEPHALY;BIFIDOBACTERIUM;BIPOLAR II DISORDER;CLINICAL DEMENTIA RATING;JADAD SCALE;MANIA;MICROCOCCACEAE;NEURAL TUBE DEFECT;PIPERACILLIN;RELATIVE SURVIVAL;SALMONELLA ENTERICA;SALMONELLA ENTERITIDIS;SEROPREVALENCE;SUICIDAL IDEATION;TRANSCRIPTOME;VECTOR (MOLECULAR BIOLOGY)","2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;FEMALE;MALE;ADULT;MIDDLE AGED;ADOLESCENT;ANTI-BACTERIAL AGENTS;COLORECTAL NEOPLASMS;AGED;ENDOMETRIOSIS;ITALY;PSYCHOTIC DISORDERS;YOUNG ADULT;CALICIVIRIDAE INFECTIONS;ANIMALS;BIFIDOBACTERIUM;CALICIVIRIDAE;NEOPLASMS;SCHIZOPHRENIA","19;17;14;13;12;9;8;7;7;6;6;6;6;6;5;4;4;4;4;4","MENTAL HEALTH AND PSYCHIATRY;COLORECTAL CANCER SCREENING AND DETECTION;MUSCULOSKELETAL PAIN AND REHABILITATION;ANTIBIOTIC RESISTANCE IN BACTERIA;ANTIMICROBIAL RESISTANCE IN STAPHYLOCOCCUS;AUTOIMMUNE AND INFLAMMATORY DISORDERS;BALANCE, GAIT, AND FALLS PREVENTION;BIPOLAR DISORDER AND TREATMENT;BOTULINUM TOXIN AND RELATED NEUROLOGICAL DISORDERS;CEREBRAL PALSY AND MOVEMENT DISORDERS;CHILD AND ADOLESCENT PSYCHOSOCIAL AND EMOTIONAL DEVELOPMENT;CRUSTACEAN BIOLOGY AND ECOLOGY;DIABETES MANAGEMENT AND RESEARCH;ELECTROMAGNETIC FIELDS AND BIOLOGICAL EFFECTS;EMERGENCY AND ACUTE CARE STUDIES;ENDOMETRIOSIS RESEARCH AND TREATMENT;ENVIRONMENTAL JUSTICE AND HEALTH DISPARITIES;EPILEPSY RESEARCH AND TREATMENT;FOLATE AND B VITAMINS RESEARCH;FOOT AND ANKLE SURGERY","3;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";BIOMECHANICS;CROSSOVER STUDY;CUMULATIVE INCIDENCE;DEPRESSION;EXPOSURE ASSESSMENT;MOTION ANALYSIS;REPRESENTATION;TORSO;ABDOMINAL CAVITY;ABNORMALITY;ADAPTABILITY;ANENCEPHALY;ASSOCIATION (PSYCHOLOGY);BERG BALANCE SCALE;BIFIDOBACTERIUM BREVE;BIPOLAR II DISORDER;CLINICAL DEMENTIA RATING;CONCORDANCE;CONGENITAL MALFORMATIONS","7;3;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1","REGGIO EMILIA;TRUNK KINEMATICS;COLORECTAL CANCER;EXPOSURE ASSESSMENT;MULTI-SEGMENT TRUNK;NAIL PSORIASIS;ACTIVITY AMPLITUDE;AETIOPATHOGENETIC BASIS;AFFECTING ANKLE;ALTERNATIVE EXPOSURE;AMPLITUDE ASSOCIATION;ANALYSIS PROTOCOLS;ANKLE KINEMATICS;ANOMALOUS SELF-EXPERIENCE;ARTIFACTS AFFECTING;ASHWORTH SCALE;ASSESS SPASTICITY;ASSESSMENT METHODS;AT-RISK MENTAL;BALANCE GAIT;BEDREST CONDITION;BEHAVIOURAL THERAPY;BIFIDOBACTERIUM BREVE;BIPOLAR DISORDER;BIRTH DEFECTS;BOIS NOIR;BRACHYURA RETROPLUMIDAE;CANCER GUIDELINES;CANCER SURVIVAL;CANTON TICINO","4;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","SCHIZOTYPAL DISORDER;SCHIZOPHRENIA SPECTRUM;CUMULATIVE EXPOSURE;ANOMALOUS SUBJECTIVE;SUBJECTIVE EXPERIENCES;NOVOPEN USERS;PERSONALITY DISORDER;SPECTRUM DISORDER;SUBJECTIVE EXPERIENCE;BIPOLAR DISORDER;CHART MATERIAL;EUROPEAN COUNTRIES;EXPOSURE ASSESSMENT;FOLLOW-UP PERIOD;INITIAL ASSESSMENT;LOGISTIC REGRESSION;PERCEPTUAL DISORDERS;RETROSPECTIVE COHORT;SAB SAB;SALMONELLA ENTERITIDIS;SALMONELLA HADAR;SCHIZOTYPAL PATIENTS;ACUTE NON-AFFECTIVE;BASELINE SOCIO-DEMOGRAPHIC;BASIC SYMPTOMS;BD PATIENTS;BLEND INCLUDED;BORDERLINE PERSONALITY;CANCER SUBSITE;CECAL CONTENTS","17;15;7;6;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2",8,0.21,3.25,1.25,0,0,0,0,1,0,1,1.25,0,0,1.5,0,1,0,0,1,2,0,0,85,85,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_AUSLREGGIOEMILIA",2012,51,8.90196078431373,1.54901960784314,0.645569620253165,0.392156862745098,0.0980392156862745,0.137254901960784,0.294117647058824,3,19,16,4,8,0.37,0.31,0.08,0.16,35.57,0.851569199458561,0.372549019607843,0.843137254901961,5.14457831325301,0.548271379259712,0.375862068965517,0.16,0.333333333333333,"GABRIELE TONNI;STEFANO GUAZZETTI;ANDREA RABALLO;ANDREA MERLO;MARIO LITUANIA;PIERPAOLO PATTACINI;PAOLO GIORGI ROSSI;ALESSANDRO VENTURA;ANTONIO PRETI;ROBERTO G. LUCCHINI;MARIA PAOLA BONASONI;SILVIA CANDELA;ELZA BONTEMPI;SABRINA ROCCHI;FRANCESCA CAROZZI;UGO LUCCA;SILVIA ZONI;MANUEL ZORZI;CATHERINE M. CRESPI;ENRICA ZANDA","7;5;5;5;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2","GABRIELE TONNI;ANDREA RABALLO;MARIO LITUANIA;SILVIA CANDELA;MARCO MANFREDI;ANDREA MERLO;PIERPAOLO PATTACINI;ALESSANDRO VENTURA;MARIA PAOLA BONASONI;STEFANO GUAZZETTI;L. ROSIGNOLI;JOSEF PARNAS;ANTONIO PRETI;MARCELLO VELLANTE;MATTEO CELLA;GABRIELE CENTINI;ROBERTO G. LUCCHINI;ELZA BONTEMPI;DANIO SOMENZI;SONIA PASQUALI","2.1;2.04;1.53;1.28;1;0.64;0.57;0.57;0.57;0.54;0.53;0.5;0.46;0.42;0.42;0.37;0.34;0.34;0.33;0.33","GABRIELE TONNI;STEFANO GUAZZETTI;ANDREA RABALLO;ANDREA MERLO;PIERPAOLO PATTACINI;PAOLO GIORGI ROSSI;ALESSANDRO VENTURA;MARIA PAOLA BONASONI;SILVIA CANDELA;LUCA PINGANI;SÍLVIA FERRARI;ANNIBALE VERSARI;ISABELLA CAMPANINI;VIVIANA VINCI;C. IOTTI;FRANCESCO LOMBARDI;ALBERTO CAVAZZA;MASSIMO VICENTINI;E. CAGNI;BENEDETTA DAMIANO","7;5;5;5;3;3;3;3;3;2;2;2;2;2;1;1;1;1;1;1","GABRIELE TONNI;ANDREA RABALLO;SILVIA CANDELA;MARCO MANFREDI;ANDREA MERLO;PIERPAOLO PATTACINI;ALESSANDRO VENTURA;MARIA PAOLA BONASONI;STEFANO GUAZZETTI;DANIO SOMENZI;LUCA PINGANI;SÍLVIA FERRARI;VIVIANA VINCI;ISABELLA CAMPANINI;GIAMPAOLO RUSSI;PAOLO GIORGI ROSSI;MARCO PANTEGHINI;BRUNO FERRARI;ANNIBALE VERSARI;LELLA GANDINI","2.1;2.04;1.28;1;0.64;0.57;0.57;0.57;0.54;0.33;0.31;0.31;0.31;0.25;0.25;0.22;0.2;0.2;0.18;0.17","STEFANO GUAZZETTI;DONALD R. SMITH;ELZA BONTEMPI;ROBERTO G. LUCCHINI;SILVIA ZONI;ANDREA RABALLO;ANNALISA ZACCO;FILIPPO DONNA;NEIL J. ZIMMERMAN;MARCO SALMISTRARO;STEPHANIE PETER;CARLOTTA MALAGOLI;CATHERINE M. CRESPI;MARCO VINCETI;PAOLO GIORGI ROSSI;ANNA GILLIO‐TOS;ANNAROSA DEL MISTRO;FRANCESCA CAROZZI;GUGLIELMO RONCO;MANUEL ZORZI","447;404;404;404;365;317;271;271;271;232;232;219;219;219;177;154;154;154;154;154","STEFANO GUAZZETTI;ANDREA RABALLO;PAOLO GIORGI ROSSI;FRANCESCA BONVICINI;ANDREA MERLO;ERICA SANTELLI;VIRGINIA GIUBERTI;ALESSANDRO MEGGIATO;LUCÌA MANGONE;FRANCESCO LOMBARDI;ISOTTA COLORETTI;GABRIELE TONNI;ANNIBALE VERSARI;C. BONI;ERMANNO ROSSI;M. FABIANI;SILVIA CANDELA;ALESSANDRO VENTURA;SARA CATELLANI;VIVIANA VINCI","447;317;177;131;128;99;99;88;80;58;54;49;39;33;28;21;21;16;12;12","GABRIELE TONNI;ANDREA MERLO;ANDREA RABALLO;STEFANO GUAZZETTI;ALESSANDRO VENTURA;PAOLO GIORGI ROSSI;SILVIA CANDELA;ANNIBALE VERSARI;ISABELLA CAMPANINI;VIVIANA VINCI;A ANGRISANO;ALBERTO CAVAZZA;ALESSANDRO MEGGIATO;ANGELO GHIRARDUZZI;BRUNO FERRARI;C. BONI;ERICA SANTELLI;ERMANNO ROSSI;FRANCESCA BONVICINI;FRANCESCO LOMBARDI","7;5;5;5;3;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;PSYCHOLOGY;CHEMISTRY;COMPUTER SCIENCE;MATHEMATICS;ENGINEERING;ENVIRONMENTAL SCIENCE;HISTORY;PHILOSOPHY;PHYSICS;POLITICAL SCIENCE;SOCIOLOGY;ART;BUSINESS;ECONOMICS;MATERIALS SCIENCE","44;15;14;6;6;4;3;2;2;2;2;2;2;1;1;1;1","INTERNAL MEDICINE;CLINICAL PSYCHOLOGY;PATHOLOGY;PSYCHIATRY;ENVIRONMENTAL HEALTH;GENETICS;IMMUNOLOGY;RADIOLOGY;DEVELOPMENTAL PSYCHOLOGY;PEDIATRICS;PHYSICAL THERAPY;SURGERY;GYNECOLOGY;NEUROSCIENCE;PHYSICAL MEDICINE AND REHABILITATION;SOCIAL PSYCHOLOGY;ANATOMY;EMERGENCY MEDICINE;ENVIRONMENTAL CHEMISTRY;ONCOLOGY;ORGANIC CHEMISTRY;PALEONTOLOGY;STATISTICS;TOXICOLOGY","24;10;10;10;8;7;7;7;5;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3","POPULATION;PREGNANCY;CANCER;DISEASE;COGNITION;PSYCHOSIS;RANDOMIZED CONTROLLED TRIAL;ADVERSE EFFECT;ANTIBODY;CHEMOTHERAPY;COHORT STUDY;CONFIDENCE INTERVAL;GAIT;MENTAL HEALTH;OBSERVATIONAL STUDY;PROSPECTIVE COHORT STUDY;PSYCHOMETRICS;PSYCHOPATHOLOGY;SCHIZOPHRENIA (OBJECT-ORIENTED PROGRAMMING);VACCINATION","6;6;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3","FETUS;CERVICAL CANCER;CYCLOPHOSPHAMIDE;FUNCTIONAL INDEPENDENCE MEASURE;INFECTIOUS DISEASE (MEDICAL SPECIALTY);INFLUENZA VACCINE;INTERSTITIAL LUNG DISEASE;PLASMAPHERESIS;SCHIZOPHRENIA SPECTRUM;SCHIZOTYPY;TOLERABILITY;ALPHA INTERFERON;APHERESIS;ASCOSPORE;ATRIAL FLUTTER;AZATHIOPRINE;BIPOLAR DISORDER;BREAST CANCER;BRIEF PSYCHIATRIC RATING SCALE;BRONCHODILATOR;CANCER REGISTRY;CENTER OF PRESSURE (FLUID MECHANICS);CHEMOTHERAPY REGIMEN;CLINICAL ENDPOINT;COGNITIVE IMPAIRMENT;COLOR DOPPLER;COLORECTAL CANCER;CROHN'S DISEASE;CRYPTOGENIC ORGANIZING PNEUMONIA;DEMENTIA;EMERGENT LITERACY;EXPLORATORY FACTOR ANALYSIS;FAST SPIN ECHO;FIBULA;FRESH FROZEN PLASMA;GAIT ANALYSIS;GENERAL HEALTH QUESTIONNAIRE;HEART DEFECT;HUMAN FACTORS AND ERGONOMICS;HYPERALDOSTERONISM;HYPOTRICHOSIS;IDIOPATHIC PULMONARY FIBROSIS;IMMUNITY;INFLAMMATORY BOWEL DISEASE;INHALER;INJURY PREVENTION;INTELLIGENCE QUOTIENT;INTERIM ANALYSIS;INTERNAL CONSISTENCY;LEAD EXPOSURE;LEUKOPENIA;LUNG BIOPSY;LYMPHOBLASTIC LEUKEMIA;MENTAL ILLNESS;METALLOID;MINIMALLY CONSCIOUS STATE;NEUROPSYCHOLOGY;NEUROREHABILITATION;OVERWEIGHT;PERMANENT DENTITION;PHARMACOVIGILANCE;PHENOTYPE;POSITIVE AND NEGATIVE SYNDROME SCALE;POSTMARKETING SURVEILLANCE;POSTUROGRAPHY;PRIMARY ALDOSTERONISM;PROMOTION (CHESS);RADIATION TREATMENT PLANNING;RANDOMIZATION;RAW SCORE;RELATIVE RISK;RELIABILITY (SEMICONDUCTOR);REPRESENTATION (POLITICS);RESPIRATORY DISEASE;RIVERMEAD POST-CONCUSSION SYMPTOMS QUESTIONNAIRE;SELENATE;SEROCONVERSION;SINUS RHYTHM;SORAFENIB;SUICIDE PREVENTION;T CELL;THROMBOTIC THROMBOCYTOPENIC PURPURA;VASCULITIS;VENOUS THROMBOEMBOLISM;WECHSLER ADULT INTELLIGENCE SCALE;WEIGHT GAIN","6;3;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PRENATAL DIAGNOSIS;COLPOSCOPY;CORONAVIRUS DISEASE 2019 (COVID-19);ANENCEPHALY;ASCUS (BRYOZOA);BLOOD LEAD LEVEL;CERVICAL INTRAEPITHELIAL NEOPLASIA;CHILDHOOD LEUKEMIA;CHILDHOOD OBESITY;CONCURRENT VALIDITY;ELISPOT;EOSINOPHILIC PNEUMONIA;FALL PREVENTION;FEAR OF FALLING;IDIOPATHIC INTERSTITIAL PNEUMONIA;INTERFERON ALFA;MANIA;METERED-DOSE INHALER;PERSISTENT VEGETATIVE STATE;RELATIVE SURVIVAL;USUAL INTERSTITIAL PNEUMONIA;VINCRISTINE;WECHSLER MEMORY SCALE","6;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","FEMALE;HUMANS;MALE;ADULT;ITALY;;MIDDLE AGED;ADOLESCENT;AGED;CERVICAL INTRAEPITHELIAL NEOPLASIA;UTERINE CERVICAL NEOPLASMS;INFLUENZA VACCINES;SCHIZOPHRENIA;ULTRASONOGRAPHY, PRENATAL;AGED, 80 AND OVER;CHILD;YOUNG ADULT;DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS;ENVIRONMENTAL EXPOSURE;HALLUCINATIONS","33;33;24;17;17;16;12;10;10;9;9;8;8;8;7;7;7;6;6;6","MENTAL HEALTH AND PSYCHIATRY;BALANCE, GAIT, AND FALLS PREVENTION;CERVICAL CANCER AND HPV RESEARCH;CLEFT LIP AND PALATE RESEARCH;HEAVY METAL EXPOSURE AND TOXICITY;INFLUENZA VIRUS RESEARCH STUDIES;ACTION OBSERVATION AND SYNCHRONIZATION;AIR QUALITY AND HEALTH IMPACTS;ANIMAL VIRUS INFECTIONS STUDIES;ANTIMICROBIAL RESISTANCE IN STAPHYLOCOCCUS;BLOOD GROUPS AND TRANSFUSION;CHILD AND ADOLESCENT PSYCHOSOCIAL AND EMOTIONAL DEVELOPMENT;CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) RESEARCH;CRANIOFACIAL DISORDERS AND TREATMENTS;DIABETIC FOOT ULCER ASSESSMENT AND MANAGEMENT;EATING DISORDERS AND BEHAVIORS;GENETIC AND KIDNEY CYST DISEASES;GLOBAL CANCER INCIDENCE AND SCREENING;HEAVY METALS IN ENVIRONMENT;HORMONAL REGULATION AND HYPERTENSION","4;3;3;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1",";FERROALLOY;FUNCTIONAL INDEPENDENCE MEASURE;PANDEMIC;PLASMAPHERESIS;SCHIZOPHRENIA SPECTRUM;TOLERABILITY;ABVD;AMBIGUOUS GENITALIA;ANENCEPHALY;ASCUS (BRYOZOA);BLOOD LEAD LEVEL;CERTAINTY;CHEMOTHERAPY REGIMEN;CHILDHOOD LEUKEMIA;CLINICAL ENDPOINT;COLOR DOPPLER;COMA (OPTICS);COMPARABILITY;CONCURRENT VALIDITY","9;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","CANTON TICINO;COHORT STUDY;EMILIA-ROMAGNA REGION;INFLUENZA VACCINE;ITALIAN ADOLESCENTS;MRI DIAGNOSIS;OMNIVIEW ALGORITHM;PANDEMIC INFLUENZA;POSTURAL STABILITY;PRENATAL ULTRASOUND;SCHIZOPHRENIA SPECTRUM;TICINO STUDY;VACCINE FOCETRIA;ACTIVE SURVEILLANCE;ADOLESCENT MENTAL;ADOLESCENTS EXPOSED;AIRFLOW OBSTRUCTION;ANALYSIS MEASUREMENTS;ANOMALOUS SELF-EXPERIENCE;ANTENATAL SINGLE-SHOT;APHERESIS TREATMENT;ASPHYXIATING THORACIC;ATRIAL FLUTTER;AUREUS CONTAMINATION;BALANCE GAIT;BASED COHORT;BASELINE P-INKA;BLOOD LEAD;BONE BOWING;BONES UNILATERAL","2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","COLORECTAL CANCER;MEDIAN PPM;REPEAT CYTOLOGIC;SURFACE SOIL;UNSATISFACTORY CYTOLOGIC;ASD CHILDREN;BREAST CANCER;CANCER REGISTRIES;CHILD PSYCHIATRISTS;CHILDHOOD LEUKEMIA;CHILDREN TREATED;CYTOLOGIC EXAMINATION;CYTOLOGIC FINDINGS;HPV TEST;MENTAL DISORDERS;SOIL METAL;TENYEAR SURVIVAL;WOMEN AGED;CANCER PREVALENCE;CERVICAL CANCER;CHICHORIUM SPP;CONTROL SAMPLES;CYTOLOGIC TEST;CYTOLOGIC TESTING;EASTERN EUROPE;EUROPEAN WOMEN;FARE SIGNIFICANTLY;FE MEDIAN;FERROALLOY PLANT;HOME GARDENS","4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2",15,0.29,2.12,3.5,1,0,1,0,0,1,2,3.5,0,0,2.75,0,0,1,1,3,1,0,0,101,101,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,1,16,2.04,0,0,1,0,0,0,0,0,0,0,1,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES","1;1;1","AGING;ARTHRITIS;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;ORPHAN DRUG;PAIN RESEARCH;PREVENTION;RARE DISEASES","1;1;1;1;1;1;1;1",NA,NA,"5.1 PHARMACEUTICALS","1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_AUSLREGGIOEMILIA",2013,77,8.1038961038961,1.68831168831169,0.592307692307692,0.454545454545455,0.207792207792208,0.207792207792208,0.441558441558442,7,22,20,18,10,0.29,0.26,0.23,0.13,35.77,1.02503883229896,0.272727272727273,0.753246753246753,6.77832512315272,0.569684608825743,0.462121212121212,0.439716312056738,0.461538461538462,"PAOLO GIORGI ROSSI;GABRIELE TONNI;ANDREA RABALLO;GIUSEPPE CHESI;ANDREA MERLO;MASSIMO VICENTINI;CARLO SALVARANI;FABIO FALCINI;GUGLIELMO RONCO;MIRCO LUSUARDI;GIOVANNI GABUTTI;LUCA PINGANI;PAOLO MARCHETTINI;EMILIA PERINETTI;BENEDETTA DAMIANO;SÍLVIA FERRARI;ANTONIO VOLPI;ISABELLA CAMPANINI;HÉLÈNE BRICOUT;MARCO RIGATELLI","13;6;6;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3","GABRIELE TONNI;ANDREA RABALLO;PAOLO GIORGI ROSSI;GIUSEPPE CHESI;CARLO SALVARANI;ANDREA MERLO;MAURO SILINGARDI;GIORGIO ZECCHI;GIAMPOALO GRISOLIA;ROBERTO NARDI;BENEDETTA DAMIANO;ISABELLA CAMPANINI;MASSIMO VICENTINI;GUGLIELMO RONCO;MIRCO LUSUARDI;MICHELE POLETTI;UBALDO BONUCCELLI;GIAMPAOLO GRISOLIA;YUICHIRO ABE;M. DOTTORI","3.03;2.82;2.58;2.2;1.39;1.22;1;1;1;0.83;0.78;0.78;0.78;0.72;0.63;0.5;0.5;0.5;0.5;0.44","PAOLO GIORGI ROSSI;GABRIELE TONNI;ANDREA RABALLO;GIUSEPPE CHESI;ANDREA MERLO;MASSIMO VICENTINI;CARLO SALVARANI;GUGLIELMO RONCO;MIRCO LUSUARDI;LUCA PINGANI;BENEDETTA DAMIANO;ISABELLA CAMPANINI;PIETRO RAGNI;MARÍA PATRIZIA BOLOGNA;FRANCESCO DEFILIPPO;E. CAGNI;AUGUSTO VAGLIO;A. BOTTI;ANNIBALE VERSARI;CARLO BUZIO","13;6;6;5;5;4;4;4;4;3;3;3;3;2;2;2;2;2;2;2","GABRIELE TONNI;ANDREA RABALLO;PAOLO GIORGI ROSSI;GIUSEPPE CHESI;CARLO SALVARANI;ANDREA MERLO;MAURO SILINGARDI;GIORGIO ZECCHI;BENEDETTA DAMIANO;ISABELLA CAMPANINI;MASSIMO VICENTINI;GUGLIELMO RONCO;MIRCO LUSUARDI;MICHELE POLETTI;YUICHIRO ABE;FRANCESCO DEFILIPPO;IDO IORI;LUCA PINGANI;PIETRO RAGNI;E. CAGNI","3.03;2.82;2.58;2.2;1.39;1.22;1;1;0.78;0.78;0.78;0.72;0.63;0.5;0.5;0.44;0.41;0.38;0.38;0.34","PAOLO GIORGI ROSSI;GUGLIELMO RONCO;CHRIS J.L.M. MEIJER;CLARE GILHAM;HENRY C KITCHENER;JOAKIM DILLNER;JOHANNES BERKHOF;JULIAN PETO;K. MIRIAM ELFSTRÖM;MARC ARBYN;NEREO SEGNAN;PETER J.F. SNIJDERS;SARA TÙNESI;ANDREA MERLO;ANDREA RABALLO;BENEDETTA DAMIANO;ISABELLA CAMPANINI;LUCA PINGANI;MARCO RIGATELLI;SÍLVIA FERRARI","1821;1630;1546;1546;1546;1546;1546;1546;1546;1546;1546;1546;1546;208;147;96;96;67;67;67","PAOLO GIORGI ROSSI;ANDREA MERLO;ANDREA RABALLO;BENEDETTA DAMIANO;ISABELLA CAMPANINI;LUCA PINGANI;PAOLA BALLOTARI;GABRIELE TONNI;MOIRA RAGAZZI;SIMONETTA PIANA;MARÍA PATRIZIA BOLOGNA;SILVIA CANDELA;MASSIMO VICENTINI;CINZIA CAMPARI;FRANCESCO DEFILIPPO;CATERINA LONGO;MARCO MASSARI;LAURA BONVICINI;ROBERTO CRUCCO;SERENA BROCCOLI","1821;208;145;96;96;67;64;62;62;62;56;56;54;41;37;36;36;32;32;32","PAOLO GIORGI ROSSI;ANDREA MERLO;ANDREA RABALLO;GABRIELE TONNI;GIUSEPPE CHESI;MASSIMO VICENTINI;BENEDETTA DAMIANO;ISABELLA CAMPANINI;LUCA PINGANI;PIETRO RAGNI;MIRCO LUSUARDI;CARLO SALVARANI;CINZIA CAMPARI;GIANCARLO GARUTI;IDO IORI;MARÍA PATRIZIA BOLOGNA;PAOLA BALLOTARI;SILVIA CANDELA;ALESSANDRO VENTURA;ANDREA LANDINI","13;5;5;5;5;4;3;3;3;3;3;2;2;2;2;2;2;2;1;1","MEDICINE;BIOLOGY;PSYCHOLOGY;COMPUTER SCIENCE;PHYSICS;ECONOMICS;SOCIOLOGY;ENGINEERING;PHILOSOPHY;POLITICAL SCIENCE;ART;CHEMISTRY;MATHEMATICS;BUSINESS;HISTORY;MATERIALS SCIENCE;GEOGRAPHY","71;15;15;10;9;8;7;6;5;5;4;4;4;2;2;2;1","INTERNAL MEDICINE;PATHOLOGY;PSYCHIATRY;ENVIRONMENTAL HEALTH;RADIOLOGY;SURGERY;FAMILY MEDICINE;GYNECOLOGY;INTENSIVE CARE MEDICINE;ANATOMY;CLINICAL PSYCHOLOGY;GENETICS;NURSING;PALEONTOLOGY;PHYSICAL THERAPY;LAW;ONCOLOGY;PEDIATRICS;PHYSICAL MEDICINE AND REHABILITATION;CARDIOLOGY;EMERGENCY MEDICINE;GENERAL SURGERY;MACROECONOMICS;OPTICS;VIROLOGY","40;21;16;14;11;11;10;9;9;7;7;6;6;6;6;5;5;5;5;4;4;4;4;4;4","CANCER;DISEASE;POPULATION;CONFIDENCE INTERVAL;ANXIETY;COHORT;ALTERNATIVE MEDICINE;DEPRESSION (ECONOMICS);PREGNANCY;PSYCHOLOGICAL INTERVENTION;PSYCHOPATHOLOGY;RANDOMIZED CONTROLLED TRIAL;SCHIZOPHRENIA (OBJECT-ORIENTED PROGRAMMING);CHEMOTHERAPY;COGNITION;CYTOLOGY;DISTRESS;GAIT;GENE;MENTAL HEALTH;OBSERVATIONAL STUDY;PROSPECTIVE COHORT STUDY;PSYCHOSIS;REFERRAL;STAGE (STRATIGRAPHY);STROKE (ENGINE);ULTRASOUND","18;13;12;6;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3","CERVICAL CANCER;CANCER SCREENING;COLORECTAL CANCER;FETUS;VASCULITIS;CANCER REGISTRY;RELATIVE RISK;ASCENDING AORTA;BECK DEPRESSION INVENTORY;MULTICENTER STUDY;MUTATION;NEURALGIA;NEUROCOGNITIVE;NEUROPSYCHOLOGY;PROTOCOL (SCIENCE);RECORD LINKAGE;THYROID CANCER;WARFARIN;ADVERSE DRUG REACTION;ALLELE;ANTIDEPRESSANT;ANTIPSYCHOTIC;ANXIETY DISORDER;AORTIC ARCH;AUTISM SPECTRUM DISORDER;AZATHIOPRINE;BEHCET DISEASE;BEHCET'S DISEASE;BENIGN PAROXYSMAL POSITIONAL VERTIGO;BEVACIZUMAB;BIPOLAR DISORDER;BREAST CANCER;BRIEF PSYCHIATRIC RATING SCALE;CALLIPHORIDAE;CANCER PREVENTION;CANCER STEM CELL;CENSUS;CHEMORADIOTHERAPY;CHONDROCYTE;CHROMOSOME;CISPLATIN;CLOSTRIDIUM BOTULINUM;COCHRANE LIBRARY;COLLABORATIVE CARE;CONCILIATION;CONTROL THEORY (SOCIOLOGY);COST-EFFECTIVENESS ANALYSIS;CRACK CLOSURE;CUMULATIVE INCIDENCE;DEMENTIA;DOCETAXEL;DYSPHORIA;ENDOCRINE SYSTEM;EVIDENCE-BASED MEDICINE;EXECUTIVE FUNCTIONS;FIBULA;FIRST-DEGREE RELATIVES;FORENSIC ENTOMOLOGY;GAIT ANALYSIS;GESTATION;GROUND REACTION FORCE;HAZARD RATIO;IRRITABILITY;JERK;LIFE EXPECTANCY;MAXIMUM BUBBLE PRESSURE METHOD;METASTASIS;MULTIPLE CHOICE;NEUROMUSCULAR DISEASE;NOTCH SIGNALING PATHWAY;OCCULT;ORIGINALITY;PHARMACOVIGILANCE;POSITIVE AND NEGATIVE SYNDROME SCALE;PROCALCITONIN;PSYCHOTIC DEPRESSION;PUPA;QUALITY ASSURANCE;QUALITY-ADJUSTED LIFE YEAR;RADIATION TREATMENT PLANNING;REIMBURSEMENT;RITUXIMAB;SEMIOLOGY;SOCIAL FUNCTIONING;SOMATIZATION;SUNITINIB;TENSION (GEOLOGY);THYROID CARCINOMA;TIBIALIS ANTERIOR MUSCLE;TRANSCRIPTION FACTOR;TRANSEPIDERMAL WATER LOSS;TYPE 2 DIABETES;TYPICALLY DEVELOPING;UNIVARIATE ANALYSIS;VARICELLA ZOSTER VIRUS;VERIFIABLE SECRET SHARING;VIRAL LOAD;VITAMIN D DEFICIENCY;ZEBRAFISH","8;4;4;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CERVICAL SCREENING;CERVICAL CANCER SCREENING;CERVICAL INTRAEPITHELIAL NEOPLASIA;FIRST TRIMESTER;COLONOSCOPY;COLPOSCOPY;DABIGATRAN;GRANULOMATOSIS WITH POLYANGIITIS;PRENATAL DIAGNOSIS;ALLELE FREQUENCY;ANEUPLOIDY;CALLIPHORA VICINA;CAPECITABINE;CARBOPLATIN;CHURG-STRAUSS SYNDROME;CRACK TIP OPENING DISPLACEMENT;EARLY PREGNANCY FACTOR;EXECUTIVE DYSFUNCTION;FRONTOTEMPORAL DEMENTIA;INTERFACE (MATTER);MAMMOGRAPHY;MICROSCOPIC POLYANGIITIS;MISSENSE MUTATION;NOTCH 1;OXALIPLATIN;PAPILLARY THYROID CANCER;PAPILLOMAVIRIDAE;PRIMARY TUMOR;RELATIVE SURVIVAL;RIVAROXABAN;SOMATIZATION DISORDER;SOX9;V600E","4;3;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;ADULT;;ITALY;MALE;MIDDLE AGED;UTERINE CERVICAL NEOPLASMS;AGED;YOUNG ADULT;PAPILLOMAVIRUS INFECTIONS;ADOLESCENT;CERVICAL INTRAEPITHELIAL NEOPLASIA;MASS SCREENING;EARLY DETECTION OF CANCER;THYROID NEOPLASMS;DEPRESSION;PAPILLOMAVIRIDAE;ULTRASONOGRAPHY, PRENATAL;AGED, 80 AND OVER","41;39;35;34;33;27;26;22;20;18;11;10;10;10;9;9;8;7;7;6","CERVICAL CANCER AND HPV RESEARCH;MENTAL HEALTH AND PSYCHIATRY;HERPESVIRUS INFECTIONS AND TREATMENTS;ADVANCED RADIOTHERAPY TECHNIQUES;ATRIAL FIBRILLATION MANAGEMENT AND OUTCOMES;GLOBAL CANCER INCIDENCE AND SCREENING;LUNG CANCER DIAGNOSIS AND TREATMENT;MENTAL HEALTH TREATMENT AND ACCESS;OCULAR DISEASES AND BEHÇET’S SYNDROME;STROKE REHABILITATION AND RECOVERY;THYROID CANCER DIAGNOSIS AND TREATMENT;ACUTE ISCHEMIC STROKE MANAGEMENT;ADVANCEMENTS IN TRANSDERMAL DRUG DELIVERY;AUTISM SPECTRUM DISORDER RESEARCH;BALANCE, GAIT, AND FALLS PREVENTION;BIOFIELD EFFECTS AND BIOPHYSICS;BOTULINUM TOXIN AND RELATED NEUROLOGICAL DISORDERS;CANCER-RELATED MOLECULAR MECHANISMS RESEARCH;CARDIAC IMAGING AND DIAGNOSTICS;CARDIAC, ANESTHESIA AND SURGICAL OUTCOMES","7;4;3;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1",";CANCER SCREENING;CERVICAL SCREENING;DEPRESSION;PULMONOLOGISTS;STROKE;GRANULOMATOSIS WITH POLYANGIITIS;MOTION ANALYSIS;NEUROCOGNITIVE;PAP TEST;PULMONOLOGY;RECORD LINKAGE;ADVERSE DRUG REACTION;AIR MONITORING;ANAS;APIXABAN;ARTERITIS;BEHCET DISEASE;BOTULISM;BREAST CANCER SCREENING","13;4;4;4;3;3;2;2;2;2;2;2;1;1;1;1;1;1;1;1","CERVICAL CANCER;CANCER PATIENTS;CANCER SCREENING;HERPES ZOSTER;INTERNAL MEDICINE;NORTHERN ITALY;OBSERVATIONAL STUDY;ATRIAL FIBRILLATION;CIN HISTOLOGY;COLORECTAL CANCER;DIFFERENTIAL DIAGNOSIS;EMILIA ROMAGNA;HERPETIC NEURALGIA;HISTOLOGY RESULT;INFECTIVE ENDOCARDITIS;INTRACRANIAL TRANSLUCENCY;INVASIVE CERVICAL;ITALIAN REGISTRY;NATIONAL SURVEY;PATIENTS AGED;POPULATION-BASED STUDY;POST HERPETIC;PROSPECTIVE OBSERVATIONAL;REGGIO EMILIA;RESLICING TECHNIQUE;ROMAGNA REGION;STIFF-KNEE GAIT;STROKE PATIENTS;ZOSTER PATIENTS;ABSTRACT NOTCH","5;4;4;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1","STROKETIA SYMPTOMS;ALLELE PERCENTAGE;CANCER PATIENTS;EDUCATIONAL LEVEL;HPV TYPES;VE MUTATION;BACTERIAL INFECTION;BRAF VE;BREAST CANCER;CERVICAL CANCER;CLINICAL PRACTICE;DOSE ESCALATION;EMOTIONAL STIMULI;ER UTILISATION;HC-TARGETED TYPES;HPV DNA;PCT VALUES;POSITIVE PREDICTIVE;REGGIO EMILIA;RR CI;TOTAL DOSE;ACTIVE DISEASE;ANXIETY DISORDER;ATRIAL FIBRILLATION;DEPRESSIVE DISORDERS;DOSAGE UNITS;NEGATIVE COLPOSCOPY;SCREENING PROGRAMME;UTILISATION RATE;ABSOLUTE CIN","6;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;2",14,0.18,3,2.75,4,3,3,14.75,1,1,5.5,3,0,1,2,1,1.5,4,19.75,1.75,14.5,0,0,95,95,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_AUSLREGGIOEMILIA",2014,55,13.0181818181818,2,0.5,0.327272727272727,0.218181818181818,0.345454545454545,0.472727272727273,4,25,15,7,2,0.45,0.27,0.13,0.04,23.96,0.634097849076298,0.345454545454545,0.854545454545454,4.86475409836065,0.450200457451678,0.461038961038961,0.454545454545455,0.444256756756757,"PAOLO GIORGI ROSSI;MICHELE POLETTI;PAOLO CONTIERO;IRENE FLORIANI;FILIPPO BALDACCI;GABRIELE TONNI;CARLO SALVARANI;CLAUDIO LUCETTI;CARMINE PINTO;DAVIDE POLI;STEFANO GUAZZETTI;BARBARA GAMBERI;ANDREA RABALLO;EMILIO BAJETTA;MARIA DI BARTOLOMEO;UBALDO BONUCCELLI;PIETER SONNEVELD;G. COMELLA;ANNA LAURA FANTUZZI;ALFREDO FALCONE","12;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2","PAOLO GIORGI ROSSI;MICHELE POLETTI;NICOLÒ PIPITONE;CLAUDIO TANA;ANNA LAURA FANTUZZI;ROSSELLA GIANNINI;FRANCESCA LUGLI;A. MELO;PAULO ROBERTO ROSA;GABRIELE TONNI;FILIPPO BALDACCI;CLAUDIO LUCETTI;UBALDO BONUCCELLI;CARLO SALVARANI;ANDREA RABALLO;PAOLO DEL DOTTO;STEFANO GUAZZETTI;MARCELLA PALMISANO;ALESSANDRO VENTURA;AVE MARIA BAFFICO","2.06;1.42;1.11;1;0.67;0.67;0.67;0.5;0.5;0.43;0.42;0.42;0.42;0.35;0.34;0.32;0.32;0.29;0.29;0.29","PAOLO GIORGI ROSSI;MICHELE POLETTI;GABRIELE TONNI;CARLO SALVARANI;STEFANO GUAZZETTI;BARBARA GAMBERI;ANDREA RABALLO;MASSIMO VICENTINI;MARCELLA PALMISANO;FRANCESCA LUGLI;ALESSANDRO VENTURA;NEREO SEGNAN;NICOLÒ PIPITONE;PIETRO RAGNI;M LORENZANI;ENRICO VECCHIATI;K. MIRIAM ELFSTRÖM;MATTEO MORETTI;FRANCESCO LOMBARDI;O SALA","12;4;3;3;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1;1","PAOLO GIORGI ROSSI;MICHELE POLETTI;NICOLÒ PIPITONE;CLAUDIO TANA;FRANCESCA LUGLI;A. MELO;GABRIELE TONNI;CARLO SALVARANI;ANDREA RABALLO;STEFANO GUAZZETTI;MARCELLA PALMISANO;ALESSANDRO VENTURA;PIETRO RAGNI;LUCA PINGANI;LORENZO PELIZZA;PAOLO GAMBINI;CHIERICI GIUSEPPINA;HAROLD GÖTHSON;MAURIZIO BINELLO;MARTINA PINI","2.06;1.42;1.11;1;0.67;0.5;0.43;0.35;0.34;0.32;0.29;0.29;0.26;0.25;0.2;0.2;0.2;0.2;0.2;0.2","CARMINE PINTO;DAVIDE POLI;EMILIO BAJETTA;IRENE FLORIANI;MARIA DI BARTOLOMEO;STEFANO GUAZZETTI;ALBERTO MARCHET;ALFREDO FALCONE;BRUNO DANIELE;D. AMADORI;D. NITTI;ENRICO MINI;FRANCESCO DI COSTANZO;G. COMELLA;G. PINOTTI;GERARDO ROSATI;ROBERTO LABIANCA;ALBERTO TOSETTO;ANGELO GHIRARDUZZI;BENILDE COSMI","264;264;264;264;264;179;176;176;176;176;176;176;176;176;176;176;176;172;172;172","STEFANO GUAZZETTI;ANGELO GHIRARDUZZI;MICHELE POLETTI;ANDREA RABALLO;PAOLO GIORGI ROSSI;NICOLA FAZIO;ANDREA MERLO;ISABELLA CAMPANINI;LUCA PINGANI;ANNA MARÍA FERRARI;MARTINA PINI;PAOLO NERI;FAUSTO NICOLINI;LUISA PATERLINI;ROSSELLA RODOLFI;FERDINANDO LUBERTO;EZIO BERGAMINI;KABALA MFUTA;LILLO BRUNO CERAMI;LUCA GIANNELLA","179;172;153;123;89;88;69;69;62;57;57;57;56;56;56;41;33;33;33;33","PAOLO GIORGI ROSSI;MICHELE POLETTI;ANDREA RABALLO;BARBARA GAMBERI;GABRIELE TONNI;STEFANO GUAZZETTI;ALESSANDRO VENTURA;CARLO SALVARANI;MARCELLA PALMISANO;PIETRO RAGNI;ANDREA MERLO;ANGELO BRIGANTI;ANGELO GHIRARDUZZI;ANNA MARÍA FERRARI;ANTONELLA CAMPANILE;ANTONELLA MESSORI;ANTONIO FRATTINI;BRUNA MILLI;CHIERICI GIUSEPPINA;CHRIS J.L.M. MEIJER","10;4;3;3;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1","MEDICINE;BIOLOGY;PSYCHOLOGY;PHYSICS;SOCIOLOGY;CHEMISTRY;COMPUTER SCIENCE;ECONOMICS;MATERIALS SCIENCE;MATHEMATICS;PHILOSOPHY;BUSINESS;ENGINEERING;ENVIRONMENTAL SCIENCE;GEOLOGY;POLITICAL SCIENCE;ART;GEOGRAPHY","47;16;11;10;8;6;5;5;4;4;4;3;3;3;3;3;2;1","INTERNAL MEDICINE;PATHOLOGY;SURGERY;ENVIRONMENTAL HEALTH;PSYCHIATRY;GENETICS;RADIOLOGY;FAMILY MEDICINE;GASTROENTEROLOGY;PEDIATRICS;CLINICAL PSYCHOLOGY;GYNECOLOGY;NURSING;OBSTETRICS;ONCOLOGY;OPTICS;DEMOGRAPHY;ECONOMIC GROWTH;INTENSIVE CARE MEDICINE;NEUROSCIENCE;PHYSICAL THERAPY;QUANTUM MECHANICS;SOCIAL PSYCHOLOGY","31;16;12;11;10;8;8;6;6;6;5;5;5;5;5;5;4;4;4;4;4;4;4","CANCER;POPULATION;DISEASE;GENE;ALTERNATIVE MEDICINE;COGNITION;PREGNANCY;EPIDEMIOLOGY;HEALTH CARE;INCIDENCE (GEOMETRY);AORTA;CHEMOTHERAPY;COHORT STUDY;CONFIDENCE INTERVAL;MULTIPLE MYELOMA;POWER (PHYSICS);RANDOMIZED CONTROLLED TRIAL;REHABILITATION;ANTIBIOTICS;COHORT;CYTOLOGY;DIALYSIS;HUMAN PAPILLOMAVIRUS;LUMEN (ANATOMY);MAGNETIC RESONANCE IMAGING;MANGANESE;NARRATIVE;OCCUPATIONAL SAFETY AND HEALTH;ODDS RATIO;POISON CONTROL;PSYCHOSIS;QUALITATIVE RESEARCH;REGIMEN;SCHIZOPHRENIA (OBJECT-ORIENTED PROGRAMMING);TEST (BIOLOGY)","10;10;8;6;5;5;5;4;4;4;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","CERVICAL CANCER;PARKINSON'S DISEASE;RELIABILITY (SEMICONDUCTOR);AORTIC ARCH;CANCER SCREENING;COLORECTAL CANCER;ESCHERICHIA COLI;FETUS;INJURY PREVENTION;LENALIDOMIDE;MELPHALAN;PROSTATE;PROTOCOL (SCIENCE);SUICIDE PREVENTION;THALIDOMIDE;VASCULITIS;ABDOMINAL AORTA;ADALIMUMAB;ANHEDONIA;ANTIBIOTIC RESISTANCE;ASYMPTOMATIC CARRIER;AUTOLOGOUS STEM-CELL TRANSPLANTATION;AZATHIOPRINE;BORTEZOMIB;BRACHYTHERAPY;CAESAREAN SECTION;CANCER DETECTION;CANCER REGISTRY;CARBAPENEM;CHOROID;CHROMOSOMAL TRANSLOCATION;CHROMOSOME;CHRYSOTILE;CISPLATIN;COLISTIN;CONTRAST-ENHANCED ULTRASOUND;CYCLOPHOSPHAMIDE;DIFFERENTIAL THERMAL ANALYSIS;DOCETAXEL;DOPAMINERGIC;ECOLOGICAL STUDY;EHEALTH;ENDOMETRIAL CANCER;ENVIRONMENTAL REMEDIATION;ETANERCEPT;FLUOROURACIL;GAIT ANALYSIS;GENETIC DIVERSITY;GENOTYPE;HUMAN FACTORS AND ERGONOMICS;HYPERSEXUALITY;INFLIXIMAB;INTELLIGENCE QUOTIENT;INTERPRETATIVE PHENOMENOLOGICAL ANALYSIS;MAGNETIC RESONANCE ANGIOGRAPHY;MENTAL AGE;MICROBUBBLES;MINIMUM INHIBITORY CONCENTRATION;NEUROCOGNITIVE;NEUROTOXICITY;OCCULT;ODDS;OFFSPRING;PARKINSONISM;PERSEVERATION;PERSONALITY DISORDERS;PET THERAPY;PHILOSOPHY OF MEDICINE;PLASMID;POLYMERASE CHAIN REACTION;POPULATION HEALTH;PORTAL HYPERTENSION;PSORIATIC ARTHRITIS;PSYCHIC;RELATIVE RISK;REPRODUCTIVE MEDICINE;RETINOBLASTOMA;RITUXIMAB;SEXUAL AROUSAL;SIMILARITY (GEOMETRY);SPINAL CORD INJURY;SPONDYLITIS;TREMOLITE;TYPE 2 DIABETES;VAGINAL BLEEDING;VENOUS THROMBOEMBOLISM;WAVEFORM;WECHSLER ADULT INTELLIGENCE SCALE;WHITE MATTER;WORKING MEMORY","5;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","CERVICAL INTRAEPITHELIAL NEOPLASIA;CERVICAL CANCER SCREENING;CERVICAL SCREENING;COLPOSCOPY;HPV INFECTION;INTRAEPITHELIAL NEOPLASIA;KLEBSIELLA PNEUMONIAE;ANEUPLOIDY;ANIMAL-ASSISTED THERAPY;ANTIMICROBIAL STEWARDSHIP;BASDAI;BROTH MICRODILUTION;COLONOSCOPY;ENTEROBACTER;ENTEROBACTERIACEAE;EXTERNAL BEAM RADIOTHERAPY;FOLINIC ACID;FRACTIONAL ANISOTROPY;GIANT CELL ARTERITIS;GRANULOMATOSIS WITH POLYANGIITIS;HUBZERO;IRINOTECAN;LEVODOPA;MECHANICAL INDEX;MEMORY SPAN;MILLON CLINICAL MULTIAXIAL INVENTORY;MULTIPLEX POLYMERASE CHAIN REACTION;PORTAL VENOUS SYSTEM;PRENATAL DIAGNOSIS;RAPD;VOXEL-BASED MORPHOMETRY;WECHSLER INTELLIGENCE SCALE FOR CHILDREN","3;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;ITALY;;ADULT;MALE;MIDDLE AGED;AGED;CERVICAL INTRAEPITHELIAL NEOPLASIA;UTERINE CERVICAL NEOPLASMS;EARLY DETECTION OF CANCER;CROSS INFECTION;PARKINSON DISEASE;PREGNANCY;ACCIDENTS, TRAFFIC;ADOLESCENT;BACTERIAL PROTEINS;BETA-LACTAMASES;CYSTS;ENTEROBACTERIACEAE","34;25;23;21;17;17;14;12;11;11;8;7;7;7;6;6;5;5;5;5","CERVICAL CANCER AND HPV RESEARCH;MENTAL HEALTH AND PSYCHIATRY;MULTIPLE MYELOMA RESEARCH AND TREATMENTS;VASCULITIS AND RELATED CONDITIONS;ANTIBIOTIC RESISTANCE IN BACTERIA;CANCER SURVIVORSHIP AND CARE;HEAVY METAL EXPOSURE AND TOXICITY;PARKINSON'S DISEASE MECHANISMS AND TREATMENTS;ASTRO AND PLANETARY SCIENCE;BALANCE, GAIT, AND FALLS PREVENTION;BUSINESS AND MANAGEMENT STUDIES;CARDIAC, ANESTHESIA AND SURGICAL OUTCOMES;CHEMISTRY AND CHEMICAL ENGINEERING;CLINICAL PRACTICE GUIDELINES IMPLEMENTATION;COLORECTAL CANCER SCREENING AND DETECTION;CONGENITAL DIAPHRAGMATIC HERNIA STUDIES;CONGENITAL LIMB AND HAND ANOMALIES;DIABETES MANAGEMENT AND RESEARCH;DIETETICS, NUTRITION, AND EDUCATION;DIGITAL MENTAL HEALTH INTERVENTIONS","5;3;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1",";CANCER SCREENING;CERVICAL SCREENING;LUMEN (ANATOMY);MELPHALAN;PAP TEST;REGIMEN;ABDOMINAL AORTA;AFFECTION;ANHEDONIA;ANIMAL-ASSISTED THERAPY;ANTIMICROBIAL STEWARDSHIP;ANTISEPTIC;ARTERITIS;ASYMPTOMATIC CARRIER;AUTOLOGOUS STEM-CELL TRANSPLANTATION;BASFI;BOLUS (DIGESTION);BROTH MICRODILUTION;BUSINESS PLAN","15;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1","NEWLY DIAGNOSED;PARKINSONS DISEASE;ANKYLOSING SPONDYLITIS;CANCER REHABILITATION;CERVICAL CANCER;COHORT STUDY;DIAGNOSED MULTIPLE;ITALIAN POPULATION-BASED;MULTIPLE MYELOMA;POPULATION-BASED COHORT;REGGIO EMILIA;REHABILITATION SERVICES;ABANDONED MINE;ABERRANT SALIENCE;ABNORMAL BODILY;ADJUVANT TREATMENT;AMERICAN SOCIETY;ANESTHESIOLOGISTS PHYSICAL;ANEURYSMS REPAIR;ANNULMENT DRIVE;ANTI-TNFΑ DRUGS;ANTISEPTICS EXPERIENCE;ANÁLISE EM;ARTERY ANEURYSMS;ASBESTOS MINERALS;ASSESSMENT STUDY;ASSOCIATIONS DANDY-WALKER;AUDITORY VERBAL;AUTOTRANSPLANTATION-ELIGIBLE NEWLY;BIRTH DEFECTS","3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PORTAL VENOUS;ENDOMETRIAL CANCER;PD PATIENTS;ANKYLOSING SPONDYLITIS;CLOVERLEAF SKULL;ENDOMETRIAL THICKNESS;GENE KP;HPV GENOTYPES;RISK-SCORING MODEL;BATH ANKYLOSING;BIOPSY SPECIMENS;CERVICAL CANCER;CONTROL SUBJECTS;CS FREQUENCY;DISEASE DURATION;HPV INFECTION;INTENTION-TO-TREAT ANALYSIS;INTERDISCIPLINARY APPROACH;KP EC;NEGATIVE PERINATAL;ODDS RATIO;PERINATAL OUTCOMES;PHASE STARTING;POSTMENOPAUSAL WOMEN;TD TYPE;THICKNESS MM;TRACHEAL CANNULA;TYPE II;VENOUS SYSTEM;WAVEFORM SIMILARITY","6;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3",24,0.44,4.56,3,2,1,0,4.25,0,0,1,3.25,0,0,3.75,0,2,1.75,1,3.5,2.25,0,0,94.5,94.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,6,128,2.38,0,0,19.5,0,0,1,0,0,0,0,1,0,1,1,0,0,0,0,0,0,1,1,0,2,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3213 PAEDIATRICS;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;4206 PUBLIC HEALTH","2;1;1;1;1;1","CANCER;CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PEDIATRIC;PREVENTION","1;1;1;1;1","CANCER","1","6.1 PHARMACEUTICALS","1","CERVICAL CANCER","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_AUSLREGGIOEMILIA",2015,89,10.8876404494382,2.26966292134831,0.440594059405941,0.348314606741573,0.292134831460674,0.191011235955056,0.49438202247191,2,48,20,11,7,0.54,0.22,0.12,0.08,31.99,0.858339208369377,0.460674157303371,0.876404494382023,4.99283154121864,0.500621336179745,0.468789013732834,0.566037735849057,0.531216931216931,"PAOLO GIORGI ROSSI;GABRIELE TONNI;SERENA BROCCOLI;CARLO SALVARANI;MANUEL ZORZI;CINZIA CAMPARI;ANDREA MERLO;LAURA BONVICINI;STEFANIA CAROLI;ANDREA RABALLO;PAOLA BALLOTARI;MASSIMO VICENTINI;ALESSIO PETRELLI;EDWARD ARAUJO JÚNIOR;ISABELLA CAMPANINI;NICOLÒ PIPITONE;NICOLÁS ZENGARINI;GABRIELE LEVRINI;LORENZO SPAGGIARI;ALESSANDRA FABBRI","23;9;8;7;6;6;6;6;5;5;5;4;4;4;4;4;3;3;3;3","PAOLO GIORGI ROSSI;GABRIELE TONNI;NICOLÒ PIPITONE;ANDREA MERLO;CESARE SECCHI;ISABELLA CAMPANINI;EDWARD ARAUJO JÚNIOR;L. ROSIGNOLI;SERENA BROCCOLI;CARLO SALVARANI;ANDREA RABALLO;STEFANIA CAROLI;LAURA BONVICINI;CINZIA CAMPARI;GIUSEPPE CHESI;MARIA LUIGIA CIPOLLINI;STEFANO OSSICINI;CLAUDIO GIUMELLI;FRANCESCO CIPOLLINI;CARLA GALEONE","2.94;1.83;1.35;1.1;1;0.83;0.75;0.73;0.67;0.66;0.58;0.57;0.52;0.51;0.5;0.5;0.5;0.5;0.5;0.45","PAOLO GIORGI ROSSI;GABRIELE TONNI;SERENA BROCCOLI;CARLO SALVARANI;MANUEL ZORZI;CINZIA CAMPARI;ANDREA MERLO;LAURA BONVICINI;STEFANIA CAROLI;ANDREA RABALLO;PAOLA BALLOTARI;MASSIMO VICENTINI;ISABELLA CAMPANINI;NICOLÒ PIPITONE;GABRIELE LEVRINI;LORENZO SPAGGIARI;ALESSANDRA FABBRI;LUCA PINGANI;COSTANTINO PANZA;ANTONIO CHIARENZA","23;9;8;7;6;6;6;6;5;5;5;4;4;4;3;3;3;3;3;3","PAOLO GIORGI ROSSI;GABRIELE TONNI;NICOLÒ PIPITONE;ANDREA MERLO;CESARE SECCHI;ISABELLA CAMPANINI;SERENA BROCCOLI;CARLO SALVARANI;ANDREA RABALLO;STEFANIA CAROLI;LAURA BONVICINI;CINZIA CAMPARI;GIUSEPPE CHESI;MARIA LUIGIA CIPOLLINI;STEFANO OSSICINI;CLAUDIO GIUMELLI;FRANCESCO CIPOLLINI;MIRCO LUSUARDI;PAOLA BALLOTARI;LUCA PINGANI","2.94;1.83;1.35;1.1;1;0.83;0.67;0.66;0.58;0.57;0.52;0.51;0.5;0.5;0.5;0.5;0.5;0.45;0.44;0.43","CARLO SALVARANI;PAOLO GIORGI ROSSI;ANDREA RABALLO;ANITA RIECHER‐RÖSSLER;ANNA MENEGHELLI;ANTHONY P. MORRISON;BG SCHIMMELMANN;FRAUKE SCHULTZE‐LUTTER;JOACHIM KLOSTERKÖTTER;MARK VAN DER GAAG;MARY MARSHALL;MERETE NORDENTOFT;NADJA P. MARIĆ;RAIMO K. R. SALOKANGAS;STEFANIE J. SCHMIDT;STEPHAN RUHRMANN;AJESH B. MAHARAJ;ALEXANDRE WAGNER;ANDREAS P. DIAMANTOPOULOS;ANDREW HUTCHINGS","733;699;568;538;538;538;538;538;538;538;538;538;538;538;538;538;531;531;531;531","CARLO SALVARANI;PAOLO GIORGI ROSSI;ANDREA RABALLO;STEFANIA CAROLI;CINZIA CAMPARI;FRANCESCA FERRARI;STEFANO GUAZZETTI;MASSIMO VICENTINI;LUISA PATERLINI;ENZA DI FELICE;ANNAMARIA PEZZAROSSI;CLAUDIO SACCHETTINI;FRANCESCA RONCAGLIA;LUCÌA MANGONE;ROBERTO SACCHERO;LAURA BONVICINI;MICHELE POLETTI;SERENA BROCCOLI;SILVIA CANDELA;ANDREA BELLESIA","701;669;568;215;201;171;164;162;152;143;136;135;135;135;135;104;104;104;104;103","PAOLO GIORGI ROSSI;GABRIELE TONNI;SERENA BROCCOLI;CARLO SALVARANI;ANDREA RABALLO;ANDREA MERLO;CINZIA CAMPARI;LAURA BONVICINI;NICOLÒ PIPITONE;LUCA PINGANI;FRANCESCA FERRARI;GABRIELE LEVRINI;LORENZO SPAGGIARI;MASSIMO VICENTINI;PAOLA BALLOTARI;SILVIA CANDELA;CLAUDIO TANA;ISABELLA CAMPANINI;MIRCO LUSUARDI;STEFANIA CAROLI","21;9;7;6;5;5;5;5;4;3;3;3;3;3;3;3;3;3;3;3","MEDICINE;BIOLOGY;PSYCHOLOGY;SOCIOLOGY;PHYSICS;CHEMISTRY;COMPUTER SCIENCE;GEOGRAPHY;ECONOMICS;MATHEMATICS;POLITICAL SCIENCE;ENGINEERING;MATERIALS SCIENCE;PHILOSOPHY;BUSINESS;ENVIRONMENTAL SCIENCE;HISTORY;ART","80;17;16;14;11;8;8;7;6;6;6;5;5;4;3;3;3;1","INTERNAL MEDICINE;PATHOLOGY;ENVIRONMENTAL HEALTH;PSYCHIATRY;FAMILY MEDICINE;RADIOLOGY;SURGERY;OBSTETRICS;DEMOGRAPHY;GENETICS;GYNECOLOGY;PHYSICAL THERAPY;ARCHAEOLOGY;CARDIOLOGY;CLINICAL PSYCHOLOGY;NURSING;PEDIATRICS;QUANTUM MECHANICS;GERONTOLOGY;INTENSIVE CARE MEDICINE;PHYSICAL MEDICINE AND REHABILITATION","50;17;16;15;14;14;14;12;11;11;9;8;7;7;7;7;7;6;5;5;5","CANCER;DISEASE;POPULATION;PREGNANCY;CONFIDENCE INTERVAL;COHORT;EPIDEMIOLOGY;IMMIGRATION;INCIDENCE (GEOMETRY);RHEUMATOLOGY;HEALTH CARE;INTERVENTION (COUNSELING);MAGNETIC RESONANCE IMAGING;ULTRASOUND;ALTERNATIVE MEDICINE;ANXIETY;CHEMOTHERAPY;CYTOLOGY;DERMATOMYOSITIS;DIABETES MELLITUS;LUNG;MIGRAINE;MYOSITIS;POLYMYOSITIS;PRIMARY CARE;PSYCHOMETRICS;PSYCHOSIS;PUBLIC HEALTH;RANDOMIZED CONTROLLED TRIAL;REFERRAL;SCHIZOPHRENIA (OBJECT-ORIENTED PROGRAMMING);TRIAGE","16;12;11;10;7;6;6;6;5;5;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","CERVICAL CANCER;FETUS;COLORECTAL CANCER;VASCULITIS;BREAST CANCER;GESTATION;GESTATIONAL AGE;INTRACLASS CORRELATION;AIRWAY RESISTANCE;ATELECTASIS;BRAIN BIOPSY;CHROMOSOME;CUMULATIVE INCIDENCE;CYCLOPHOSPHAMIDE;DEPRESSIVE SYMPTOMS;HEMIPARESIS;INFECTIOUS DISEASE (MEDICAL SPECIALTY);LEUKOPENIA;MOTIVATIONAL INTERVIEWING;OVERWEIGHT;PAIN MEDICINE","6;6;5;5;4;4;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","COLONOSCOPY;COLPOSCOPY;PRENATAL DIAGNOSIS;BRONCHIAL THERMOPLASTY;CERVICAL CANCER SCREENING;CERVICAL INTRAEPITHELIAL NEOPLASIA;GIANT CELL ARTERITIS;AXILLA;BRONCHUS;CANAKINUMAB;CEREBRAL AMYLOID ANGIOPATHY;CEREBRAL VASCULITIS;CETUXIMAB;COMPARATIVE GENOMIC HYBRIDIZATION;DACLIZUMAB;DIABETES MANAGEMENT;DUCTUS VENOSUS;EARLY PREGNANCY FACTOR;ECULIZUMAB;ELLAGIC ACID;FLUORESCENCE IN SITU HYBRIDIZATION;GLYCATED HEMOGLOBIN;GOLIMUMAB;HOLOPROSENCEPHALY;JET QUENCHING;KARYOTYPE;MAMMOGRAPHY;MEPOLIZUMAB;NEOADJUVANT THERAPY;OMALIZUMAB;PAPILLOMAVIRIDAE;PARADOXICAL EMBOLISM;PATIENT HEALTH QUESTIONNAIRE;PROTHROMBIN COMPLEX CONCENTRATE;PSEUDORAPIDITY;PULSATILITY INDEX;SENTINEL LYMPH NODE;SENTINEL NODE;SMALL FOR GESTATIONAL AGE;TRASTUZUMAB;UMBILICAL ARTERY;UTERINE ARTERY;VIRAL MENINGITIS","3;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;FEMALE;ITALY;MALE;ADULT;MIDDLE AGED;UTERINE CERVICAL NEOPLASMS;AGED;EARLY DETECTION OF CANCER;CERVICAL INTRAEPITHELIAL NEOPLASIA;MASS SCREENING;PAPILLOMAVIRUS INFECTIONS;PREGNANCY;SCHIZOPHRENIA;YOUNG ADULT;ADOLESCENT;COLORECTAL NEOPLASMS;EMIGRANTS AND IMMIGRANTS;ENVIRONMENTAL EXPOSURE","45;44;36;28;25;23;22;17;16;11;10;9;9;8;8;8;7;7;7;7","CERVICAL CANCER AND HPV RESEARCH;MIGRATION, HEALTH AND TRAUMA;VASCULITIS AND RELATED CONDITIONS;AIR QUALITY AND HEALTH IMPACTS;ASTHMA AND RESPIRATORY DISEASES;COLORECTAL CANCER SCREENING AND DETECTION;INFLAMMATORY MYOPATHIES AND DERMATOMYOSITIS;MENTAL HEALTH AND PSYCHIATRY;BALANCE, GAIT, AND FALLS PREVENTION;CEREBRAL PALSY AND MOVEMENT DISORDERS;CHILD AND ADOLESCENT PSYCHOSOCIAL AND EMOTIONAL DEVELOPMENT;GLOBAL CANCER INCIDENCE AND SCREENING;HEAVY METALS IN ENVIRONMENT;MIGRAINE AND HEADACHE STUDIES;OBESITY, PHYSICAL ACTIVITY, DIET;SARCOIDOSIS AND BERYLLIUM TOXICITY RESEARCH;;AORTIC ANEURYSM REPAIR TREATMENTS;ATRIAL FIBRILLATION MANAGEMENT AND OUTCOMES;AUTOPSY TECHNIQUES AND OUTCOMES","6;4;4;3;3;3;3;3;2;2;2;2;2;2;2;2;1;1;1;1",";TRIAGE;ATELECTASIS;BRAIN BIOPSY;BRONCHIAL THERMOPLASTY;COLORECTAL CANCER SCREENING;CUMULATIVE INCIDENCE;HEMIPARESIS;LEUKOPENIA;LONGITUDINAL STUDY;MOTIVATIONAL INTERVIEWING;PAIN MEDICINE;POLYMYALGIA RHEUMATICA;RHEUMATISM;SAMPLE (MATERIAL);STROKE;3D ULTRASOUND;ABDOMINAL AORTA;ADENOMYOMA;ADENOMYOSIS","27;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1","CANCER SCREENING;CERVICAL CANCER;COLORECTAL CANCER;POPULATION-BASED STUDY;SCHIZOPHRENIA SPECTRUM;ABNORMAL EXPERIENCE;ANOMALOUS ECHO;BLOOD PRESSURE;BRONCHIAL THERMOPLASTY;CENTRAL NERVOUS;COGNITIVE IMPAIRMENT;COHORT STUDY;COLLABORATIVE INITIATIVE;CONGENITAL ANOMALIES;CONTROLLED TRIAL;ECHO EXPLORING;EMOTIONAL MOTOR;EUROPEAN LEAGUE;EXPERIENCE CORRELATES;EXPLORING ABNORMAL;FIBRIN PLUGS;FREQUENT FALLERS;INFECTIOUS DISEASES;LONGITUDINAL STUDIES;LUNG ATELECTASIS;MATERNAL EXPOSURE;METROPOLITAN LONGITUDINAL;MONITOR INFECTIOUS;MOTIVATIONAL INTERVIEWING;MOTOR RESONANCE","5;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","RESPIRATORY FAILURE;BORN ABROAD;MONTH FOLLOW-UP;REGGIO EMILIA;SEVERE ASTHMA;CLINICAL PRACTICE;EMERGENCY PHYSICIANS;IRR CI;LEFT LOWER;NON-INVASIVE VENTILATION;AGE-ADJ RR;CHEST X-RAY;CONTROL CONDITIONS;CYSTIC ADENOMYOSIS;DIABETES REGISTER;HEALTH PROFESSIONALS;HMPC CITIZENS;HPV POSITIVITY;HYSTEROSCOPIC FETOSCOPY;INFECTIOUS DISEASES;ITALIAN EMERGENCY;MANAGEMENT STRATEGIES;OVERWEIGHT CHILDREN;RISK FACTOR;SCREENING PROGRAMMES;TOSV-INFECTED PATIENTS;ACR RECOMMENDATIONS;ACUTE RESPIRATORY;AGE-ADJUSTED PREVALENCE;ALTERATION INDUCED","6;5;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2",34,0.38,6.03,5.5,2,1,0,2,2,0,2,6.75,0,0,3.75,0,2.5,1,3,3,1,0,0,110.25,110.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_AUSLREGGIOEMILIA",2016,79,9.93670886075949,1.9493670886076,0.512987012987013,0.291139240506329,0.227848101265823,0.164556962025316,0.392405063291139,0,29,16,8,13,0.37,0.2,0.1,0.16,15.57,0.479315808267644,0.367088607594937,0.886075949367089,5.02325581395349,0.473090478522806,0.538888888888889,0.491379310344828,0.53265306122449,"PAOLO GIORGI ROSSI;GABRIELE TONNI;CLAUDIO TANA;EDWARD ARAUJO JÚNIOR;CARMINE PINTO;FERDINANDO LUBERTO;MASSIMO VICENTINI;LUCÌA MANGONE;SERENA BROCCOLI;CLAUDIO SACCHETTINI;MAURO SILINGARDI;TORELLO LOTTI;UWE WOLLINA;GEORGI TCHERNEV;PEDRO DALTRO;PAOLA BALLOTARI;PAOLA ANGELINI;COSIMA SCHIAVONE;FRANCESCA CAROZZI;O SALA","17;10;10;8;6;6;5;5;5;4;4;4;4;4;4;4;4;3;3;3","PAOLO GIORGI ROSSI;GABRIELE TONNI;CLAUDIO TANA;CARMINE PINTO;EDWARD ARAUJO JÚNIOR;LUCÌA MANGONE;ENRICO BORGHI;MAURO SILINGARDI;MASSIMO VICENTINI;CLAUDIO SACCHETTINI;MICHELE POLETTI;L. ROSIGNOLI;VITTORIO GARILLI;SERENA BROCCOLI;PEDRO DALTRO;PAOLA BALLOTARI;COSIMA SCHIAVONE;TORELLO LOTTI;UWE WOLLINA;GEORGI TCHERNEV","1.81;1.79;1.51;1.26;1.17;1.06;0.83;0.81;0.76;0.73;0.58;0.5;0.5;0.49;0.48;0.48;0.46;0.44;0.44;0.44","PAOLO GIORGI ROSSI;GABRIELE TONNI;CLAUDIO TANA;EDWARD ARAUJO JÚNIOR;CARMINE PINTO;FERDINANDO LUBERTO;MASSIMO VICENTINI;LUCÌA MANGONE;SERENA BROCCOLI;CLAUDIO SACCHETTINI;MAURO SILINGARDI;PAOLA BALLOTARI;O SALA;STEFANO GUAZZETTI;SILVIA CANDELA;ENRICO BORGHI;GIANPAOLO GRISOLIA;MICHELE POLETTI;LAURA BONVICINI;LUIGI BOIARDI","17;10;10;8;6;6;5;5;5;4;4;4;3;3;3;2;2;2;2;2","PAOLO GIORGI ROSSI;GABRIELE TONNI;CLAUDIO TANA;CARMINE PINTO;EDWARD ARAUJO JÚNIOR;LUCÌA MANGONE;ENRICO BORGHI;MAURO SILINGARDI;MASSIMO VICENTINI;CLAUDIO SACCHETTINI;MICHELE POLETTI;SERENA BROCCOLI;PAOLA BALLOTARI;FERDINANDO LUBERTO;MAURO IORI;ROBERTO SGHEDONI;STEFANO GUAZZETTI;MARCO TANA;GIANPAOLO GRISOLIA;LAURA BONVICINI","1.81;1.79;1.51;1.26;1.17;1.06;0.83;0.81;0.76;0.73;0.58;0.49;0.48;0.42;0.4;0.4;0.37;0.37;0.36;0.34","PAOLO GIORGI ROSSI;CLAUDIO TANA;GABRIELE TONNI;EDWARD ARAUJO JÚNIOR;CARLO SALVARANI;LUIGI BOIARDI;NICOLÒ PIPITONE;PIERLUIGI MACCHIONI;FRANCESCA CAROZZI;GIANNAPIA AFFAITATI;GUGLIELMO RONCO;MARIA ADELE GIAMBERARDINO;MASSIMO CONFORTINI;RAFFAELE COSTANTINI;COSIMA SCHIAVONE;ANNAROSA DEL MISTRO;DOMENICO LAPENNA;FRANCESCO CIPOLLONE;PAOLO MARTELLETTI;MANUEL ZORZI","346;171;171;170;144;144;144;144;123;123;123;123;123;123;115;113;113;113;113;112","PAOLO GIORGI ROSSI;CLAUDIO TANA;GABRIELE TONNI;CARLO SALVARANI;LUIGI BOIARDI;NICOLÒ PIPITONE;PIERLUIGI MACCHIONI;LUCÌA MANGONE;ALBERTO NICOLINI;ANNIBALE VERSARI;GIUSEPPE GERMANÒ;MASSIMILIANO CASALI;NICCOLÒ POSSEMATO;FERDINANDO LUBERTO;PAMELA MANCUSO;ALBERTO CAVAZZA;FRANCESCO MURATORE;G. RESTUCCIA;MARIA GRAZIA CATANOSO;ELISA CARRETTA","304;171;171;144;144;144;144;91;78;78;78;78;78;68;67;66;66;66;66;53","PAOLO GIORGI ROSSI;CLAUDIO TANA;GABRIELE TONNI;FERDINANDO LUBERTO;LUCÌA MANGONE;SERENA BROCCOLI;CLAUDIO SACCHETTINI;PAOLA BALLOTARI;CARLO SALVARANI;ENRICO BORGHI;LAURA BONVICINI;LUIGI BOIARDI;MARCELLA PALMISANO;MASSIMO VICENTINI;MAURO IORI;MAURO SILINGARDI;MICHELE POLETTI;NICOLÒ PIPITONE;PAMELA MANCUSO;PIERLUIGI MACCHIONI","14;10;10;6;5;5;4;3;2;2;2;2;2;2;2;2;2;2;2;2","MEDICINE;BIOLOGY;MATHEMATICS;SOCIOLOGY;COMPUTER SCIENCE;PSYCHOLOGY;PHYSICS;CHEMISTRY;ENGINEERING;MATERIALS SCIENCE;GEOGRAPHY;ENVIRONMENTAL SCIENCE;GEOLOGY;POLITICAL SCIENCE;ECONOMICS;PHILOSOPHY","71;25;13;12;11;11;10;7;7;7;4;3;3;3;2;2","INTERNAL MEDICINE;ENVIRONMENTAL HEALTH;PATHOLOGY;GYNECOLOGY;OBSTETRICS;DEMOGRAPHY;GENETICS;SURGERY;STATISTICS;ONCOLOGY;PALEONTOLOGY;PSYCHIATRY;OPTICS;RADIOLOGY;PEDIATRICS;CLINICAL PSYCHOLOGY;FAMILY MEDICINE;GASTROENTEROLOGY;NURSING;SOCIAL PSYCHOLOGY","47;27;22;14;14;12;12;12;11;8;8;8;7;7;6;5;5;5;5;5","CANCER;POPULATION;PREGNANCY;CONFIDENCE INTERVAL;DISEASE;EPIDEMIOLOGY;COHORT;LUNG;ULTRASOUND;CYTOLOGY;INCIDENCE (GEOMETRY);LOGISTIC REGRESSION;LUNG CANCER;MORTALITY RATE;DIABETES MELLITUS;GENE;ASBESTOS;CONTEXT (ARCHAEOLOGY);MAGNETIC RESONANCE IMAGING;MASS SPECTROMETRY;MESOTHELIOMA;ODDS RATIO;REFERRAL;VIRUS","21;21;10;8;7;7;6;6;6;5;5;5;5;5;4;4;3;3;3;3;3;3;3;3","CERVICAL CANCER;FETUS;POISSON REGRESSION;ZIKA VIRUS;ACCELERATOR MASS SPECTROMETRY;CANCER REGISTRY;CERVIX;COLORECTAL CANCER;ENDOMETRIAL CANCER;GESTATION;GESTATIONAL AGE;HAZARD RATIO;INFECTIOUS DISEASE (MEDICAL SPECIALTY);LINEAR PARTICLE ACCELERATOR;NOCICEPTION;PANCREATIC CANCER;RESPIRATORY DISEASE;TYPE 2 DIABETES;VASCULITIS;3D ULTRASOUND;ADENOCARCINOMA;ALLELE;AMPLIFIER;ANTIBIOTIC PROPHYLAXIS;ASBESTOSIS;ASCOSPORE;ATHEROSCLEROSIS RISK IN COMMUNITIES;AUTISM SPECTRUM DISORDER;AUTOIMMUNE DISEASE;BIRTH WEIGHT;CANCER INCIDENCE;CANCER PREVENTION;CARCINOGENESIS;CENTRIFUGAL FAN;CEREBELLAR ATAXIA;CHLOROQUINE;COMMON CAROTID ARTERY;CONFIRMATORY FACTOR ANALYSIS;CONTRAST-ENHANCED ULTRASOUND;CRONBACH'S ALPHA;CROSSBITE;CYTOPATHOLOGY;DIAPHRAGMATIC BREATHING;EARLY PLEISTOCENE;EARLY PSYCHOSIS;ECHOGENICITY;ELITE ATHLETES;EPIDERMAL GROWTH FACTOR RECEPTOR;FATTY LIVER;GEMCITABINE;GENE EXPRESSION;GENETIC PREDISPOSITION;GENOTYPE;HEART RATE;HEPATIC FIBROSIS;HERD IMMUNITY;HIGH-RESOLUTION COMPUTED TOMOGRAPHY;HODGKIN LYMPHOMA;IMMUNOSTAINING;IMPEDANCE MATCHING;IMPUTATION (STATISTICS);INDUCTIVELY COUPLED PLASMA MASS SPECTROMETRY;INFORMED CONSENT;INTENTION TREMOR;INTRACLASS CORRELATION;LABOR INDUCTION;LIFE EXPECTANCY;LOW BIRTH WEIGHT;LUPUS ERYTHEMATOSUS;MENTAL ILLNESS;METASTASIS;MICRORNA;NEURODEVELOPMENTAL DISORDER;NEUTROPHIL TO LYMPHOCYTE RATIO;OBSTETRICS AND GYNAECOLOGY;OVARIAN CANCER;PACLITAXEL;PARKINSONISM;PARTICLE NUMBER;PERIPHERALLY INSERTED CENTRAL CATHETER;PROCALCITONIN;PRODROME;PROMOTION (CHESS);PROSTATE;PROSTATE CANCER;QUARTILE;RELATIVE RISK;RESEARCH METHODOLOGY;SAMPLING (SIGNAL PROCESSING);SEROLOGY;STANDARDIZED MORTALITY RATIO;STANDARDIZED UPTAKE VALUE;SUSPENSION (TOPOLOGY);SYSTEMIC LUPUS ERYTHEMATOSUS;THEORY OF PLANNED BEHAVIOR;TOLERABILITY;TRANSFORMER;TRANSISTOR;TRIPTANS;ULTRASOUND IMAGING;UTERINE CANCER;WARFARIN;WECHSLER ADULT INTELLIGENCE SCALE","7;7;5;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","PRENATAL DIAGNOSIS;CERVICAL CANCER SCREENING;CERVICAL INTRAEPITHELIAL NEOPLASIA;CERVICAL SCREENING;COLPOSCOPY;CORONAVIRUS DISEASE 2019 (COVID-19);GIANT CELL ARTERITIS;HYPERALGESIA;PLEURAL DISEASE;ASCUS (BRYOZOA);BISHOP SCORE;CASCODE;CONGENITAL DIAPHRAGMATIC HERNIA;CONNECTIVE TISSUE DISEASE;CORPUS UTERI;DNA MISMATCH REPAIR;ERLOTINIB;FAMILY PLANNING;FIRST TRIMESTER;GENOTYPING;GESTATIONAL DIABETES;GLYCATED HAEMOGLOBIN;HPV INFECTION;IN UTERO;IRINOTECAN;LOW-NOISE AMPLIFIER;LYMPHOVASCULAR INVASION;MICROSATELLITE;NODULAR SCLEROSIS;NOISE FIGURE;OLIGOHYDRAMNIOS;OPERATIONAL AMPLIFIER;OXALIPLATIN;RELATIVE SURVIVAL;RIGHT COMMON CAROTID ARTERY;SMALL FOR GESTATIONAL AGE;SOX9;STEATOHEPATITIS;TRANSCONDUCTANCE;UMBILICAL ARTERY;UTERINE ARTERY;VENTRICULOMEGALY;VO2 MAX;WECHSLER INTELLIGENCE SCALE FOR CHILDREN","6;4;3;3;3;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;FEMALE;;ITALY;MALE;ADULT;MIDDLE AGED;UTERINE CERVICAL NEOPLASMS;AGED;PAPILLOMAVIRUS INFECTIONS;RETROSPECTIVE STUDIES;NEOPLASMS;MAGNETIC RESONANCE IMAGING;PREGNANCY;ULTRASONOGRAPHY, PRENATAL;ADOLESCENT;CERVICAL INTRAEPITHELIAL NEOPLASIA;REGISTRIES;AGED, 80 AND OVER;EARLY DETECTION OF CANCER","44;38;35;27;27;23;21;16;12;10;10;9;8;8;8;7;7;7;6;6","CERVICAL CANCER AND HPV RESEARCH;AIR QUALITY AND HEALTH IMPACTS;MOSQUITO-BORNE DISEASES AND CONTROL;OCCUPATIONAL AND ENVIRONMENTAL LUNG DISEASES;ASSISTED REPRODUCTIVE TECHNOLOGY AND TWIN PREGNANCY;FETAL AND PEDIATRIC NEUROLOGICAL DISORDERS;FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME RESEARCH;NEUROENDOCRINE TUMOR RESEARCH ADVANCES;VASCULITIS AND RELATED CONDITIONS;APPENDICITIS DIAGNOSIS AND MANAGEMENT;ATTACHMENT AND RELATIONSHIP DYNAMICS;AUTISM SPECTRUM DISORDER RESEARCH;BONE TISSUE ENGINEERING MATERIALS;CANCER DIAGNOSIS AND TREATMENT;CANCER TREATMENT AND PHARMACOLOGY;CANCER-RELATED MOLECULAR MECHANISMS RESEARCH;CARDIAC PACING AND DEFIBRILLATION STUDIES;CONNECTIVE TISSUE DISORDERS RESEARCH;CULTURAL COMPETENCY IN HEALTH CARE;DENTAL MATERIALS AND RESTORATIONS","7;4;3;3;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1",";CERVICAL SCREENING;PAP TEST;ZIKA VIRUS;ACCELERATOR MASS SPECTROMETRY;CROSS-SECTIONAL STUDY;INTERQUARTILE RANGE;LARGE INTESTINE;MICROCEPHALY;PLEURAL DISEASE;PRENATAL ULTRASOUND;PRESENTATION (OBSTETRICS);SEASONALITY;SELF-EFFICACY;3D ULTRASOUND;ABUTMENT;ARTERITIS;ARTIFICIAL CARDIAC PACEMAKER;ASBESTOSIS;ASCUS (BRYOZOA)","10;3;3;3;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1","CANCER RISK;CERVICAL CANCER;INTRAUTERINE ZIKA;LONG-TERM MORTALITY;PROGNOSTIC FACTORS;REGGIO EMILIA;VIRUS INFECTION;ZIKA VIRUS;ASBESTOS CLEARANCE;ASBESTOS-EXPOSED WORKERS;CANCER SCREENING;ELECTRON LINEAR;EXPLAINING LONG-TERM;FINE PARTICLE;LINEAR ACCELERATOR;MONTE CARLO;MORTALITY TREND;NORTHERN ITALY;PHYSICAL MODELS;PLEURAL CANCER;POOLED COHORT;SUPERSITE PROJECT;WORKERS ROLE;ABDOMINAL SARCOIDOSIS;ACTIVATION PROCESSES;ACTIVATION PRODUCTS;ACUTE APPENDICITIS;ADENOCARCINOMA DATA;ADOLESCENTS BIOMARKERS;ADVANCED PANCREATIC","3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1","ZIKA VIRUS;HPV MRNA;CAPTURE CONTROL;FIBROMYALGIA PAIN;PARENTAL BONDING;Κ CI;CAROTID ARTERY;CONFIDENCE INTERVAL;HPV DNA;MRNA TEST;PAIN THRESHOLDS;PHYSICAL MODELS;RR CI;BRAIN SCAN;CENTRAL NERVOUS;CERVICAL CANCER;CLOSE RELATIONSHIPS;CONGENITAL ANOMALIES;FETAL REDUCTION;FFDG UPTAKE;MZ TWINNING;NERVOUS SYSTEM;RENDERING MODE;SCANNER ΜM;SIGNIFICANTLY INCREASED;VASCULAR FFDG;VIRUS INFECTION;ACTIVE VASCULAR;ATRIAL CAPTURE;CAROTID CEUS","9;8;6;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4;4;4;4;4;4;4;3;3;3",30,0.38,7.82,10.75,3,1,1,2,0,0,1,11,0,0,8.75,0,2,1,2.5,7.5,3,0,0,77,77,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,4,"PUBLIC LIBRARY OF SCIENCE","4","32 BIOMEDICAL AND CLINICAL SCIENCES;31 BIOLOGICAL SCIENCES;3103 ECOLOGY;3202 CLINICAL SCIENCES;3209 NEUROSCIENCES;41 ENVIRONMENTAL SCIENCES","2;1;1;1;1;1","CHRONIC PAIN;FIBROMYALGIA;PAIN RESEARCH","1;1;1","MUSCULOSKELETAL","1",NA,NA,"CLINICAL","1","CLINICAL MEDICINE AND SCIENCE","1",NA,NA,NA,NA
"IRCCS_AUSLREGGIOEMILIA",2017,107,14.3457943925234,2.83177570093458,0.353135313531353,0.271028037383178,0.280373831775701,0.14018691588785,0.504672897196262,0,46,28,9,17,0.43,0.26,0.08,0.16,17.46,0.592296111094757,0.457943925233645,0.981308411214953,4.89367816091954,0.5196862059188,0.465882352941177,0.476,0.519031141868512,"PAOLO GIORGI ROSSI;CARLO SALVARANI;LUCÌA MANGONE;ANDREA RABALLO;MASSIMO VICENTINI;FRANCESCO MERLI;MARIA GIUSEPPINA CABRAS;VINCENZO COVIELLO;MOIRA RAGAZZI;PAMELA MANCUSO;MARIO FUSCO;FRANCESCO CUCCARO;ADRIANO GIACOMIN;UMBERTO VITOLO;GUIDO MAZZOLENI;MANUEL ZORZI;ILARIA SCAZZA;S. TROPEA;MARTA MOSCA;IVANO MASSIRIO","15;10;9;6;5;5;4;4;4;4;4;4;4;3;3;3;3;3;3;3","CARLO SALVARANI;PAOLO GIORGI ROSSI;FEDERICO IELLI;GIANFRANCO PASQUALI;ANDREA RABALLO;VALENTINA CHIESA;MANUEL ZORZI;MICHELE POLETTI;EVA GEBHARDT;LUCÌA MANGONE;MUHAMMAD ASIM KHAN;ANTONIO CHIARENZA;HANS VERREPT;FLAVIANO ZANDONAI;MARIE DAUVRIN;GIOVANNI TENEGGI;MARINA IEMMI;ISABELLA CAMPANINI;VALERIA MANICARDI;MASSIMO VICENTINI","2.35;2.02;2;1;0.94;0.71;0.69;0.58;0.58;0.54;0.5;0.5;0.5;0.5;0.5;0.5;0.46;0.43;0.42;0.4","PAOLO GIORGI ROSSI;CARLO SALVARANI;LUCÌA MANGONE;ANDREA RABALLO;MASSIMO VICENTINI;FRANCESCO MERLI;MOIRA RAGAZZI;PAMELA MANCUSO;MARIO FUSCO;GUIDO MAZZOLENI;ILARIA SCAZZA;IVANO MASSIRIO;STEFANO LUMINARI;LORENZO PELIZZA;FEDERICA PATERLINI;LUCA BRAGLIA;FEDERICA TORRICELLI;GIANCARLO BISAGNI;ISABELLA CAMPANINI;VANNI BORGHI","15;10;9;6;5;5;4;4;4;3;3;3;3;3;3;3;3;3;3;3","CARLO SALVARANI;PAOLO GIORGI ROSSI;FEDERICO IELLI;GIANFRANCO PASQUALI;ANDREA RABALLO;VALENTINA CHIESA;MICHELE POLETTI;LUCÌA MANGONE;ANTONIO CHIARENZA;HANS VERREPT;GIOVANNI TENEGGI;MARINA IEMMI;ISABELLA CAMPANINI;VALERIA MANICARDI;MASSIMO VICENTINI;IVAN IVANOVSKI;PAMELA MANCUSO;PIERLUIGI MACCHIONI;ANDREA MERLO;MARINA GRECI","2.35;2.02;2;1;0.94;0.71;0.58;0.54;0.5;0.5;0.5;0.46;0.43;0.42;0.4;0.4;0.38;0.38;0.37;0.34","PAOLO GIORGI ROSSI;MOIRA RAGAZZI;MASSIMO VICENTINI;ALFREDO CARRATO;ANA GONÇALVES;ANDREA SZENTESI;ANNEGIEN BROEKS;CLAUS WILKI FRISTRUP;ESTHER MOLINA‐MONTES;FRANCISCO X. REAL;GÁBOR LAKATOS;HARLINDE DE SCHUTTER;HERMANN BRENNER;LEI HUANG;LIESBET VAN EYCKEN;LINA JANSEN;LYDIA G. VAN DER GEEST;MAJA PRIMIC‐ŽAKELJ;MARC G. BESSELINK;MARGIT MÄGI","342;236;194;192;192;192;192;192;192;192;192;192;192;192;192;192;192;192;192;192","PAOLO GIORGI ROSSI;ROMANO SASSATELLI;TIZIANA CASSETTI;MARINA GRECI;PAOLA BALLOTARI;ELISA GASPARINI;MASSIMO VICENTINI;IVANA MALAVOLTI;SABRINA CAFFARRI;VLADIMIRO GINOCCHI;FEDERICA TORRICELLI;VALERIA MANICARDI;MOIRA RAGAZZI;L. CASOLI;ALESSIA CIARROCCHI;GLORIA MANZOTTI;GRETA GANDOLFI;ISABELLA CAMPANINI;MILA GUGNONI;SIMONETTA PIANA","281;192;192;147;147;142;133;131;131;131;115;109;105;102;100;100;100;100;100;100","PAOLO GIORGI ROSSI;ANDREA RABALLO;CARLO SALVARANI;FRANCESCO MERLI;LUCÌA MANGONE;FEDERICA PATERLINI;FEDERICA TORRICELLI;ILARIA SCAZZA;IVANO MASSIRIO;LORENZO PELIZZA;MOIRA RAGAZZI;PAMELA MANCUSO;SARA GARLASSI;ISABELLA CAMPANINI;MASSIMO VICENTINI;ALESSIA CIARROCCHI;ANDREA MERLO;ANGELA FERRARI;ANTONIO CHIARENZA;CINZIA CAMPARI","13;5;5;5;5;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2","MEDICINE;BIOLOGY;PSYCHOLOGY;PHYSICS;POLITICAL SCIENCE;SOCIOLOGY;COMPUTER SCIENCE;ENGINEERING;MATHEMATICS;GEOGRAPHY;PHILOSOPHY;ECONOMICS;ART;BUSINESS;CHEMISTRY;MATERIALS SCIENCE;ENVIRONMENTAL SCIENCE;GEOLOGY;HISTORY","91;29;21;15;13;10;9;9;9;8;8;7;5;5;5;4;2;1;1","INTERNAL MEDICINE;PATHOLOGY;ENVIRONMENTAL HEALTH;PSYCHIATRY;ONCOLOGY;FAMILY MEDICINE;SURGERY;GASTROENTEROLOGY;GENETICS;IMMUNOLOGY;LAW;RADIOLOGY;PEDIATRICS;GYNECOLOGY;COGNITIVE PSYCHOLOGY;OPTICS;PALEONTOLOGY;CLINICAL PSYCHOLOGY;DEMOGRAPHY;NURSING;SOCIAL PSYCHOLOGY;VIROLOGY","68;22;21;17;16;13;13;12;12;11;11;11;10;9;8;8;8;7;7;7;7;7","CANCER;POPULATION;DISEASE;INCIDENCE (GEOMETRY);HEALTH CARE;RHEUMATOLOGY;EPIDEMIOLOGY;LYMPHOMA;ANTIBODY;CHEMOTHERAPY;PSYCHOSIS;VIRUS;COHORT;CONFIDENCE INTERVAL;GENE;MAGNETIC RESONANCE IMAGING;PREGNANCY;OBSERVATIONAL STUDY;RANDOMIZED CONTROLLED TRIAL;ALTERNATIVE MEDICINE;ANXIETY;BIOPSY;CHECKLIST;DIABETES MELLITUS;LUNG CANCER;MENTAL HEALTH;MESOTHELIOMA;PSYCHOMETRICS;PSYCHOPATHOLOGY;RHEUMATOID ARTHRITIS;SCHIZOPHRENIA (OBJECT-ORIENTED PROGRAMMING);STAGE (STRATIGRAPHY);SUBCLINICAL INFECTION;TEST (BIOLOGY)","26;16;9;9;8;8;7;7;6;6;6;6;5;5;5;5;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3","BREAST CANCER;CERVICAL CANCER;CLINICAL ENDPOINT;COLORECTAL CANCER;SEROLOGY;CANCER REGISTRY;METASTASIS;RITUXIMAB;SYNOVITIS;TYPE 2 DIABETES;VASCULITIS;CHEMOTHERAPY REGIMEN;CHINESE HAMSTER OVARY CELL;FETUS;HAZARD RATIO;JOINT EFFUSION;NEUTROPENIA;PHASES OF CLINICAL RESEARCH;PROGRESSIVE DISEASE;PROSTATE CANCER;PSORIATIC ARTHRITIS;STANDARDIZED MORTALITY RATIO;UNIVARIATE ANALYSIS;ZIKA VIRUS","10;5;4;4;4;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2","MAMMOGRAPHY;CERVICAL CANCER SCREENING;CERVICAL SCREENING;COLPOSCOPY;ENTHESITIS;GIANT CELL ARTERITIS;RIBAVIRIN;SEROPREVALENCE;VENTRICULOMEGALY;ANAPLASTIC LYMPHOMA KINASE;ANTIMICROBIAL STEWARDSHIP;ANTIRETROVIRAL THERAPY;B-CELL ACTIVATING FACTOR;BENDAMUSTINE;BLASTOID;BROMODOMAIN;BRONCHIAL THERMOPLASTY;CHLORAMBUCIL;CIRCULATING TUMOR CELL;CORONAVIRUS DISEASE 2019 (COVID-19);DOMESTIC VIOLENCE;ENHANCER;ESTROGEN RECEPTOR;GENE EXPRESSION PROFILING;GOLIMUMAB;HIGHLY PATHOGENIC;HORMONE RECEPTOR;INSULIN-LIKE GROWTH FACTOR 1 RECEPTOR;LAMIVUDINE;MACE;MEPOLIZUMAB;METASTATIC BREAST CANCER;MUCOSA-ASSOCIATED LYMPHOID TISSUE;NEOADJUVANT THERAPY;OMALIZUMAB;PALIPERIDONE PALMITATE;PAZOPANIB;PERIPHERAL T-CELL LYMPHOMA;PRASUGREL;PRIMARY TUMOR;REFLEXOLOGY;RELATIVE SURVIVAL;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;RUNX2;RUXOLITINIB;SOLITARY FIBROUS TUMOR;SPLENIC MARGINAL ZONE LYMPHOMA;TAKAYASU ARTERITIS;TAMOXIFEN;TICAGRELOR;UREA CYCLE","4;2;2;2;2;2;2;2;2;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1;1","HUMANS;;ITALY;FEMALE;MALE;ADULT;MIDDLE AGED;AGED;BREAST NEOPLASMS;EARLY DETECTION OF CANCER;UTERINE CERVICAL NEOPLASMS;PAPILLOMAVIRUS INFECTIONS;PSYCHOTIC DISORDERS;REGISTRIES;AGED, 80 AND OVER;MASS SCREENING;NEOPLASMS;CALICIVIRIDAE INFECTIONS;YOUNG ADULT;MAMMOGRAPHY","53;50;50;40;36;30;28;21;19;16;16;14;11;11;10;10;10;9;9;8","LYMPHOMA DIAGNOSIS AND TREATMENT;SCHIZOPHRENIA RESEARCH AND TREATMENT;CERVICAL CANCER AND HPV RESEARCH;GLOBAL CANCER INCIDENCE AND SCREENING;OCCUPATIONAL AND ENVIRONMENTAL LUNG DISEASES;RHEUMATOID ARTHRITIS RESEARCH AND THERAPIES;VASCULITIS AND RELATED CONDITIONS;VIRAL GASTROENTERITIS RESEARCH AND EPIDEMIOLOGY;CEREBRAL PALSY AND MOVEMENT DISORDERS;COLORECTAL CANCER SCREENING AND DETECTION;DIGITAL RADIOGRAPHY AND BREAST IMAGING;MENTAL HEALTH AND PSYCHIATRY;MIGRATION, HEALTH AND TRAUMA;MOSQUITO-BORNE DISEASES AND CONTROL;PREGNANCY AND MEDICATION IMPACT;ACTION OBSERVATION AND SYNCHRONIZATION;AGING AND GERONTOLOGY RESEARCH;ANIMAL VIRUS INFECTIONS STUDIES;ANTIBIOTIC USE AND RESISTANCE;ANTIPLATELET THERAPY AND CARDIOVASCULAR DISEASES","6;5;4;4;3;3;3;3;2;2;2;2;2;2;2;1;1;1;1;1",";CLINICAL ENDPOINT;SUBCLINICAL INFECTION;ARTERITIS;BREAST CANCER SCREENING;CERVICAL SCREENING;CHEMOTHERAPY REGIMEN;CONCOMITANT;DISCONTINUATION;ETIOLOGY;JOINT EFFUSION;MICROCEPHALY;OUTPATIENT CLINIC;PAP TEST;REGIMEN;SEROPREVALENCE;STANDARDIZED MORTALITY RATIO;TRIAGE;UNIVARIATE ANALYSIS;VENTRICULOMEGALY","21;4;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","BREAST CANCER;CANCER SCREENING;NORTHERN ITALY;CLINICAL PRACTICE;RECALL SURVEY;SCREENING PROGRAMMES;B-CELL LYMPHOMA;CELL LYMPHOMA;COHORT STUDY;CONGENITAL ZIKA;EXPRESSIVE WRITING;FONDAZIONE ITALIANA;HEALTH CARE;II STUDY;INTENSIVE CARE;ITALIAN CERVICAL;ITALIANA LINFOMI;LYMPHOID TISSUE;MAINTENANCE THERAPY;MARGINAL ZONE;MENTAL HEALTH;NATIONAL SURVEY;NEUROIMAGING FINDINGS;PHASE II;PRIMARY CARE;RHEUMATOLOGY CENTERS;T-CELL PROJECT;TISSUE MALT;TYPE DIABETES;VIRUS INFECTION","6;4;4;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","REGGIO EMILIA;RA PTS;HR CI;CHRONIC OBSTRUCTIVE;CLINICAL PRACTICE;IRR CI;MTP JOINTS;OBSTRUCTIVE PULMONARY;PD SIGNAL;PULMONARY DISEASE;TYPE DIABETES;CONFIDENCE INTERVAL;EMILIA ITALY;INVITATION COVERAGE;LOCAL RHEUMATOLOGISTS;LUNG CANCER;LV GCA;POWER DOPPLER;BONE EROSIONS;BREAST CANCER;CANCER SCREENING;CHILDREN BORN;DI REGGIO;DIABETES DURATION;DISEASE ACTIVITY;ENDOMETRIAL CANCER;EXCESS RISK;HALO SIGN;HPV DNA;INCREASED RISK","19;12;8;7;7;7;7;7;7;7;7;6;6;6;6;6;6;6;5;5;5;5;5;5;5;5;5;5;5;5",39,0.36,4.46,5,1.75,1,1,27,0,0,1.5,5.5,0,0,5,0,0,1,5.5,3.25,3,0,0,80,80,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,4.5,1000.5,0.96,1,0.5,126.5,0,0,0,0,1,0,0,1,0,2,0,0,0,0,0,0,0,1,1,0,2,0,0,0,0,0,0,0,0,0,"Italy","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS;4206 PUBLIC HEALTH","2;2;1;1;1;1","CANCER;CLINICAL RESEARCH;AGING;BIOMEDICAL IMAGING;BREAST CANCER;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;HEALTH SERVICES;HEMATOLOGY;LYMPHOMA;ORPHAN DRUG;PREVENTION;RARE DISEASES","2;2;1;1;1;1;1;1;1;1;1;1","CANCER","1","6.1 PHARMACEUTICALS","1","BREAST CANCER;NON-HODGKIN'S LYMPHOMA","1;1","4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;6.5 EDUCATION AND COMMUNICATION","1;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_AUSLREGGIOEMILIA",2018,214,12.4532710280374,2.91588785046729,0.342948717948718,0.448598130841121,0.275700934579439,0.401869158878505,0.490654205607477,3,114,45,15,19,0.53,0.21,0.07,0.09,17.36,0.568867036101225,0.397196261682243,0.962616822429907,4.49047619047619,0.458318388494537,0.408691465029493,0.433967876264128,0.411815068493151,"CARLO SALVARANI;PAOLO GIORGI ROSSI;CARMINE PINTO;FRANCESCO MURATORE;MATTEO RICCÒ;LUIGI BOIARDI;SIMONETTA PIANA;MARIA CECILIA MENGOLI;LUCA CIMINO;LOREDANA DE MARCO;MAGDA ZANELLI;LUIGI VEZZOSI;C. IOTTI;CATERINA LONGO;ALBERTO CAVAZZA;ALESSIA CIARROCCHI;GABRIELE TONNI;PAMELA MANCUSO;M. ESPOSITO;GIOVANNI PELLACANI","19;14;11;10;9;8;8;8;8;7;7;7;6;6;6;6;6;6;6;5","MATTEO RICCÒ;FRANCESCO MURATORE;PAOLO GIORGI ROSSI;LUIGI VEZZOSI;CARLO SALVARANI;MICHELE POLETTI;MARIA CECILIA MENGOLI;GABRIELE TONNI;MAGDA ZANELLI;CARMINE PINTO;FRANCESCO BERNI;EDWARD ARAUJO JÚNIOR;LOREDANA DE MARCO;SIMONETTA PIANA;LUIGI BOIARDI;CARLO SIGNORELLI;LUCA CIMINO;PAMELA MANCUSO;ANDREA RABALLO;FRANCESCO LEALI","2.53;2.24;2.04;1.94;1.85;1.52;1.15;1.11;1.09;1.06;1;0.94;0.92;0.9;0.85;0.83;0.74;0.69;0.68;0.67","CARLO SALVARANI;PAOLO GIORGI ROSSI;CARMINE PINTO;FRANCESCO MURATORE;MATTEO RICCÒ;LUIGI BOIARDI;SIMONETTA PIANA;MARIA CECILIA MENGOLI;LUCA CIMINO;LOREDANA DE MARCO;MAGDA ZANELLI;C. IOTTI;CATERINA LONGO;ALBERTO CAVAZZA;ALESSIA CIARROCCHI;GABRIELE TONNI;PAMELA MANCUSO;G. RESTUCCIA;ILARIA SCAZZA;MAURIZIO ZIZZO","19;14;11;10;9;8;8;8;8;7;7;6;6;6;6;6;6;5;5;5","MATTEO RICCÒ;FRANCESCO MURATORE;PAOLO GIORGI ROSSI;CARLO SALVARANI;MICHELE POLETTI;MARIA CECILIA MENGOLI;GABRIELE TONNI;MAGDA ZANELLI;CARMINE PINTO;FRANCESCO BERNI;LOREDANA DE MARCO;SIMONETTA PIANA;LUIGI BOIARDI;LUCA CIMINO;PAMELA MANCUSO;MATTIA SANTACHIARA;CATERINA LONGO;ALESSIA CIARROCCHI;MAURIZIO ZIZZO;STEFANO LUMINARI","2.53;2.24;2.04;1.85;1.52;1.15;1.11;1.09;1.06;1;0.92;0.9;0.85;0.74;0.69;0.67;0.66;0.64;0.63;0.59","CARLO SALVARANI;PENTTI A. JÄRVINEN;ALAN M. SOLINGER;CHANDRASENA PAMULAPATI;DAVID B. HALL;DOMINIQUE BAETEN;JAMES CHENG‐CHUNG WEI;JOACHIM SIEPER;LAI‐SHAN TAM;MIKKEL ØSTERGAARD;PAOLO GIORGI ROSSI;PAUL SCHOLL;STELLA ASLANYAN;STEVEN J. PADULA;SUDHA VISVANATHAN;TAE‐HWAN KIM;YAKOV DATSENKO;SILVIO CAVUTO;ATUL DEODHAR;CÉSAR PACHECO‐TENA","757;505;323;323;323;323;323;323;323;323;323;323;323;323;323;323;323;187;182;182","CARLO SALVARANI;PAOLO GIORGI ROSSI;SILVIO CAVUTO;LUCÌA MANGONE;FEDERICA PATERLINI;ILARIA SCAZZA;LORENZO PELIZZA;SARA GARLASSI;SILVIA AZZALI;G. PREVITI;SIMONETTA PIANA;LUCA BRAGLIA;CATERINA LONGO;MICHELE POLETTI;CARLO FUSCO;IVAN IVANOVSKI;STEFANO GIUSEPPE CARAFFI;SIMONA PUPO;VALENTINA IOTTI;RICCARDO PAMPENA","722;323;187;176;172;172;172;172;172;163;162;159;153;130;122;122;122;120;118;117","CARLO SALVARANI;PAOLO GIORGI ROSSI;CARMINE PINTO;MARIA CECILIA MENGOLI;LOREDANA DE MARCO;MATTEO RICCÒ;SIMONETTA PIANA;MAGDA ZANELLI;ALESSIA CIARROCCHI;GABRIELE TONNI;C. IOTTI;CATERINA LONGO;FRANCESCO MURATORE;MAURO IORI;MICHELE POLETTI;CANDIDA BONELLI;FEDERICA PATERLINI;FEDERICA TORRICELLI;ILARIA SCAZZA;LORENZO PELIZZA","16;13;11;8;7;7;7;7;6;6;6;6;5;5;5;5;5;5;5;5","MEDICINE;BIOLOGY;COMPUTER SCIENCE;PHYSICS;PSYCHOLOGY;MATHEMATICS;SOCIOLOGY;POLITICAL SCIENCE;CHEMISTRY;ECONOMICS;ENGINEERING;ART;BUSINESS;MATERIALS SCIENCE;GEOGRAPHY;PHILOSOPHY;ENVIRONMENTAL SCIENCE;GEOLOGY;HISTORY","193;65;27;25;24;16;16;15;14;14;13;8;7;7;6;6;4;4;1","INTERNAL MEDICINE;PATHOLOGY;SURGERY;ONCOLOGY;ENVIRONMENTAL HEALTH;GENETICS;RADIOLOGY;GASTROENTEROLOGY;PSYCHIATRY;NUCLEAR MEDICINE;NURSING;ARTIFICIAL INTELLIGENCE;PALEONTOLOGY;BIOCHEMISTRY;CANCER RESEARCH;IMMUNOLOGY;LAW;PHYSICAL THERAPY;FAMILY MEDICINE;OPTICS","128;52;34;32;27;27;22;20;20;18;18;14;14;13;13;13;13;13;12;12","CANCER;DISEASE;GENE;POPULATION;COHORT;CONFIDENCE INTERVAL;HEALTH CARE;PREGNANCY;CHEMOTHERAPY;LYMPHOMA;INCIDENCE (GEOMETRY);RETROSPECTIVE COHORT STUDY;STAGE (STRATIGRAPHY);VIRUS;RHEUMATOLOGY;ALTERNATIVE MEDICINE;IMMUNOHISTOCHEMISTRY;PSYCHOSIS;RADIATION THERAPY;RANDOMIZED CONTROLLED TRIAL","38;28;19;17;14;13;12;12;11;9;8;8;8;8;7;6;6;6;6;6","BREAST CANCER;VASCULITIS;FETUS;GENOTYPE;HAZARD RATIO;PHENOTYPE;COLORECTAL CANCER;PSORIATIC ARTHRITIS;AT RISK MENTAL STATE;CLINICAL ENDPOINT;DIFFUSE LARGE B-CELL LYMPHOMA;IMATINIB;METASTASIS;THYROID CANCER;CERVICAL CANCER;CRONBACH'S ALPHA;GAIT ANALYSIS;GESTATION;IMAGE QUALITY;LENALIDOMIDE;MUTATION;PERONEUS LONGUS;POLYMERASE CHAIN REACTION;PRODROME;PROSTATE;PROSTATE CANCER;QUALITY ASSURANCE;VIRAL DISEASE","12;12;9;6;6;6;5;5;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3","GIANT CELL ARTERITIS;MAMMOGRAPHY;DASATINIB;ENTHESITIS;MISSENSE MUTATION;PRENATAL DIAGNOSIS;AMNIOTIC FLUID;AMPLICON;BRONCHIAL THERMOPLASTY;CEREBRAL VASCULITIS;CONCURRENT VALIDITY;EXOME SEQUENCING;FRAMESHIFT MUTATION;HERPESVIRIDAE;IMATINIB MESYLATE;INTERNATIONAL PROGNOSTIC INDEX;IRINOTECAN;NILOTINIB;NIVOLUMAB;PLACENTA;SINGLE-NUCLEOTIDE POLYMORPHISM;TRASTUZUMAB","9;6;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;;FEMALE;MALE;MIDDLE AGED;ADULT;AGED;ITALY;RETROSPECTIVE STUDIES;AGED, 80 AND OVER;LUNG NEOPLASMS;ADOLESCENT;YOUNG ADULT;PSYCHOTIC DISORDERS;SKIN NEOPLASMS;BREAST NEOPLASMS;CHILD;EARLY DETECTION OF CANCER;ANTIRHEUMATIC AGENTS;ABNORMALITIES, MULTIPLE","116;91;89;76;66;59;46;44;23;20;19;17;17;15;15;14;14;13;12;11","VASCULITIS AND RELATED CONDITIONS;SCHIZOPHRENIA RESEARCH AND TREATMENT;DIGITAL RADIOGRAPHY AND BREAST IMAGING;OCULAR DISEASES AND BEHÇET’S SYNDROME;SPONDYLOARTHRITIS STUDIES AND TREATMENTS;CUTANEOUS MELANOMA DETECTION AND MANAGEMENT;LYMPHOMA DIAGNOSIS AND TREATMENT;OCCUPATIONAL AND ENVIRONMENTAL LUNG DISEASES;RADIOMICS AND MACHINE LEARNING IN MEDICAL IMAGING;ADVANCED RADIOTHERAPY TECHNIQUES;CHRONIC MYELOID LEUKEMIA TREATMENTS;MAGNESIUM IN HEALTH AND DISEASE;MULTIPLE MYELOMA RESEARCH AND TREATMENTS;PALLIATIVE CARE AND END-OF-LIFE ISSUES;PROSTATE CANCER DIAGNOSIS AND TREATMENT;THYROID CANCER DIAGNOSIS AND TREATMENT;VIRAL-ASSOCIATED CANCERS AND DISORDERS;ADVANCED MRI TECHNIQUES AND APPLICATIONS;ADVANCED NEUROIMAGING TECHNIQUES AND APPLICATIONS;ASTHMA AND RESPIRATORY DISEASES","12;6;5;5;5;4;4;4;4;3;3;3;3;3;3;3;3;2;2;2",";ARTERITIS;CLINICAL ENDPOINT;DIGITAL MAMMOGRAPHY;REGIMEN;CONCORDANCE;DEPRESSION;DIGITAL BREAST TOMOSYNTHESIS;ETIOLOGY;PERONEUS LONGUS;POLYMYALGIA RHEUMATICA;PRODROME;AMPLICON;ASSOCIATION (PSYCHOLOGY);ATYPIA;BOSUTINIB;BRAIN BIOPSY;BREAST CANCER SCREENING;BRONCHIAL THERMOPLASTY;CALRETININ","37;4;4;4;4;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2","REGGIO EMILIA;CELL ARTERITIS;GIANT CELL;NORTHERN ITALY;CONFOCAL MICROSCOPY;BREAST CANCER;POPULATION-BASED STUDY;CANCER PATIENTS;CASE-CONTROL STUDY;DIGITAL MAMMOGRAPHY;HEALTH CARE;ITALIAN NATIONAL;ITEM PRODROMAL;MYELOID LEUKEMIA;NATIONAL SURVEY;PERONEUS LONGUS;PHASE II;PRODROMAL QUESTIONNAIRE;PROSPECTIVE STUDY;PROSTATE CANCER;STAGE III;STEM CELL;AIR TEMPERATURES;ANTERIOR RECRUITMENT;ANTERIOR UVEITIS;AORTIC DILATATION;ASYLUM SEEKERS;AUGMENTED REALITY;AXIAL SPONDYLOARTHRITIS;BALANCE MODEL","8;6;6;6;5;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2","REGGIO EMILIA;THYROID CANCER;HR CI;DISEASE ACTIVITY;CELL ARTERITIS;GIANT CELL;HAZARD RATIO;AORTIC DILATATION;CONFIDENCE INTERVAL;FINAL DIAGNOSIS;LUNG CANCER;MMLMATH XMLNSMMLHTTPWWWWORGMATHMATHML;TYROSINE KINASE;BD PATIENTS;GRANTRESEARCH SUPPORT;HP GV;LV GCA;VIVO FCM;ARTERITIS GCA;BIOPSY PROVEN;BIOPSY-PROVEN GCA;BREAST CANCER;CELLS EXPRESSING;CHRONIC MYELOID;CONSECUTIVE PATIENTS;IL- EXPRESSION;INCREASED RISK;KINASE INHIBITORS;MYELOID LEUKEMIA;ODDS RATIO","17;12;11;10;9;9;9;8;8;8;8;8;8;7;7;7;7;7;6;6;6;6;6;6;6;6;6;6;6;6",76,0.36,4.71,6,1.5,1,2,6,2.5,0,2,9,0,1,5.75,1,2,1,3,4.5,2,0,0,66,66,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,4,321,0.99,0,0,27,0,0,2,0,0,0,0,1,0,2,1,0,0,0,0,0,0,3,0,0,3,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY","3;2;2;1","CLINICAL RESEARCH;CANCER;HEMATOLOGY;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;LUNG;LUNG CANCER;LYMPHOMA;PEDIATRIC;RARE DISEASES","3;2;2;1;1;1;1;1;1","CANCER;BLOOD","2;1","2.4 SURVEILLANCE AND DISTRIBUTION;6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES","1;1;1","LEUKEMIA / LEUKAEMIA;LUNG CANCER","1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","2",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_AUSLREGGIOEMILIA",2019,349,13.9713467048711,2.77650429799427,0.360165118679051,0.375358166189112,0.26647564469914,0.237822349570201,0.512893982808023,4,177,67,31,32,0.51,0.19,0.09,0.09,18.38,0.755898097945318,0.418338108882521,0.965616045845272,4.13522537562604,0.504375436782475,0.441935483870968,0.484551495016611,0.474033689802195,"PAOLO GIORGI ROSSI;FRANCESCO MERLI;CATERINA LONGO;ALESSANDRA IURLO;CARLO SALVARANI;MATTEO RICCÒ;MASSIMILIANO BONIFACIO;ALESSIA CIARROCCHI;FEDERICA TORRICELLI;CARMINE PINTO;MAGDA ZANELLI;MONICA CRUGNOLA;STEFANO LUMINARI;ANNIBALE VERSARI;GIOVANNI PELLACANI;MAURIZIO ZIZZO;MASSIMO BRECCIA;FRANCESCA PALANDRI;ISABELLA CAPODANNO;ALESSIA TIEGHI","22;18;16;15;15;15;15;14;14;13;13;12;12;12;11;11;11;10;10;10","MICHELE POLETTI;MATTEO RICCÒ;ANDREA RABALLO;PAOLO GIORGI ROSSI;CATERINA LONGO;MAGDA ZANELLI;MAURIZIO ZIZZO;ANTONIO CHIARENZA;M FORESTI;CARLO SALVARANI;FEDERICA BALZARINI;STEFANO ASCANI;SIMONETTA PIANA;FEDERICA TORRICELLI;ISABELLA CAMPANINI;FRANCESCO MERLI;ALESSIA CIARROCCHI;LORENZO PELIZZA;DAVIDE GIORDANO;LUCA GHIROTTO","3.32;2.78;2.32;2.25;2.14;1.84;1.67;1.53;1.5;1.49;1.49;1.45;1.4;1.38;1.33;1.3;1.3;1.21;1.2;1.18","PAOLO GIORGI ROSSI;FRANCESCO MERLI;CATERINA LONGO;CARLO SALVARANI;MATTEO RICCÒ;ALESSIA CIARROCCHI;FEDERICA TORRICELLI;CARMINE PINTO;MAGDA ZANELLI;STEFANO LUMINARI;ANNIBALE VERSARI;MAURIZIO ZIZZO;ISABELLA CAPODANNO;ALESSIA TIEGHI;MICHELE POLETTI;FEDERICA BALZARINI;LORENZO PELIZZA;SIMONETTA PIANA;LUCA GHIROTTO;LOREDANA DE MARCO","22;18;16;15;15;14;14;13;13;12;12;11;10;10;10;8;8;8;8;7","MICHELE POLETTI;MATTEO RICCÒ;PAOLO GIORGI ROSSI;CATERINA LONGO;MAGDA ZANELLI;MAURIZIO ZIZZO;ANTONIO CHIARENZA;M FORESTI;CARLO SALVARANI;FEDERICA BALZARINI;SIMONETTA PIANA;FEDERICA TORRICELLI;ISABELLA CAMPANINI;FRANCESCO MERLI;ALESSIA CIARROCCHI;LORENZO PELIZZA;DAVIDE GIORDANO;LUCA GHIROTTO;CARMINE PINTO;ANDREA MERLO","3.32;2.78;2.25;2.14;1.84;1.67;1.53;1.5;1.49;1.49;1.4;1.38;1.33;1.3;1.3;1.21;1.2;1.18;1.18;1","CATERINA LONGO;JOSEP MALVEHY;PAOLO GIORGI ROSSI;GIUSEPPE ARGENZIANO;AIMILIOS LALLAS;ALON SCOPE;SUSANA PUIG;CARLO SALVARANI;IRIS ZALAUDEK;CHRISTOPH SINZ;HARALD KITTLER;PHILIPP TSCHANDL;ALLAN C. HALPERN;AMANDA OAKLEY;ASHFAQ A. MARGHOOB;BENGÜ NISA AKAY;BRIAN HELBA;CLAUS RINNER;CLIFF ROSENDAHL;DAVID GUTMAN","658;539;511;486;480;469;467;452;446;444;444;444;427;427;427;427;427;427;427;427","CATERINA LONGO;PAOLO GIORGI ROSSI;CARLO SALVARANI;FRANCESCO MERLI;ALESSIA TIEGHI;ALBERTO CAVAZZA;ISABELLA CAPODANNO;ANNIBALE VERSARI;MATTEO RICCÒ;FEDERICA TORRICELLI;ALESSIA CIARROCCHI;CRISTINA MASINI;LUCA GHIROTTO;MICHELE POLETTI;LORENZO PELIZZA;ANGELA FERRARI;GIANCARLO BISAGNI;CARMINE PINTO;SILVIA AZZALI;FEDERICA PATERLINI","658;511;398;372;339;267;243;216;202;201;186;177;177;164;141;131;130;126;126;125","PAOLO GIORGI ROSSI;FRANCESCO MERLI;CATERINA LONGO;MATTEO RICCÒ;ALESSIA CIARROCCHI;CARLO SALVARANI;FEDERICA TORRICELLI;MAGDA ZANELLI;ANNIBALE VERSARI;CARMINE PINTO;ALESSIA TIEGHI;ISABELLA CAPODANNO;MICHELE POLETTI;SIMONETTA PIANA;LUCA GHIROTTO;MAURIZIO ZIZZO;GIANCARLO BISAGNI;MASSIMILIANO PACI;STEFANO LUMINARI;LORENZO PELIZZA","22;18;16;15;14;14;13;13;12;12;10;10;10;8;8;7;7;7;7;7","MEDICINE;BIOLOGY;PSYCHOLOGY;PHYSICS;COMPUTER SCIENCE;SOCIOLOGY;MATHEMATICS;CHEMISTRY;POLITICAL SCIENCE;ECONOMICS;ENGINEERING;GEOGRAPHY;PHILOSOPHY;BUSINESS;MATERIALS SCIENCE;HISTORY;ART;ENVIRONMENTAL SCIENCE;GEOLOGY","322;83;48;38;34;32;28;25;24;19;15;13;11;10;9;2;1;1;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;ONCOLOGY;ENVIRONMENTAL HEALTH;GASTROENTEROLOGY;PSYCHIATRY;GENETICS;RADIOLOGY;CANCER RESEARCH;BIOCHEMISTRY;IMMUNOLOGY;LAW;FAMILY MEDICINE;NURSING;PEDIATRICS;DEMOGRAPHY;PHYSICAL THERAPY;DERMATOLOGY;NUCLEAR MEDICINE","230;83;77;75;55;41;37;33;32;26;24;24;24;23;23;21;20;20;19;19","CANCER;POPULATION;CHEMOTHERAPY;DISEASE;CONFIDENCE INTERVAL;CLINICAL TRIAL;GENE;LYMPHOMA;COHORT;HEALTH CARE;RANDOMIZED CONTROLLED TRIAL;RETROSPECTIVE COHORT STUDY;PROSPECTIVE COHORT STUDY;ADVERSE EFFECT;BIOPSY;ALTERNATIVE MEDICINE;LUNG;OBSERVATIONAL STUDY;BONE MARROW;INCIDENCE (GEOMETRY);MELANOMA","93;43;33;29;26;25;25;25;21;17;16;16;15;13;13;12;12;12;11;11;11","BREAST CANCER;CLINICAL ENDPOINT;COLORECTAL CANCER;RITUXIMAB;PHASES OF CLINICAL RESEARCH;DIFFUSE LARGE B-CELL LYMPHOMA;INTERIM ANALYSIS;VASCULITIS;CERVICAL CANCER;LENALIDOMIDE;CYCLOPHOSPHAMIDE;HAZARD RATIO;IMATINIB;IMMUNOTHERAPY;MYELOFIBROSIS;PAIN MEDICINE;PSORIATIC ARTHRITIS;FETUS;HEALTH PROFESSIONALS;PLACEBO;PROSTATE CANCER","29;14;12;12;10;9;9;9;8;8;7;7;6;6;6;6;6;5;5;5;5","ANTHRACYCLINE;NIVOLUMAB;CARFILZOMIB;CERVICAL INTRAEPITHELIAL NEOPLASIA;GIANT CELL ARTERITIS;VINCRISTINE;DASATINIB;MAMMOGRAPHY;APGAR SCORE;COLONOSCOPY;ENTHESITIS;MYELOPROLIFERATIVE NEOPLASM;NEOADJUVANT THERAPY;NILOTINIB;PEMETREXED;TAXANE;TRASTUZUMAB;BASDAI;BENDAMUSTINE;CERVICAL CANCER SCREENING;CERVICAL SCREENING;CHEMOIMMUNOTHERAPY;COLPOSCOPY;DARATUMUMAB;DNA METHYLATION;EXOME SEQUENCING;FETAL HEART;FOLLICLE-STIMULATING HORMONE;FOLLICULAR FLUID;HISTONE DEACETYLASE;HPV INFECTION;IMATINIB MESYLATE;KRAS;LYMPHEDEMA;OXALIPLATIN;PAPILLARY THYROID CANCER;PLEURAL DISEASE;POLYCYSTIC OVARY;PROSTATECTOMY;RUXOLITINIB;SINGLE-NUCLEOTIDE POLYMORPHISM;TAKAYASU ARTERITIS;TAKAYASU'S ARTERITIS;TAMOXIFEN;UROTHELIAL CARCINOMA","7;6;5;5;5;5;4;4;3;3;3;3;3;3;3;3;3;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2;2","HUMANS;;FEMALE;MALE;MIDDLE AGED;AGED;ITALY;ADULT;RETROSPECTIVE STUDIES;SKIN NEOPLASMS;AGED, 80 AND OVER;YOUNG ADULT;PSYCHOTIC DISORDERS;TREATMENT OUTCOME;ADOLESCENT;BREAST NEOPLASMS;MELANOMA;NEOPLASMS;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;LUNG NEOPLASMS","192;155;139;122;100;82;80;78;40;35;34;32;27;27;24;24;22;22;21;20","LYMPHOMA DIAGNOSIS AND TREATMENT;CUTANEOUS MELANOMA DETECTION AND MANAGEMENT;MYELOPROLIFERATIVE NEOPLASMS: DIAGNOSIS AND TREATMENT;OCCUPATIONAL AND ENVIRONMENTAL LUNG DISEASES;VASCULITIS AND RELATED CONDITIONS;CHRONIC MYELOID LEUKEMIA TREATMENTS;MULTIPLE MYELOMA RESEARCH AND TREATMENTS;SCHIZOPHRENIA RESEARCH AND TREATMENT;CERVICAL CANCER AND HPV RESEARCH;PALLIATIVE CARE AND END-OF-LIFE ISSUES;CLIMATE CHANGE AND HEALTH IMPACTS;COLORECTAL CANCER SCREENING AND DETECTION;COLORECTAL CANCER TREATMENTS AND STUDIES;ACUTE MYELOID LEUKEMIA RESEARCH;ADVANCED RADIOTHERAPY TECHNIQUES;CANCER AND SKIN LESIONS;CANCER IMMUNOTHERAPY AND BIOMARKERS;GLOBAL CANCER INCIDENCE AND SCREENING;INTERSTITIAL LUNG DISEASES AND IDIOPATHIC PULMONARY FIBROSIS;SPONDYLOARTHRITIS STUDIES AND TREATMENTS","17;9;9;9;8;7;7;7;6;6;5;5;5;4;4;4;4;4;4;4",";CLINICAL ENDPOINT;INTERIM ANALYSIS;STROKE;REGIMEN;CONCORDANCE;PAIN MEDICINE;DISCONTINUATION;HEALTH PROFESSIONALS;INTERQUARTILE RANGE;ABVD;ARTERITIS;CHEMOTHERAPY REGIMEN;CONCOMITANT;DEPRESSION;FOLLICULAR LYMPHOMA;PRODROME;PROGRESSION-FREE SURVIVAL;REFRACTORY (PLANETARY SCIENCE);UNIVARIATE ANALYSIS","64;14;9;9;8;6;6;5;5;5;4;4;4;4;4;4;4;4;4;4","BREAST CANCER;OBSERVATIONAL STUDY;CANCER PATIENTS;FONDAZIONE ITALIANA;ITALIANA LINFOMI;CHRONIC MYELOID;INTERIM ANALYSIS;MYELOID LEUKEMIA;PHASE II;CELL CARCINOMA;MALIGNANT PLEURAL;PALLIATIVE CARE;PATIENTS TREATED;PLEURAL MESOTHELIOMA;PROSPECTIVE OBSERVATIONAL;B-CELL LYMPHOMA;CELL ARTERITIS;CONFOCAL MICROSCOPY;GIANT CELL;HODGKIN LYMPHOMA;MULTICENTER STUDY;REGGIO EMILIA;CANCER CELLS;CANCER SCREENING;CASE-CONTROL STUDY;CLINICAL PRACTICE;CLINICAL TRIAL;COLON CANCER;II STUDY;MULTIPLE MYELOMA","10;9;8;8;8;7;7;7;7;6;6;6;6;6;6;5;5;5;5;5;5;5;4;4;4;4;4;4;4;4","PALLIATIVE CARE;ELI LILLY;CANCER PATIENTS;SPEAKERS BUREAU;PATIENTS TREATED;BREAST CANCER;HEALTHCARE PROFESSIONALS;GRANTRESEARCH SUPPORT;INCREASED RISK;PATIENTS RECEIVED;CLINICAL PRACTICE;CONFIDENCE INTERVAL;CONTENT HTTPSLINKSLWWCOMHSA;DIGITAL CONTENT;OVARIAN CANCER;SUPPLEMENTAL DIGITAL;B-CELL LYMPHOMA;BRISTOL-MYERS SQUIBB;REGRESSION ANALYSIS;EMERGENCY DEPARTMENT;HEALTHY SUBJECTS;HEALTH CARE;INFLUENZA EPIDEMICS;SOIL MN;ADAMTS ACTIVITY;ADVERSE EVENTS;CEA LEVEL;COLON CANCER;ETHICS CONSULTATION;EULAR RECOMMENDATIONS","30;21;19;19;18;15;15;12;12;12;11;11;11;11;11;11;10;10;10;9;9;8;8;8;7;7;7;7;7;7",165,0.47,7,7,1,2,0,3,2.75,1,1,9,1,1,7,1,1.5,1,3,5.75,5,0,0,48,48,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,5,4.6,10800.4,1.21,2,0.4,36.4,0,0,1,0,0,0,0,4,0,3,2,0,0,0,0,0,0,4,1,0,5,0,0,0,0,0,0,0,0,0,"United States","4","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3202 CLINICAL SCIENCES;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","5;5;2;1;1;1","CANCER;CLINICAL RESEARCH;HEMATOLOGY;RARE DISEASES;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;LYMPHOMA;BREAST CANCER;COMPARATIVE EFFECTIVENESS RESEARCH;GENETIC TESTING;GENETICS;HEALTH SERVICES;PATIENT SAFETY;PREVENTION","5;5;4;4;3;3;1;1;1;1;1;1;1","CANCER","3","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;4.4 POPULATION SCREENING;6.2 CELLULAR AND GENE THERAPIES;7.1 INDIVIDUAL CARE NEEDS","2;1;1;1;1","LEUKEMIA / LEUKAEMIA;NON-HODGKIN'S LYMPHOMA;BREAST CANCER","2;2;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;4.4 RESOURCES AND INFRASTRUCTURE RELATED TO DETECTION, DIAGNOSIS, OR PROGNOSIS;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","2;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_AUSLREGGIOEMILIA",2020,488,16.2540983606557,3.30532786885246,0.302541847489151,0.377049180327869,0.32172131147541,0.350409836065574,0.561475409836066,3,214,131,40,38,0.44,0.27,0.08,0.08,23.86,0.946986602530165,0.350409836065574,0.975409836065574,5.56963470319635,0.55716998594103,0.485186382245206,0.480412149833637,0.462575687571432,"PAOLO GIORGI ROSSI;CARLO SALVARANI;CATERINA LONGO;ALBERTO CAVAZZA;GIOVANNI PELLACANI;ISABELLA CAPODANNO;MASSIMO COSTANTINI;FRANCESCO MURATORE;MASSIMO BRECCIA;CARLO SALVARANI;MASSIMILIANO BONIFACIO;MICHÈLE CAVO;LUCA CIMINO;GIOVANNA ARTIOLI;MICHELE POLETTI;LORENZO PELIZZA;GIOVANNI CAOCCI;MARCO MASSARI;GIANNI BINOTTO;SILVIA AZZALI","43;25;24;18;17;16;16;16;16;16;15;15;15;14;14;14;14;13;13;13","PAOLO GIORGI ROSSI;MICHELE POLETTI;CARLO SALVARANI;CATERINA LONGO;MICHELE ANTONELLI;DAVIDE DONELLI;GIOVANNA ARTIOLI;GIOVANNI PELLACANI;MASSIMO COSTANTINI;LUDOVICA DE PANFILIS;ANDREA RABALLO;ALBERTO CAVAZZA;MATTEO RICCÒ;LUCA GHIROTTO;ADRIANO FERRARI;LORENZO PELIZZA;FRANCESCO MURATORE;SILVIA TANZI;LUCA CIMINO;SILVIA AZZALI","3.51;2.94;2.73;2.62;2.62;2.62;2.22;2;1.96;1.94;1.9;1.84;1.83;1.68;1.63;1.57;1.55;1.54;1.53;1.5","PAOLO GIORGI ROSSI;CARLO SALVARANI;CATERINA LONGO;ALBERTO CAVAZZA;ISABELLA CAPODANNO;MASSIMO COSTANTINI;FRANCESCO MURATORE;CARLO SALVARANI;LUCA CIMINO;GIOVANNA ARTIOLI;MICHELE POLETTI;LORENZO PELIZZA;MARCO MASSARI;SILVIA AZZALI;NICOLA FACCIOLONGO;CARMINE PINTO;LUCÌA MANGONE;PAMELA MANCUSO;MASSIMO VICENTINI;RICCARDO PAMPENA","43;25;24;18;16;16;16;16;15;14;14;14;13;13;12;12;12;12;11;11","PAOLO GIORGI ROSSI;MICHELE POLETTI;CARLO SALVARANI;CATERINA LONGO;MICHELE ANTONELLI;DAVIDE DONELLI;GIOVANNA ARTIOLI;MASSIMO COSTANTINI;LUDOVICA DE PANFILIS;ALBERTO CAVAZZA;MATTEO RICCÒ;LUCA GHIROTTO;ADRIANO FERRARI;LORENZO PELIZZA;FRANCESCO MURATORE;SILVIA TANZI;LUCA CIMINO;SILVIA AZZALI;MAURIZIO ZIZZO;ANGELO GHIDINI","3.51;2.94;2.73;2.62;2.62;2.62;2.22;1.96;1.94;1.84;1.83;1.68;1.63;1.57;1.55;1.54;1.53;1.5;1.44;1.41","CARLO SALVARANI;MARCO MASSARI;GIOVANNI DOLCI;RENATO PASCALE;GIOVANNI GUARALDI;ENRICO CLINI;ROBERTO TONELLI;LUCA TABBÌ;NICOLA FACCIOLONGO;CRISTINA MUSSINI;MASSIMO COSTANTINI;MICHÈLE CAVO;PAOLO GIORGI ROSSI;ANDREA COSSARIZZA;IVANA CASTANIERE;RICCARDO FANTINI;ANTONELLO PIETRANGELO;ALESSANDRO COZZI‐LEPRI;ANDREA BEDINI;ANTONELLA SANTORO","2391;2098;1781;1621;1252;1234;1234;1233;1154;1077;1074;1052;1035;988;975;975;961;958;958;958","CARLO SALVARANI;MARCO MASSARI;NICOLA FACCIOLONGO;MASSIMO COSTANTINI;PAOLO GIORGI ROSSI;LUCA BRAGLIA;DOMENICO FRANCO MERLO;SILVIO CAVUTO;MATTEO RICCÒ;LUISA SAVOLDI;ELISABETTA TEOPOMPI;CATERINA TURRÀ;FABRIZIO BONI;FRANCESCO MERLI;BARBARA GAMBERI;FRANCESCO CAVALLIERI;FRANCESCO VENTURELLI;EMANUELE ALBERTO NEGRI;MASSIMILIANO MARINO;MASSIMO VICENTINI","1997;1872;1085;1074;1016;898;866;723;710;690;668;663;663;612;468;413;413;412;391;374","PAOLO GIORGI ROSSI;CARLO SALVARANI;CATERINA LONGO;ALBERTO CAVAZZA;FRANCESCO MURATORE;MASSIMO COSTANTINI;ISABELLA CAPODANNO;LUCA CIMINO;MICHELE POLETTI;SILVIA AZZALI;CARMINE PINTO;GIOVANNA ARTIOLI;PAMELA MANCUSO;RICCARDO PAMPENA;MARCO MASSARI;MATTEO RICCÒ;ANGELO GHIDINI;MASSIMO VICENTINI;FRANCESCO CAVALLIERI;MARIALUISA ZEDDE","42;27;23;18;16;16;16;14;14;13;12;12;12;11;11;11;11;10;10;10","MEDICINE;BIOLOGY;PSYCHOLOGY;PHYSICS;COMPUTER SCIENCE;SOCIOLOGY;POLITICAL SCIENCE;ECONOMICS;MATHEMATICS;ENGINEERING;CHEMISTRY;PHILOSOPHY;BUSINESS;GEOGRAPHY;MATERIALS SCIENCE;ART;ENVIRONMENTAL SCIENCE;GEOLOGY;HISTORY","464;107;70;64;47;36;30;29;29;28;27;15;12;9;8;4;2;2;2","INTERNAL MEDICINE;PATHOLOGY;SURGERY;ONCOLOGY;ENVIRONMENTAL HEALTH;PSYCHIATRY;GASTROENTEROLOGY;GENETICS;NURSING;RADIOLOGY;PEDIATRICS;INTENSIVE CARE MEDICINE;OPTICS;CANCER RESEARCH;VIROLOGY;FAMILY MEDICINE;IMMUNOLOGY;PALEONTOLOGY;PHYSICAL THERAPY;CLINICAL PSYCHOLOGY","333;115;100;83;71;53;47;46;45;43;40;39;38;36;34;32;32;32;31;29","CANCER;DISEASE;POPULATION;COHORT;GENE;CONFIDENCE INTERVAL;RETROSPECTIVE COHORT STUDY;OUTBREAK;CHEMOTHERAPY;INCIDENCE (GEOMETRY);CLINICAL TRIAL;HEALTH CARE;RANDOMIZED CONTROLLED TRIAL;LUNG;COHORT STUDY;LYMPHOMA;CONTEXT (ARCHAEOLOGY);MELANOMA;BIOPSY;OBSERVATIONAL STUDY;PROSPECTIVE COHORT STUDY","109;109;65;48;41;38;37;34;29;29;27;25;20;19;18;18;17;17;16;16;16","INFECTIOUS DISEASE (MEDICAL SPECIALTY);BREAST CANCER;2019-20 CORONAVIRUS OUTBREAK;CLINICAL ENDPOINT;COLORECTAL CANCER;HAZARD RATIO;VASCULITIS;IMMUNOTHERAPY;PHENOTYPE;CERVICAL CANCER;MUTATION;IMATINIB;METASTASIS;NEURORADIOLOGY;PSORIATIC ARTHRITIS;TOCILIZUMAB;UNIVARIATE ANALYSIS;INTERSTITIAL LUNG DISEASE;LENALIDOMIDE;ADENOCARCINOMA;CUMULATIVE INCIDENCE;DEMENTIA;DERMATOSCOPY;GENE EXPRESSION;GENOTYPE;GROUNDED THEORY;NEVUS;OVARIAN CANCER;PHASES OF CLINICAL RESEARCH;PROGRESSION-FREE SURVIVAL;RANDOMIZATION;RITUXIMAB","55;31;28;20;18;18;15;14;10;9;9;8;8;8;8;8;8;7;7;6;6;6;6;6;6;6;6;6;6;6;6;6","CORONAVIRUS DISEASE 2019 (COVID-19);GIANT CELL ARTERITIS;NIVOLUMAB;CERVICAL INTRAEPITHELIAL NEOPLASIA;ENTHESITIS;DASATINIB;NILOTINIB;SENTINEL LYMPH NODE;COLONOSCOPY;COLPOSCOPY;EXOME SEQUENCING;GRANULOMATOSIS WITH POLYANGIITIS;IMATINIB MESYLATE;INTERNATIONAL PROGNOSTIC SCORING SYSTEM;LYMPHOVASCULAR INVASION;MAMMOGRAPHY;SUICIDAL IDEATION;TRASTUZUMAB;USUAL INTERSTITIAL PNEUMONIA;ADJUVANT CHEMOTHERAPY;ANDROGEN DEPRIVATION THERAPY;BRCA MUTATION;CHILDHOOD OBESITY;COMPOUND HETEROZYGOSITY;DARATUMUMAB;DNA METHYLATION;ESTROGEN RECEPTOR;FOLLICLE-STIMULATING HORMONE;GENOTYPING;IBRUTINIB;MICROSCOPIC POLYANGIITIS;MISSENSE MUTATION;ONCOGENE;OXALIPLATIN;PRENATAL DIAGNOSIS;RUXOLITINIB;SUICIDE ATTEMPT;TAXANE;VINCRISTINE","55;9;9;8;8;6;5;5;4;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3",";HUMANS;FEMALE;MALE;MIDDLE AGED;ITALY;ADULT;AGED;RETROSPECTIVE STUDIES;COVID-19;CORONAVIRUS INFECTIONS;PNEUMONIA, VIRAL;YOUNG ADULT;ADOLESCENT;AGED, 80 AND OVER;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;SARS-COV-2;SKIN NEOPLASMS;BETACORONAVIRUS;PANDEMICS","269;218;146;119;102;101;95;74;49;46;43;43;37;32;30;30;28;27;25;25","CUTANEOUS MELANOMA DETECTION AND MANAGEMENT;VASCULITIS AND RELATED CONDITIONS;COVID-19 AND HEALTHCARE IMPACTS;COVID-19 CLINICAL RESEARCH STUDIES;PALLIATIVE CARE AND END-OF-LIFE ISSUES;CHRONIC MYELOID LEUKEMIA TREATMENTS;CERVICAL CANCER AND HPV RESEARCH;SCHIZOPHRENIA RESEARCH AND TREATMENT;OCCUPATIONAL AND ENVIRONMENTAL LUNG DISEASES;CEREBRAL PALSY AND MOVEMENT DISORDERS;LYMPHOMA DIAGNOSIS AND TREATMENT;RENAL CELL CARCINOMA TREATMENT;MULTIPLE MYELOMA RESEARCH AND TREATMENTS;OCULAR DISEASES AND BEHÇET’S SYNDROME;CHRONIC LYMPHOCYTIC LEUKEMIA RESEARCH;COLORECTAL CANCER SURGICAL TREATMENTS;GLOBAL CANCER INCIDENCE AND SCREENING;INTERSTITIAL LUNG DISEASES AND IDIOPATHIC PULMONARY FIBROSIS;MYELOPROLIFERATIVE NEOPLASMS: DIAGNOSIS AND TREATMENT;SPONDYLOARTHRITIS STUDIES AND TREATMENTS","19;15;14;14;13;12;10;10;9;8;8;8;7;7;6;6;5;5;5;5",";2019-20 CORONAVIRUS OUTBREAK;PANDEMIC;CLINICAL ENDPOINT;DISCONTINUATION;NEURORADIOLOGY;REFRACTORY (PLANETARY SCIENCE);REGIMEN;STROKE;TOCILIZUMAB;UNIVARIATE ANALYSIS;HEMATOLOGY;ARTERITIS;CORONAVIRUS;CUMULATIVE INCIDENCE;DERMATOSCOPY;PROGRESSION-FREE SURVIVAL;BRESLOW THICKNESS;CROSS-SECTIONAL STUDY;DACTYLITIS","72;28;28;20;9;8;8;8;8;8;8;7;6;6;6;6;6;5;5;5","BREAST CANCER;CANCER PATIENTS;CELL CARCINOMA;COHORT STUDY;REGGIO EMILIA;CHRONIC MYELOID;COVID- PANDEMIC;MYELOID LEUKEMIA;NORTHERN ITALY;PALLIATIVE CARE;PHASE II;MULTICENTER STUDY;PATIENTS TREATED;CONFOCAL MICROSCOPY;LUNG CANCER;RENAL CELL;CANCER SCREENING;LEUKEMIA PATIENTS;MULTIPLE MYELOMA;RETROSPECTIVE STUDY;CELL ARTERITIS;COVID- PNEUMONIA;GIANT CELL;LONGITUDINAL STUDY;METASTATIC RENAL;OBSERVATIONAL STUDY;PATIENTS PTS;REFLECTANCE CONFOCAL;RISK FACTORS;CEREBRAL PALSY","18;13;13;12;12;10;10;10;10;10;10;9;9;8;8;8;7;7;7;7;6;6;6;6;6;6;6;6;6;5","HR CI;REGGIO EMILIA;LUNG CANCER;CANCER PATIENTS;PALLIATIVE CARE;COVID- PANDEMIC;ACUTE RESPIRATORY;CORONAVIRUS DISEASE;MDS PATIENTS;MEDIAN FOLLOW-UP;COHORT STUDY;SEVERE ACUTE;DISEASE COVID-;LOGISTIC REGRESSION;SARS-COV- INFECTION;CONSECUTIVE PATIENTS;COVID- PATIENTS;PATIENTS TREATED;RESPIRATORY SYNDROME;STATISTICALLY SIGNIFICANT;CANCER SURVIVORS;CONFIDENCE INTERVAL;MEDIAN AGE;ODDS RATIO;RISK FACTORS;INCREASED RISK;ABSORBED DOSE;CORONAVIRUS SARS-COV-;INTENSIVE CARE;INTERVAL CI","36;25;21;20;20;19;16;16;16;16;15;15;14;14;14;13;13;13;13;13;12;12;12;12;12;11;10;10;10;10",255,0.52,7.8,7,1,2,0,4.75,2,1,1.5,10,1,1,7,0,3,2,4,6,3,0,0,68.5,66.5,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,11,3.18,437.73,1.92,7,0.64,26.09,0,0,2,0,2,0,0,7,0,5,6,0,0,0,0,0,0,10,0,1,10,0,0,1,0,0,0,0,0,0,"Italy;Germany;Switzerland","2;1;1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;42 HEALTH SCIENCES;4203 HEALTH SERVICES AND SYSTEMS","11;7;3;2;1;1","CLINICAL RESEARCH;CANCER;HEMATOLOGY;RARE DISEASES;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;PATIENT SAFETY;INFECTIOUS DISEASES;DIGESTIVE DISEASES;EMERGING INFECTIOUS DISEASES;LUNG;LYMPHOMA;PEDIATRIC;PEDIATRIC CANCER;PNEUMONIA;PNEUMONIA & INFLUENZA;PREVENTION;BIOMEDICAL IMAGING;CARDIOVASCULAR;CHILDHOOD LEUKEMIA;CHRONIC LIVER DISEASE AND CIRRHOSIS","10;7;7;7;4;4;3;2;2;2;2;2;2;2;2;2;1;1;1;1","CANCER;CARDIOVASCULAR;INFECTION","5;1;1","6.1 PHARMACEUTICALS;4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.2 CELLULAR AND GENE THERAPIES;7.1 INDIVIDUAL CARE NEEDS;2.2 FACTORS RELATING TO THE PHYSICAL ENVIRONMENT;8.1 ORGANISATION AND DELIVERY OF SERVICES","6;2;2;2;1;1","LEUKEMIA / LEUKAEMIA;BLOOD CANCER;LUNG CANCER;NON-HODGKIN'S LYMPHOMA;PANCREATIC CANCER","6;1;1;1;1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS;4.1 TECHNOLOGY DEVELOPMENT AND/OR MARKER DISCOVERY;4.3 TECHNOLOGY AND/OR MARKER TESTING IN A CLINICAL SETTING;6.1 PATIENT CARE AND SURVIVORSHIP ISSUES","4;1;1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,"SCIELO JOURNALS","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3215 REPRODUCTIVE MEDICINE","2;1","CLINICAL RESEARCH;HEALTH SERVICES;INFECTIOUS DISEASES;PREVENTION","1;1;1;1","INFECTION;REPRODUCTIVE HEALTH AND CHILDBIRTH","1;1",NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_AUSLREGGIOEMILIA",2021,547,17.7970749542962,2.94698354661792,0.339330024813896,0.30164533820841,0.294332723948812,0.281535648994516,0.703839122486289,1,224,145,43,33,0.41,0.27,0.08,0.06,14.23,0.922807445287363,0.383912248628885,0.985374771480804,6.26804915514592,0.501804220589129,0.4673004897724,0.469678342311733,0.429428571428571,"PAOLO GIORGI ROSSI;CARMINE PINTO;FRANCESCO MERLI;CARLO SALVARANI;CATERINA LONGO;STEFANO LUMINARI;GIULIA BESUTTI;LUIGI MARCHESELLI;PAMELA MANCUSO;CARLO SALVARANI;LORENZO PELIZZA;ANNALISA ARCARI;SARA GALIMBERTI;ISABELLA CAPODANNO;MARCO MASSARI;VITTORIO RUGGERO ZILIOLI;MASSIMILIANO BONIFACIO;GIOVANNI PELLACANI;STEFANIA COSTI;ANNIBALE VERSARI","32;29;23;22;21;18;18;15;15;15;14;14;13;13;13;13;13;12;12;12","MATTEO RICCÒ;PAOLO GIORGI ROSSI;CARMINE PINTO;MICHELE POLETTI;ANDREA RABALLO;CATERINA LONGO;GIOVANNA ARTIOLI;LORENZO PELIZZA;LUCA GHIROTTO;LEOPOLDO SARLI;CARLO SALVARANI;GIULIA BESUTTI;SILVIA AZZALI;STEFANIA COSTI;PAMELA MANCUSO;MAURIZIO ZIZZO;FRANCESCO MERLI;SIMONA PERUZZI;MICHELE ANTONELLI;DAVIDE MAESTRI","3.31;3.25;2.78;2.6;2.55;1.9;1.76;1.74;1.63;1.62;1.53;1.51;1.47;1.41;1.34;1.28;1.22;1.21;1.17;1.16","PAOLO GIORGI ROSSI;CARMINE PINTO;FRANCESCO MERLI;CARLO SALVARANI;CATERINA LONGO;STEFANO LUMINARI;GIULIA BESUTTI;PAMELA MANCUSO;CARLO SALVARANI;LORENZO PELIZZA;ISABELLA CAPODANNO;MARCO MASSARI;STEFANIA COSTI;ANNIBALE VERSARI;MATTEO RICCÒ;SILVIA AZZALI;GIOVANNA ARTIOLI;MICHELE POLETTI;MARIALUISA ZEDDE;FRANCESCO CAVALLIERI","32;29;23;22;21;18;18;15;15;14;13;13;12;12;12;12;11;11;11;10","MATTEO RICCÒ;PAOLO GIORGI ROSSI;CARMINE PINTO;MICHELE POLETTI;CATERINA LONGO;GIOVANNA ARTIOLI;LORENZO PELIZZA;LUCA GHIROTTO;CARLO SALVARANI;GIULIA BESUTTI;SILVIA AZZALI;STEFANIA COSTI;PAMELA MANCUSO;MAURIZIO ZIZZO;FRANCESCO MERLI;MICHELE ANTONELLI;CARLO SALVARANI;LUCÌA MANGONE;CECILIA BOTTI;MARTA OTTONE","3.31;3.25;2.78;2.6;1.9;1.76;1.74;1.63;1.53;1.51;1.47;1.41;1.34;1.28;1.22;1.17;1.06;1.03;1.03;1.02","CARLO SALVARANI;PAOLO GIORGI ROSSI;UGO DE GIORGI;CARMINE PINTO;MARCO MASSARI;M.A.E. DE VAN DER SCHUEREN;LOREDANA BUONACCORSO;FRANCESCO MERLI;CARLA RIPAMONTI;CHRISTINE BALDWIN;CLELIA MADEDDU;FLORIAN STRASSER;JANN ARENDS;MARTIN CHASEN;PAULA RAVASCO;SILVIA GONELLA;TORA S. SOLHEIM;SANDRO PIGNATA;SAVERIO CINIERI;FRANCESCO RASPAGLIESI","851;705;438;421;371;354;351;332;329;329;329;329;329;329;329;329;329;316;302;289","PAOLO GIORGI ROSSI;CARLO SALVARANI;LOREDANA BUONACCORSO;FRANCESCO MERLI;CARMINE PINTO;MARCO MASSARI;CATERINA LONGO;MARTA OTTONE;CRISTINA MASINI;MARIALUISA ZEDDE;ALESSANDRA BOLOGNA;CHIARA MARVISI;GIULIA BESUTTI;ANGELA FERRARI;PIERPAOLO PATTACINI;FRANCESCO CAVALLIERI;PAMELA MANCUSO;SILVIA AZZALI;DANILO IANNETTA;FRANCESCO MURATORE","705;644;351;332;309;277;239;216;214;214;212;205;202;195;187;186;181;176;167;165","PAOLO GIORGI ROSSI;CARLO SALVARANI;CARMINE PINTO;FRANCESCO MERLI;CATERINA LONGO;GIULIA BESUTTI;PAMELA MANCUSO;STEFANO LUMINARI;ISABELLA CAPODANNO;MARCO MASSARI;SILVIA AZZALI;MATTEO RICCÒ;GIOVANNA ARTIOLI;MICHELE POLETTI;ANNIBALE VERSARI;LUCÌA MANGONE;LIVIA GARAVELLI;MARIALUISA ZEDDE;PIERPAOLO PATTACINI;MARTA OTTONE","32;31;27;23;20;14;14;14;13;13;12;11;11;11;10;10;10;10;10;10","MEDICINE;BIOLOGY;PSYCHOLOGY;COMPUTER SCIENCE;PHYSICS;POLITICAL SCIENCE;SOCIOLOGY;MATHEMATICS;ECONOMICS;ENGINEERING;CHEMISTRY;PHILOSOPHY;BUSINESS;GEOGRAPHY;MATERIALS SCIENCE;HISTORY;ART;GEOLOGY;ENVIRONMENTAL SCIENCE","518;129;78;56;46;37;36;34;29;23;22;15;11;6;5;4;2;2;1","INTERNAL MEDICINE;PATHOLOGY;ONCOLOGY;SURGERY;ENVIRONMENTAL HEALTH;PSYCHIATRY;GENETICS;RADIOLOGY;GASTROENTEROLOGY;IMMUNOLOGY;NURSING;PHYSICAL THERAPY;PEDIATRICS;CLINICAL PSYCHOLOGY;FAMILY MEDICINE;LAW;VIROLOGY;INTENSIVE CARE MEDICINE;CARDIOLOGY;PALEONTOLOGY","374;125;109;105;79;57;56;56;53;48;43;41;39;37;37;33;31;30;29;29","DISEASE;CANCER;POPULATION;GENE;LYMPHOMA;RETROSPECTIVE COHORT STUDY;COHORT;CHEMOTHERAPY;CONFIDENCE INTERVAL;CLINICAL TRIAL;RANDOMIZED CONTROLLED TRIAL;OUTBREAK;HEALTH CARE;INCIDENCE (GEOMETRY);INTERVENTION (COUNSELING);ALTERNATIVE MEDICINE;RADIATION THERAPY;PSYCHOSIS;STAGE (STRATIGRAPHY);OBSERVATIONAL STUDY;PREGNANCY","114;102;74;39;39;39;38;34;34;28;28;26;25;23;23;21;21;18;18;17;17","INFECTIOUS DISEASE (MEDICAL SPECIALTY);BREAST CANCER;2019-20 CORONAVIRUS OUTBREAK;CLINICAL ENDPOINT;COLORECTAL CANCER;IMMUNOTHERAPY;PROSTATE CANCER;PHASES OF CLINICAL RESEARCH;DIFFUSE LARGE B-CELL LYMPHOMA;VASCULITIS;HAZARD RATIO;MUTATION;RITUXIMAB;FOLLICULAR LYMPHOMA;LENALIDOMIDE;PLACEBO;PROGRESSION-FREE SURVIVAL;FETUS;IMATINIB;PHENOTYPE;PROTOCOL (SCIENCE);TOCILIZUMAB","66;32;22;20;18;17;17;14;13;13;11;11;11;10;9;9;9;8;8;8;8;8","CORONAVIRUS DISEASE 2019 (COVID-19);NIVOLUMAB;GIANT CELL ARTERITIS;NILOTINIB;INTERNATIONAL PROGNOSTIC INDEX;HORMONE RECEPTOR;PROBAND;ANTHRACYCLINE;ASSISTED REPRODUCTIVE TECHNOLOGY;DASATINIB;ESTROGEN RECEPTOR;EXOME SEQUENCING;FEBRILE NEUTROPENIA;MAMMOGRAPHY;MEPOLIZUMAB;MISSENSE MUTATION;VINCRISTINE;ANDROGEN DEPRIVATION THERAPY;CERVICAL INTRAEPITHELIAL NEOPLASIA;COMPOUND HETEROZYGOSITY;ENTHESITIS;EXTERNAL BEAM RADIOTHERAPY;HISTONE DEACETYLASE;IMATINIB MESYLATE;KLEBSIELLA PNEUMONIAE;NEOADJUVANT THERAPY;PEMBROLIZUMAB;PRENATAL DIAGNOSIS;PRIMARY TUMOR","66;10;7;7;6;5;5;4;4;4;4;4;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3",";HUMANS;FEMALE;MALE;ITALY;COVID-19;MIDDLE AGED;ADULT;AGED;RETROSPECTIVE STUDIES;NEOPLASMS;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;TREATMENT OUTCOME;SARS-COV-2;BREAST NEOPLASMS;AGED, 80 AND OVER;SKIN NEOPLASMS;ADOLESCENT;PROGNOSIS;PROSPECTIVE STUDIES","289;254;118;105;80;79;76;70;63;61;38;34;34;33;27;26;25;24;24;23","COVID-19 AND HEALTHCARE IMPACTS;LYMPHOMA DIAGNOSIS AND TREATMENT;SCHIZOPHRENIA RESEARCH AND TREATMENT;CHRONIC MYELOID LEUKEMIA TREATMENTS;COVID-19 CLINICAL RESEARCH STUDIES;VASCULITIS AND RELATED CONDITIONS;COVID-19 AND MENTAL HEALTH;NUTRITION AND HEALTH IN AGING;NONMELANOMA SKIN CANCER STUDIES;BREAST CANCER TREATMENT STUDIES;ADVANCED RADIOTHERAPY TECHNIQUES;ASTHMA AND RESPIRATORY DISEASES;CANCER IMMUNOTHERAPY AND BIOMARKERS;CERVICAL CANCER AND HPV RESEARCH;LONG-TERM EFFECTS OF COVID-19;MULTIPLE MYELOMA RESEARCH AND TREATMENTS;NEUROENDOCRINE TUMOR RESEARCH ADVANCES;CEREBRAL PALSY AND MOVEMENT DISORDERS;COLORECTAL CANCER TREATMENTS AND STUDIES;FIBROMYALGIA AND CHRONIC FATIGUE SYNDROME RESEARCH","21;21;13;11;11;11;10;9;8;7;6;6;6;6;6;6;6;5;5;5",";PANDEMIC;2019-20 CORONAVIRUS OUTBREAK;CLINICAL ENDPOINT;CROSS-SECTIONAL STUDY;DISCONTINUATION;FOLLICULAR LYMPHOMA;PROGRESSION-FREE SURVIVAL;HEMATOLOGY;REGIMEN;STROKE;TOCILIZUMAB;AUTOLOGOUS STEM-CELL TRANSPLANTATION;CUMULATIVE INCIDENCE;GUIDELINE;HEPATITIS C;INTERNATIONAL PROGNOSTIC INDEX;REFRACTORY (PLANETARY SCIENCE);ARTERITIS;PROBAND","92;39;22;20;13;11;10;9;8;8;8;8;6;6;6;6;6;6;5;5","BREAST CANCER;COVID- PANDEMIC;CELL CARCINOMA;FONDAZIONE ITALIANA;ITALIANA LINFOMI;CANCER PATIENTS;PHASE II;CHRONIC MYELOID;OBSERVATIONAL STUDY;COHORT STUDY;FOLLICULAR LYMPHOMA;MYELOID LEUKEMIA;PROSTATE CANCER;CROSS-SECTIONAL STUDY;CELL ARTERITIS;GIANT CELL;HODGKIN LYMPHOMA;LINFOMI FIL;MULTIPLE MYELOMA;NEWLY DIAGNOSED;PALLIATIVE CARE;PHASE III;CONTROLLED TRIAL;NORTHERN ITALY;PHASE STUDY;PHASE TRIAL;STUDY PROTOCOL;B-CELL LYMPHOMA;COLORECTAL CANCER;CONFOCAL MICROSCOPY","18;17;15;13;13;11;11;10;10;9;9;9;9;8;7;7;7;7;7;7;7;7;6;6;6;6;6;5;5;5","HR CI;COVID- PANDEMIC;REGGIO EMILIA;RISK FACTORS;SURVIVAL OS;CANCER PATIENTS;BREAST CANCER;CLINICAL PRACTICE;CORONAVIRUS DISEASE;CONFIDENCE INTERVAL;COMPLETE RESPONSE;DISEASE COVID-;PATIENTS TREATED;ODDS RATIO;DE NOVO;LUNG CANCER;ADVERSE EVENTS;HAZARD RATIO;RESPONSE RATE;MONTHS CI;SIGNIFICANT DIFFERENCES;CELL LINES;CELL LYMPHOMA;INCREASED RISK;INTERVAL CI;LOGISTIC REGRESSION;RATIO CI;SOCIAL MEDIA;SURVIVAL PFS;COVID- PATIENTS","41;35;27;25;25;22;21;21;19;18;17;17;17;16;15;15;14;14;14;13;13;12;12;12;12;12;12;12;12;11",304,0.56,6.65,7.25,1,1,0,2,1,1,1,8,1,1,7,0,1.5,1,3,5,3,0,0,37,37,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,3,2,1583.33,0.56,0,0,20.33,0,0,1,0,0,0,0,2,0,1,2,0,0,0,0,0,0,3,0,0,2,0,0,1,0,0,0,0,0,0,"Switzerland","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3211 ONCOLOGY AND CARCINOGENESIS;30 AGRICULTURAL, VETERINARY AND FOOD SCIENCES;3009 VETERINARY SCIENCES;3204 IMMUNOLOGY","2;2;1;1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES;BREAST CANCER;CANCER;CARDIOVASCULAR;DIGESTIVE DISEASES;GENETICS;HEMATOLOGY;PATIENT SAFETY","3;2;1;1;1;1;1;1;1","CANCER;CARDIOVASCULAR","1;1","4.2 EVALUATION OF MARKERS AND TECHNOLOGIES;6.1 PHARMACEUTICALS;6.4 SURGERY","1;1;1","BREAST CANCER;COLON AND RECTAL CANCER;ESOPHAGEAL / OESOPHAGEAL CANCER;LEUKEMIA / LEUKAEMIA;STOMACH CANCER","1;1;1;1;1","5.2 LOCALIZED THERAPIES - CLINICAL APPLICATIONS;5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1;1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,2,"PUBLIC LIBRARY OF SCIENCE","2","32 BIOMEDICAL AND CLINICAL SCIENCES;52 PSYCHOLOGY;3214 PHARMACOLOGY AND PHARMACEUTICAL SCIENCES;5202 BIOLOGICAL PSYCHOLOGY","4;3;2;2",NA,NA,NA,NA,NA,NA,"CLINICAL","1","CLINICAL MEDICINE AND SCIENCE","2",NA,NA,NA,NA
"IRCCS_AUSLREGGIOEMILIA",2022,533,17.703564727955,3.06754221388368,0.325993883792049,0.333958724202627,0.272045028142589,0.305816135084428,0.705440900562852,2,200,136,46,25,0.38,0.26,0.09,0.05,8.12,0.910048358685659,0.365853658536585,0.979362101313321,5.55149299207799,0.556016018097493,0.465284235323291,0.446454100420223,0.445618952285619,"PAOLO GIORGI ROSSI;CARMINE PINTO;CATERINA LONGO;STEFANO LUMINARI;CARLO SALVARANI;GIULIA BESUTTI;PAMELA MANCUSO;LUCÌA MANGONE;FRANCESCO CAVALLIERI;MARIALUISA ZEDDE;ANDREA PALICELLI;FRANCO VALZANIA;MASSIMO VICENTINI;ANTONINO NERI;ANNIBALE VERSARI;MARTA OTTONE;ALESSANDRO NAVAZIO;FRANCESCO MERLI;MICHÈLE CAVO;MARIA PAOLA BONASONI","42;18;17;17;16;16;16;15;14;14;14;13;13;13;13;13;12;12;12;12","PAOLO GIORGI ROSSI;GABRIELE TONNI;MATTEO RICCÒ;CARMINE PINTO;CATERINA LONGO;ANDREA PALICELLI;FRANCESCA MANTOVANI;PAOLO CECINATO;MICHELE ANTONELLI;LUCÌA MANGONE;LUCA GHIROTTO;MICHELE POLETTI;ANDREA RABALLO;ALESSANDRO NAVAZIO;MARIA PAOLA BONASONI;PAMELA MANCUSO;SILVIA TANZI;GIULIA BESUTTI;CARLO SALVARANI;STEFANIA COSTI","3.11;2.63;2.12;1.93;1.66;1.65;1.58;1.54;1.48;1.43;1.4;1.39;1.39;1.34;1.34;1.31;1.28;1.25;1.25;1.23","PAOLO GIORGI ROSSI;CARMINE PINTO;CATERINA LONGO;STEFANO LUMINARI;CARLO SALVARANI;GIULIA BESUTTI;PAMELA MANCUSO;LUCÌA MANGONE;FRANCESCO CAVALLIERI;MARIALUISA ZEDDE;ANDREA PALICELLI;FRANCO VALZANIA;MASSIMO VICENTINI;ANTONINO NERI;ANNIBALE VERSARI;MARTA OTTONE;ALESSANDRO NAVAZIO;FRANCESCO MERLI;MARIA PAOLA BONASONI;ROMANO SASSATELLI","42;18;17;17;16;16;16;15;14;14;14;13;13;13;13;13;12;12;12;12","PAOLO GIORGI ROSSI;GABRIELE TONNI;MATTEO RICCÒ;CARMINE PINTO;CATERINA LONGO;ANDREA PALICELLI;FRANCESCA MANTOVANI;PAOLO CECINATO;MICHELE ANTONELLI;LUCÌA MANGONE;LUCA GHIROTTO;MICHELE POLETTI;ALESSANDRO NAVAZIO;MARIA PAOLA BONASONI;PAMELA MANCUSO;SILVIA TANZI;GIULIA BESUTTI;CARLO SALVARANI;STEFANIA COSTI;ROMANO SASSATELLI","3.11;2.63;2.12;1.93;1.66;1.65;1.58;1.54;1.48;1.43;1.4;1.39;1.34;1.34;1.31;1.28;1.25;1.25;1.23;1.18","PAOLO GIORGI ROSSI;CARLO SALVARANI;PAMELA MANCUSO;MATTEO RICCÒ;MARIALUISA ZEDDE;GIULIA BESUTTI;ANNIBALE VERSARI;SILVIA RANZIERI;MASSIMO COSTANTINI;PIETRO FERRARO;ALESSANDRO ZANIBONI;LORENZO DAGNA;FEDERICO MARCHESI;ANTONIO BALDASSARRE;CATERINA LONGO;LUCA BONI;MASSIMO VICENTINI;ELIA SATTA;FRANCESCO VENTURELLI;LUCÌA MANGONE","558;392;281;268;214;204;196;188;186;182;180;175;172;170;168;165;162;159;157;153","PAOLO GIORGI ROSSI;MATTEO RICCÒ;CARLO SALVARANI;PAMELA MANCUSO;MARIALUISA ZEDDE;ANNIBALE VERSARI;GIULIA BESUTTI;CATERINA LONGO;MASSIMO VICENTINI;FRANCESCO VENTURELLI;LUCÌA MANGONE;MASSIMO COSTANTINI;MARTA OTTONE;CINZIA CAMPARI;FRANCO VALZANIA;PIERPAOLO PATTACINI;EUFEMIA BISACCIA;STEFANO LUMINARI;CARMINE PINTO;ROMANO SASSATELLI","523;268;249;246;214;196;169;168;162;156;153;126;123;121;119;110;109;108;98;98","PAOLO GIORGI ROSSI;CARLO SALVARANI;CARMINE PINTO;CATERINA LONGO;STEFANO LUMINARI;LUCÌA MANGONE;PAMELA MANCUSO;GIULIA BESUTTI;MARIALUISA ZEDDE;ANDREA PALICELLI;FRANCO VALZANIA;MARTA OTTONE;ANNIBALE VERSARI;MASSIMO VICENTINI;FRANCESCO MERLI;MARIA PAOLA BONASONI;FRANCESCO CAVALLIERI;ALESSANDRO NAVAZIO;ROMANO SASSATELLI;C. IOTTI","41;19;18;17;17;15;15;15;14;14;13;13;13;13;12;12;12;12;12;11","MEDICINE;BIOLOGY;PHYSICS;PSYCHOLOGY;SOCIOLOGY;COMPUTER SCIENCE;POLITICAL SCIENCE;CHEMISTRY;ECONOMICS;ENGINEERING;MATHEMATICS;GEOGRAPHY;PHILOSOPHY;BUSINESS;MATERIALS SCIENCE;ENVIRONMENTAL SCIENCE;ART;GEOLOGY;HISTORY","494;117;66;65;53;51;35;31;30;29;27;17;13;8;6;5;4;4;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;ONCOLOGY;ENVIRONMENTAL HEALTH;PSYCHIATRY;GENETICS;RADIOLOGY;IMMUNOLOGY;PEDIATRICS;NURSING;OPTICS;GASTROENTEROLOGY;CANCER RESEARCH;DEMOGRAPHY;LAW;FAMILY MEDICINE;PHYSICAL THERAPY;VIROLOGY;CLINICAL PSYCHOLOGY;INTENSIVE CARE MEDICINE","346;125;124;99;73;67;55;51;50;48;47;41;40;36;34;34;32;29;29;28;28","CANCER;DISEASE;POPULATION;COHORT;RETROSPECTIVE COHORT STUDY;GENE;CHEMOTHERAPY;INCIDENCE (GEOMETRY);ADVERSE EFFECT;RANDOMIZED CONTROLLED TRIAL;CONFIDENCE INTERVAL;CLINICAL TRIAL;HEALTH CARE;LYMPHOMA;OUTBREAK;PREGNANCY;ALTERNATIVE MEDICINE;OBSERVATIONAL STUDY;ODDS RATIO;RADIATION THERAPY","115;98;65;50;50;44;43;37;34;34;31;30;28;25;24;22;21;21;21;19","INFECTIOUS DISEASE (MEDICAL SPECIALTY);BREAST CANCER;CLINICAL ENDPOINT;COLORECTAL CANCER;2019-20 CORONAVIRUS OUTBREAK;IMMUNOTHERAPY;FETUS;PHASES OF CLINICAL RESEARCH;TOLERABILITY;CHRONIC LYMPHOCYTIC LEUKEMIA;GENE EXPRESSION;HAZARD RATIO;LENALIDOMIDE;MUTATION;NEUTROPENIA;RITUXIMAB;PROGRESSION-FREE SURVIVAL;FOLLICULAR LYMPHOMA;METASTASIS;PHENOTYPE","63;36;24;22;18;17;16;14;11;10;10;10;10;10;10;10;9;8;8;8","CORONAVIRUS DISEASE 2019 (COVID-19);NIVOLUMAB;MAMMOGRAPHY;CETUXIMAB;COLONOSCOPY;IRINOTECAN;MISSENSE MUTATION;NILOTINIB;PRENATAL DIAGNOSIS;CARFILZOMIB;DEEP BRAIN STIMULATION;FEBRILE NEUTROPENIA;INTERNATIONAL PROGNOSTIC INDEX;PLACENTA;ANDROGEN DEPRIVATION THERAPY;CHEMOIMMUNOTHERAPY;DNA METHYLATION;DOUBLE BLIND;FRAMESHIFT MUTATION;GIANT CELL ARTERITIS;KRAS;MASTECTOMY;PEMBROLIZUMAB;PROBAND;RUXOLITINIB;SENTINEL LYMPH NODE;SINGLE-NUCLEOTIDE POLYMORPHISM;SYSTEMIC THERAPY;TRANSCRIPTOME","63;13;6;5;5;5;5;5;5;4;4;4;4;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3",";HUMANS;COVID-19;FEMALE;RETROSPECTIVE STUDIES;MALE;ITALY;AGED;ADULT;SKIN NEOPLASMS;MIDDLE AGED;TREATMENT OUTCOME;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;SARS-COV-2;COLORECTAL NEOPLASMS;MELANOMA;PANDEMICS;PROSPECTIVE STUDIES;LUNG NEOPLASMS;BREAST NEOPLASMS","266;263;93;87;69;56;44;37;33;33;32;31;30;29;24;23;23;23;22;21","LYMPHOMA DIAGNOSIS AND TREATMENT;COVID-19 AND HEALTHCARE IMPACTS;CHRONIC LYMPHOCYTIC LEUKEMIA RESEARCH;CUTANEOUS MELANOMA DETECTION AND MANAGEMENT;LONG-TERM EFFECTS OF COVID-19;MULTIPLE MYELOMA RESEARCH AND TREATMENTS;SCHIZOPHRENIA RESEARCH AND TREATMENT;CANCER SURVIVORSHIP AND CARE;COLORECTAL CANCER TREATMENTS AND STUDIES;GASTRIC CANCER MANAGEMENT AND OUTCOMES;OVARIAN CANCER DIAGNOSIS AND TREATMENT;PALLIATIVE CARE AND END-OF-LIFE ISSUES;BREAST CANCER TREATMENT STUDIES;CEREBRAL PALSY AND MOVEMENT DISORDERS;COVID-19 AND MENTAL HEALTH;SARS-COV-2 AND COVID-19 RESEARCH;VASCULITIS AND RELATED CONDITIONS;CHRONIC MYELOID LEUKEMIA TREATMENTS;COLORECTAL CANCER SCREENING AND DETECTION;COVID-19 EPIDEMIOLOGICAL STUDIES","17;14;11;9;9;9;9;7;7;7;7;7;6;6;6;6;6;5;5;5",";PANDEMIC;CLINICAL ENDPOINT;2019-20 CORONAVIRUS OUTBREAK;STROKE;TOLERABILITY;CROSS-SECTIONAL STUDY;PROGRESSION-FREE SURVIVAL;CONCOMITANT;DISCONTINUATION;FOLLICULAR LYMPHOMA;DEPRESSION;ENDOSCOPIC SUBMUCOSAL DISSECTION;REGIMEN;HEMATOLOGY;NEURORADIOLOGY;REFRACTORY (PLANETARY SCIENCE);ENDOSCOPIC MUCOSAL RESECTION;ASSOCIATION (PSYCHOLOGY);CLINICAL PRACTICE","108;26;24;18;15;11;9;9;8;8;8;7;7;7;6;6;6;5;4;4","BREAST CANCER;COHORT STUDY;COVID- PANDEMIC;PATIENTS TREATED;PHASE II;COLORECTAL CANCER;MULTIPLE MYELOMA;NORTHERN ITALY;RETROSPECTIVE STUDY;CELL CARCINOMA;CLINICAL OUTCOMES;CROSS-SECTIONAL STUDY;ENDOSCOPIC SUBMUCOSAL;OBSERVATIONAL STUDY;CANCER SCREENING;FONDAZIONE ITALIANA;SUBMUCOSAL DISSECTION;CANCER PATIENTS;CHRONIC LYMPHOCYTIC;ITALIANA LINFOMI;LYMPHOCYTIC LEUKEMIA;CLINICAL FEATURES;CLINICAL PRACTICE;CONFOCAL MICROSCOPY;CONTROLLED TRIAL;FOLLICULAR LYMPHOMA;METASTATIC COLORECTAL;MULTICENTER RETROSPECTIVE;MULTICENTER STUDY;NEWLY DIAGNOSED","16;16;13;12;12;11;11;11;11;9;9;9;9;9;8;8;8;7;7;7;7;6;6;6;6;6;6;6;6;6","HR CI;PATIENTS TREATED;ADVERSE EVENTS;BREAST CANCER;REGGIO EMILIA;RISK FACTORS;MEDIAN AGE;PALLIATIVE CARE;RESPONSE RATE;SIGNIFICANT DIFFERENCES;COVID- PANDEMIC;AOR CI;COHORT STUDY;INCLUDED PATIENTS;MULTIPLE MYELOMA;PARKINSONS DISEASE;RAPID ANTIGEN;CONFIDENCE INTERVAL;PATIENTS RECEIVING;PROGRESSION-FREE SURVIVAL;SURVIVAL OS;INCREASED RISK;ODDS RATIO;RISK PERCEPTION;INCLUSION CRITERIA;LDL TARGET;MIGRATION PERCENTAGE;REGRESSION ANALYSIS;CEREBRAL PALSY;COLORECTAL CANCER","33;28;23;23;23;22;20;20;19;19;18;17;16;16;16;16;16;15;15;15;15;14;14;14;13;13;13;13;12;12",268,0.5,7.04,7,1,1,0,2,1,1,1,9,1,1,7,1,1.5,1,4,5,3,0,0,19,19,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,7,750,0.16,0,0,87,0,0,0,0,1,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,NA,NA,"32 BIOMEDICAL AND CLINICAL SCIENCES;3201 CARDIOVASCULAR MEDICINE AND HAEMATOLOGY;3211 ONCOLOGY AND CARCINOGENESIS","1;1;1","BIOMEDICAL IMAGING;CANCER;CLINICAL RESEARCH;HEMATOLOGY;LYMPHOMA;RARE DISEASES","1;1;1;1;1;1","CANCER","1","6.1 PHARMACEUTICALS;6.2 CELLULAR AND GENE THERAPIES","1;1","NON-HODGKIN'S LYMPHOMA","1","5.4 SYSTEMIC THERAPIES - CLINICAL APPLICATIONS","1",0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,"FRONTIERS","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3212 OPHTHALMOLOGY AND OPTOMETRY","2;1","AGING;BRAIN DISORDERS;CLINICAL RESEARCH;NEUROSCIENCES;PATIENT SAFETY;PEDIATRIC;STROKE","1;1;1;1;1;1;1","NEUROLOGICAL;STROKE","1;1","4.2 EVALUATION OF MARKERS AND TECHNOLOGIES","1","CLINICAL","1","CLINICAL MEDICINE AND SCIENCE","1",NA,NA,NA,NA
"IRCCS_AUSLREGGIOEMILIA",2023,566,19.1501766784452,2.98939929328622,0.33451536643026,0.314487632508834,0.265017667844523,0.252650176678445,0.742049469964664,5,236,117,40,37,0.42,0.21,0.07,0.07,4.23,0.965806336933336,0.429328621908127,0.959363957597173,5.19786368260426,0.543654908387123,0.506528801699363,0.537114051669817,0.462019914651494,"CARLO SALVARANI;STEFANO LUMINARI;PAOLO GIORGI ROSSI;CARMINE PINTO;ANTONINO NERI;MARIALUISA ZEDDE;ANNIBALE VERSARI;FRANCO VALZANIA;ROSARIO PASCARELLA;FRANCESCO MERLI;MASSIMO BRECCIA;FRANCESCO MURATORE;LUCÌA MANGONE;FRANCESCO CAVALLIERI;CHIARA MARVISI;MONICA BOCCHIA;ELISABETTA ABRUZZESE;GIOVANNI CAOCCI;ANDREA PALICELLI;CATERINA LONGO","29;27;27;26;26;25;23;20;20;20;20;18;17;16;16;15;15;15;15;14","PAOLO GIORGI ROSSI;MICHELE POLETTI;MARIALUISA ZEDDE;MATTEO RICCÒ;CARLO SALVARANI;ROSARIO PASCARELLA;ANDREA RABALLO;CARMINE PINTO;FEDERICO MARCHESI;GABRIELE TONNI;ANTONINO NERI;FRANCO VALZANIA;STEFANO LUMINARI;CLAUDIO MORATTI;SIMONETTA PIANA;ROMANO SASSATELLI;MANUELA NAPOLI;LUCÌA MANGONE;LUDOVICA DE PANFILIS;FRANCESCO MERLI","4.39;2.87;2.84;2.82;2.41;2.24;1.87;1.85;1.82;1.81;1.73;1.71;1.61;1.52;1.48;1.45;1.41;1.35;1.34;1.33","CARLO SALVARANI;STEFANO LUMINARI;PAOLO GIORGI ROSSI;CARMINE PINTO;ANTONINO NERI;MARIALUISA ZEDDE;ANNIBALE VERSARI;FRANCO VALZANIA;ROSARIO PASCARELLA;FRANCESCO MERLI;FRANCESCO MURATORE;LUCÌA MANGONE;FRANCESCO CAVALLIERI;CHIARA MARVISI;ANDREA PALICELLI;CATERINA LONGO;ALESSIA CIARROCCHI;PAMELA MANCUSO;ISABELLA CAPODANNO;MANUELA NAPOLI","29;27;27;26;26;25;23;20;20;20;18;17;16;16;15;14;14;14;13;13","PAOLO GIORGI ROSSI;MICHELE POLETTI;MARIALUISA ZEDDE;MATTEO RICCÒ;CARLO SALVARANI;ROSARIO PASCARELLA;CARMINE PINTO;GABRIELE TONNI;ANTONINO NERI;FRANCO VALZANIA;STEFANO LUMINARI;CLAUDIO MORATTI;SIMONETTA PIANA;ROMANO SASSATELLI;MANUELA NAPOLI;LUCÌA MANGONE;LUDOVICA DE PANFILIS;FRANCESCO MERLI;FRANCESCO CAVALLIERI;FRANCESCO MURATORE","4.39;2.87;2.84;2.82;2.41;2.24;1.85;1.81;1.73;1.71;1.61;1.52;1.48;1.45;1.41;1.35;1.34;1.33;1.31;1.3","MARIALUISA ZEDDE;CARLO SALVARANI;ROSARIO PASCARELLA;CARMINE PINTO;EDOARDO SAVARINO;ANGELO GHIDINI;GIANLUCA PELLINO;ALESSANDRA SORIANO;CATHERINE Α. HARWOOD;CHRISTOPH SCHRAMM;GIORGOS BAMIAS;HANNAH GORDON;JOHAN BURISCH;JÜRGEN MICHAEL STEIN;KONSTANTINOS ΚARMIRIS;MANUEL BARREIRO–DE ACOSTA;MARIANGELA ALLOCCA;MATHIEU UZZAN;MAURIZIO VECCHI;NURULAMIN M NOOR","181;167;138;134;110;109;109;108;102;102;102;102;102;102;102;102;102;102;102;102","MARIALUISA ZEDDE;CARLO SALVARANI;CARMINE PINTO;ANGELO GHIDINI;ALESSANDRA SORIANO;FRANCESCO MERLI;ANNIBALE VERSARI;PAOLO GIORGI ROSSI;VINCENZO DARIO MANDATO;LORENZO AGUZZOLI;ANTONINO NERI;FRANCESCO CAVALLIERI;ROSARIO PASCARELLA;STEFANO LUMINARI;FRANCO VALZANIA;ALESSIA CIARROCCHI;GIOVANNI D’IPPOLITO;MATTEO AUGUGLIARO;SILVIA AZZALI;CHIARA MARVISI","181;137;134;109;108;95;91;89;87;73;71;70;69;69;66;65;61;61;59;58","CARLO SALVARANI;PAOLO GIORGI ROSSI;CARMINE PINTO;MARIALUISA ZEDDE;STEFANO LUMINARI;ANTONINO NERI;ANNIBALE VERSARI;ROSARIO PASCARELLA;FRANCO VALZANIA;FRANCESCO MERLI;LUCÌA MANGONE;ISABELLA CAPODANNO;FRANCESCO CAVALLIERI;FRANCESCO MURATORE;ANDREA PALICELLI;PAMELA MANCUSO;ALESSIA CIARROCCHI;ELENA GALLI;FEDERICA TORRICELLI;CHIARA MARVISI","36;27;26;25;25;24;23;21;20;20;17;16;16;15;15;14;14;13;13;13","MEDICINE;BIOLOGY;PSYCHOLOGY;COMPUTER SCIENCE;PHYSICS;CHEMISTRY;SOCIOLOGY;ENGINEERING;ECONOMICS;MATHEMATICS;POLITICAL SCIENCE;PHILOSOPHY;BUSINESS;ART;GEOGRAPHY;MATERIALS SCIENCE;ENVIRONMENTAL SCIENCE;GEOLOGY;HISTORY","539;142;72;51;46;43;43;35;32;27;26;20;9;8;8;8;5;2;1","INTERNAL MEDICINE;SURGERY;PATHOLOGY;ONCOLOGY;ENVIRONMENTAL HEALTH;GENETICS;PSYCHIATRY;IMMUNOLOGY;RADIOLOGY;GASTROENTEROLOGY;CANCER RESEARCH;NURSING;PEDIATRICS;BIOCHEMISTRY;FAMILY MEDICINE;PALEONTOLOGY;CARDIOLOGY;INTENSIVE CARE MEDICINE;PHYSICAL THERAPY;DERMATOLOGY;OPTICS","379;131;123;121;71;69;69;63;61;60;46;46;46;40;36;35;31;30;30;26;26","CANCER;DISEASE;COHORT;POPULATION;GENE;CHEMOTHERAPY;LYMPHOMA;CONFIDENCE INTERVAL;RETROSPECTIVE COHORT STUDY;HEALTH CARE;CLINICAL TRIAL;ADVERSE EFFECT;PREGNANCY;PROSPECTIVE COHORT STUDY;RANDOMIZED CONTROLLED TRIAL;OBSERVATIONAL STUDY;BONE MARROW;INCIDENCE (GEOMETRY);CONTEXT (ARCHAEOLOGY);MULTIPLE MYELOMA","112;106;59;58;56;50;47;43;34;28;26;23;23;23;23;22;21;20;19;19","INFECTIOUS DISEASE (MEDICAL SPECIALTY);BREAST CANCER;CLINICAL ENDPOINT;RITUXIMAB;VASCULITIS;HAZARD RATIO;COLORECTAL CANCER;CYCLOPHOSPHAMIDE;FOLLICULAR LYMPHOMA;IMMUNOTHERAPY;GENE EXPRESSION;FETUS;METASTASIS;PARKINSON'S DISEASE;CANCER REGISTRY;LENALIDOMIDE;PHASES OF CLINICAL RESEARCH;PROGRESSION-FREE SURVIVAL;2019-20 CORONAVIRUS OUTBREAK;ALLELE;CHRONIC LYMPHOCYTIC LEUKEMIA;DIFFUSE LARGE B-CELL LYMPHOMA;MYELOFIBROSIS;PHENOTYPE","31;30;29;22;22;20;17;15;14;13;12;11;11;11;10;10;10;10;8;8;8;8;8;8","CORONAVIRUS DISEASE 2019 (COVID-19);GIANT CELL ARTERITIS;VINCRISTINE;NIVOLUMAB;BENDAMUSTINE;CETUXIMAB;DEEP BRAIN STIMULATION;IRINOTECAN;KRAS;RUXOLITINIB;CHEMOIMMUNOTHERAPY;IMATINIB MESYLATE;NILOTINIB;TRANSCRIPTOME;CARFILZOMIB;DASATINIB;INTERNATIONAL PROGNOSTIC INDEX;INTERNATIONAL PROGNOSTIC SCORING SYSTEM;MAMMOGRAPHY;MASTECTOMY;METASTATIC BREAST CANCER;PRENATAL DIAGNOSIS;TRIPLE-NEGATIVE BREAST CANCER;VENETOCLAX","31;14;13;9;6;6;6;6;6;6;5;5;5;5;4;4;4;4;4;4;4;4;4;4",";HUMANS;FEMALE;ITALY;MALE;RETROSPECTIVE STUDIES;COVID-19;ADULT;MIDDLE AGED;AGED;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;PROSPECTIVE STUDIES;SKIN NEOPLASMS;TREATMENT OUTCOME;ADOLESCENT;STROKE;NEOPLASM RECURRENCE, LOCAL;LUNG NEOPLASMS;PARKINSON DISEASE;BREAST NEOPLASMS","293;271;69;56;54;53;39;34;33;32;31;24;21;21;20;20;19;18;18;17","LYMPHOMA DIAGNOSIS AND TREATMENT;VASCULITIS AND RELATED CONDITIONS;MULTIPLE MYELOMA RESEARCH AND TREATMENTS;CUTANEOUS MELANOMA DETECTION AND MANAGEMENT;CHRONIC LYMPHOCYTIC LEUKEMIA RESEARCH;CHRONIC MYELOID LEUKEMIA TREATMENTS;COVID-19 AND HEALTHCARE IMPACTS;MYELOPROLIFERATIVE NEOPLASMS: DIAGNOSIS AND TREATMENT;SCHIZOPHRENIA RESEARCH AND TREATMENT;OCCUPATIONAL AND ENVIRONMENTAL LUNG DISEASES;ACUTE ISCHEMIC STROKE MANAGEMENT;ACUTE MYELOID LEUKEMIA RESEARCH;BREAST CANCER TREATMENT STUDIES;ADVANCED BREAST CANCER THERAPIES;CANCER GENOMICS AND DIAGNOSTICS;CANCER IMMUNOTHERAPY AND BIOMARKERS;COVID-19 AND MENTAL HEALTH;GASTRIC CANCER MANAGEMENT AND OUTCOMES;NEUROLOGICAL DISORDERS AND TREATMENTS;PALLIATIVE CARE AND END-OF-LIFE ISSUES","33;16;15;12;11;11;10;9;9;7;6;6;6;5;5;5;5;5;5;5",";CLINICAL ENDPOINT;PANDEMIC;STROKE;REGIMEN;FOLLICULAR LYMPHOMA;DISCONTINUATION;REFRACTORY (PLANETARY SCIENCE);INTERQUARTILE RANGE;PROGRESSION-FREE SURVIVAL;ARTERITIS;CROSS-SECTIONAL STUDY;2019-20 CORONAVIRUS OUTBREAK;LENTIGO MALIGNA;MINIMAL RESIDUAL DISEASE;ABVD;BENDAMUSTINE;CONCOMITANT;GUIDELINE;NEURORADIOLOGY","98;29;20;18;15;14;12;11;10;10;9;9;8;7;7;6;6;6;6;6","BREAST CANCER;COHORT STUDY;MULTIPLE MYELOMA;MYELOID LEUKEMIA;FOLLICULAR LYMPHOMA;CELL ARTERITIS;FONDAZIONE ITALIANA;GIANT CELL;ITALIANA LINFOMI;CROSS-SECTIONAL STUDY;OBSERVATIONAL STUDY;NORTHERN ITALY;CANCER PATIENTS;HODGKIN LYMPHOMA;NEWLY DIAGNOSED;PATIENTS TREATED;PROSPECTIVE STUDY;RETROSPECTIVE STUDY;ACUTE MYELOID;CHRONIC MYELOID;COVID- PANDEMIC;ENDOMETRIAL CANCER;RESIDUAL DISEASE;BRAIN STIMULATION;COLORECTAL CANCER;DEEP BRAIN;METASTATIC COLORECTAL;PHASE III;PROSPECTIVE OBSERVATIONAL;RETROSPECTIVE ANALYSIS","17;16;16;15;12;11;11;11;11;10;10;9;8;8;8;8;8;8;7;7;7;7;7;6;6;6;6;6;6;6","HR CI;ADVISORY ROLE;SARS-COV- INFECTION;MEDIAN AGE;MONTHS CI;REGGIO EMILIA;MEDIAN FOLLOW-UP;PROGRESSION-FREE SURVIVAL;CLINICAL PRACTICE;SURVIVAL OS;AOR CI;DISEASE PROGRESSION;SURVIVAL PFS;ADVERSE EVENTS;PRIMARY ENDPOINT;STATISTICALLY SIGNIFICANT;COVID- PANDEMIC;HAZARD RATIO;PATIENTS RECEIVED;BREAST CANCER;RISK FACTORS;PATIENTS TREATED;RESEARCH FUNDING;CONFIDENCE INTERVAL;LUNG CANCER;ELI LILLY;NEWLY DIAGNOSED;RESPONSE RATE;MULTIVARIATE ANALYSIS;RETROSPECTIVE STUDY","55;38;38;35;35;32;30;30;29;29;27;27;27;26;26;26;25;25;25;24;23;22;22;21;21;20;20;20;19;19",241,0.43,8,8,1,1,0,3,0,1,0,9,1,0,8,1,1,1,3,6,4,0,0,9,9,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,1,4,118,0.18,0,0,25,0,0,1,0,0,0,0,0,0,1,0,0,0,0,0,0,0,1,0,0,1,0,0,0,0,0,0,0,0,0,"United States","1","32 BIOMEDICAL AND CLINICAL SCIENCES;3202 CLINICAL SCIENCES","1;1","CLINICAL RESEARCH;CLINICAL TRIALS AND SUPPORTIVE ACTIVITIES","1;1",NA,NA,"6.1 PHARMACEUTICALS","1",NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
"IRCCS_AUSLREGGIOEMILIA",2024,533,20.9587242026266,3.14446529080675,0.318019093078759,0.25703564727955,0.25515947467167,0.144465290806754,0.530956848030019,0,266,103,40,22,0.5,0.19,0.08,0.04,1.18,1.23088275557041,0.425891181988743,0.977485928705441,4.77732053040694,0.566559293158054,0.549646387527124,0.514750365913156,0.545462962962963,"PAOLO GIORGI ROSSI;MARIALUISA ZEDDE;ANTONINO NERI;CARMINE PINTO;STEFANO LUMINARI;FRANCO VALZANIA;CARLO SALVARANI;FORTUNATO MORABITO;CATERINA LONGO;ROSARIO PASCARELLA;FRANCESCO MURATORE;CARLO SALVARANI;CHIARA MARVISI;STEFANIA CROCI;ILARIA GRISENDI;ALESSIA CIARROCCHI;ANNIBALE VERSARI;MASSIMO GENTILE;ALESSANDRO PEZZINI;FRANCESCO CAVALLIERI","39;35;27;25;23;23;21;20;19;19;19;19;18;18;17;16;16;15;15;14","MARIALUISA ZEDDE;PAOLO GIORGI ROSSI;MICHELE ANTONELLI;CARMINE PINTO;FRANCO VALZANIA;CARLO SALVARANI;GABRIELE TONNI;CARLO SALVARANI;CHIARA MARVISI;ANTONINO NERI;STEFANO LUMINARI;CATERINA LONGO;FRANCESCO MURATORE;LUCA GHIROTTO;FORTUNATO MORABITO;ROSARIO PASCARELLA;STEFANIA CROCI;ROSARIO PASCARELLA;DAVIDE DONELLI;MICHELE POLETTI","3.25;3.17;2.38;2.04;1.98;1.88;1.86;1.79;1.72;1.7;1.61;1.58;1.56;1.49;1.36;1.35;1.25;1.24;1.21;1.2","PAOLO GIORGI ROSSI;MARIALUISA ZEDDE;ANTONINO NERI;CARMINE PINTO;STEFANO LUMINARI;FRANCO VALZANIA;CARLO SALVARANI;FORTUNATO MORABITO;CATERINA LONGO;ROSARIO PASCARELLA;FRANCESCO MURATORE;CARLO SALVARANI;CHIARA MARVISI;STEFANIA CROCI;ILARIA GRISENDI;ALESSIA CIARROCCHI;ANNIBALE VERSARI;FRANCESCO CAVALLIERI;FEDERICA TORRICELLI;CLAUDIO MORATTI","39;35;27;25;23;23;21;20;19;19;19;19;18;18;17;16;16;14;14;13","MARIALUISA ZEDDE;PAOLO GIORGI ROSSI;MICHELE ANTONELLI;CARMINE PINTO;FRANCO VALZANIA;CARLO SALVARANI;GABRIELE TONNI;CARLO SALVARANI;CHIARA MARVISI;ANTONINO NERI;STEFANO LUMINARI;CATERINA LONGO;FRANCESCO MURATORE;LUCA GHIROTTO;FORTUNATO MORABITO;ROSARIO PASCARELLA;STEFANIA CROCI;ROSARIO PASCARELLA;MICHELE POLETTI;CLAUDIO MORATTI","3.25;3.17;2.38;2.04;1.98;1.88;1.86;1.79;1.72;1.7;1.61;1.58;1.56;1.49;1.36;1.35;1.25;1.24;1.2;1.16","CATERINA LONGO;AIMILIOS LALLAS;GIOVANNI PELLACANI;MARIALUISA ZEDDE;CARLO SALVARANI;FRANCESCO CAVALLIERI;CLAUS GARBE;ULRIKE LEITER;IRIS ZALAUDEK;ROSARIO PASCARELLA;KETTY PERIS;LIDIJA KANDOLF;ALESSIA CIARROCCHI;ILARIA GRISENDI;MARIA CONCETTA FARGNOLI;PAOLO GIORGI ROSSI;ANTONINO NERI;ANA‐MARIA FORSEA;BRIGITTE DRÉNO;CATHERINE Α. HARWOOD","71;46;44;42;41;39;37;37;35;35;34;34;33;30;30;30;29;28;28;28","CATERINA LONGO;MARIALUISA ZEDDE;FRANCESCO CAVALLIERI;ROSARIO PASCARELLA;ALESSIA CIARROCCHI;ILARIA GRISENDI;PAOLO GIORGI ROSSI;ANTONINO NERI;CARLO SALVARANI;BENEDETTA DONATI;FRANCESCO MERLI;MARIA PAOLA BONASONI;FRANCO VALZANIA;GABRIELE TONNI;ANNIBALE VERSARI;PAMELA MANCUSO;FEDERICA TORRICELLI;GIANCARLO BISAGNI;STEFANIA CROCI;VINCENZO GUIDUCCI","71;42;39;35;33;30;30;29;27;24;21;21;20;18;17;17;16;16;16;16","PAOLO GIORGI ROSSI;CARLO SALVARANI;MARIALUISA ZEDDE;ANTONINO NERI;CARMINE PINTO;FRANCO VALZANIA;ROSARIO PASCARELLA;STEFANO LUMINARI;CATERINA LONGO;FRANCESCO MURATORE;FRANCESCO CAVALLIERI;ILARIA GRISENDI;STEFANIA CROCI;ALESSIA CIARROCCHI;ANNIBALE VERSARI;CHIARA MARVISI;FEDERICA TORRICELLI;CLAUDIO MORATTI;MANUELA NAPOLI;LUCA CIMINO","37;34;34;27;25;25;22;22;19;18;17;17;17;16;16;15;14;13;13;12","MEDICINE;BIOLOGY;PSYCHOLOGY;COMPUTER SCIENCE;PHYSICS;ENGINEERING;SOCIOLOGY;CHEMISTRY;MATHEMATICS;POLITICAL SCIENCE;ECONOMICS;PHILOSOPHY;GEOGRAPHY;MATERIALS SCIENCE;BUSINESS;GEOLOGY;HISTORY;ENVIRONMENTAL SCIENCE","503;134;61;56;45;38;33;28;23;21;20;14;13;11;9;6;3;1","INTERNAL MEDICINE;ONCOLOGY;PATHOLOGY;SURGERY;GENETICS;RADIOLOGY;PSYCHIATRY;IMMUNOLOGY;CANCER RESEARCH;ENVIRONMENTAL HEALTH;NURSING;CARDIOLOGY;PEDIATRICS;PALEONTOLOGY;DERMATOLOGY;INTENSIVE CARE MEDICINE;FAMILY MEDICINE;MECHANICAL ENGINEERING;GASTROENTEROLOGY;MEDICAL PHYSICS","349;127;118;79;65;61;54;50;48;45;42;41;36;32;31;30;29;28;26;26","CANCER;DISEASE;GENE;POPULATION;COHORT;RANDOMIZED CONTROLLED TRIAL;LYMPHOMA;CHEMOTHERAPY;CLINICAL TRIAL;STROKE (ENGINE);RETROSPECTIVE COHORT STUDY;OBSERVATIONAL STUDY;CONFIDENCE INTERVAL;QUALITY OF LIFE (HEALTHCARE);ADVERSE EFFECT;PREGNANCY;ISCHEMIA;HEALTH CARE;LEUKEMIA;STAGE (STRATIGRAPHY)","135;89;46;43;39;35;33;29;28;25;24;21;20;18;17;17;16;15;15;15","BREAST CANCER;IMMUNOTHERAPY;VASCULITIS;COLORECTAL CANCER;FOLLICULAR LYMPHOMA;GENE EXPRESSION;INFECTIOUS DISEASE (MEDICAL SPECIALTY);CLINICAL ENDPOINT;ISCHEMIC STROKE;HAZARD RATIO;PHENOTYPE;MUTATION;OVARIAN CANCER;PROSTATE CANCER;RITUXIMAB;MULTICENTER STUDY;PARKINSON'S DISEASE;2019-20 CORONAVIRUS OUTBREAK;FETUS;LENALIDOMIDE;NEURORADIOLOGY;PHASES OF CLINICAL RESEARCH;PROGRESSION-FREE SURVIVAL","44;28;28;21;17;15;14;13;13;12;11;10;10;10;10;9;9;8;8;8;8;8;8","GIANT CELL ARTERITIS;CORONAVIRUS DISEASE 2019 (COVID-19);MAMMOGRAPHY;NIVOLUMAB;MODIFIED RANKIN SCALE;TRIPLE-NEGATIVE BREAST CANCER;IMMUNE CHECKPOINT;PEMBROLIZUMAB;TRANSCRIPTOME;COLONOSCOPY;NILOTINIB;POMALIDOMIDE;ADJUVANT CHEMOTHERAPY;ANDROGEN DEPRIVATION THERAPY;ANDROGEN RECEPTOR;COGNITIVE DECLINE;DASATINIB;EXOME SEQUENCING;GENE EXPRESSION PROFILING;GERMLINE MUTATION;GRANULOMATOSIS WITH POLYANGIITIS;HBSAG;IBRUTINIB;IN UTERO;INTERNATIONAL PROGNOSTIC INDEX;RESPONSE EVALUATION CRITERIA IN SOLID TUMORS;RUXOLITINIB;SENTINEL LYMPH NODE","19;14;10;8;7;7;6;6;6;5;5;4;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3;3",";HUMANS;FEMALE;MALE;MIDDLE AGED;AGED;ADULT;ITALY;AGED, 80 AND OVER;RETROSPECTIVE STUDIES;TREATMENT OUTCOME;PROSPECTIVE STUDIES;ADOLESCENT;YOUNG ADULT;RISK FACTORS;CHILD;EUROPE;BREAST NEOPLASMS;PROGNOSIS;ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS","318;212;137;124;108;92;82;51;44;33;32;23;21;21;16;14;14;13;13;12","LYMPHOMA DIAGNOSIS AND TREATMENT;VASCULITIS AND RELATED CONDITIONS;CANCER IMMUNOTHERAPY AND BIOMARKERS;MULTIPLE MYELOMA RESEARCH AND TREATMENTS;CHRONIC MYELOID LEUKEMIA TREATMENTS;CUTANEOUS MELANOMA DETECTION AND MANAGEMENT;ACUTE ISCHEMIC STROKE MANAGEMENT;ACUTE MYELOID LEUKEMIA RESEARCH;CANCER SURVIVORSHIP AND CARE;GALLBLADDER AND BILE DUCT DISORDERS;OCULAR DISEASES AND BEHÇET’S SYNDROME;RENAL CELL CARCINOMA TREATMENT;COLORECTAL CANCER SCREENING AND DETECTION;DIGITAL RADIOGRAPHY AND BREAST IMAGING;GLOBAL CANCER INCIDENCE AND SCREENING;PROSTATE CANCER TREATMENT AND RESEARCH;RADIOMICS AND MACHINE LEARNING IN MEDICAL IMAGING;SCHIZOPHRENIA RESEARCH AND TREATMENT;ADVANCED RADIOTHERAPY TECHNIQUES;BREAST CANCER TREATMENT STUDIES","25;22;13;10;9;9;8;7;7;7;7;7;6;6;6;6;6;6;5;5",";STROKE;FOLLICULAR LYMPHOMA;REFRACTORY (PLANETARY SCIENCE);CLINICAL ENDPOINT;DISCONTINUATION;2019-20 CORONAVIRUS OUTBREAK;NEURORADIOLOGY;PROGRESSION-FREE SURVIVAL;ARTERITIS;CLINICAL PRACTICE;TRIPLE-NEGATIVE BREAST CANCER;IMMUNE CHECKPOINT;TOCILIZUMAB;BILIARY DRAINAGE;DIGITAL BREAST TOMOSYNTHESIS;PANDEMIC;SALVAGE THERAPY;BREAST CANCER SCREENING;CONCORDANCE","121;25;17;14;13;12;8;8;8;7;7;7;6;6;5;5;5;5;4;4","BREAST CANCER;CELL ARTERITIS;GIANT CELL;FOLLICULAR LYMPHOMA;OBSERVATIONAL STUDY;CELL CARCINOMA;COHORT STUDY;CANCER PATIENTS;COLORECTAL CANCER;MYELOID LEUKEMIA;ISCHEMIC STROKE;MULTIPLE MYELOMA;NORTHERN ITALY;RENAL CELL;PARKINSONS DISEASE;CHRONIC MYELOID;CONTROLLED TRIAL;MULTICENTER STUDY;PROSTATE CANCER;CLINICAL PRACTICE;MEET-URO STUDY;OVARIAN CANCER;PATIENTS PTS;PHASE II;PHASE III;CANCER SCREENING;CENTRAL NERVOUS;CONFOCAL MICROSCOPY;LONGITUDINAL STUDY;LUNG CANCER","26;18;18;14;14;12;11;10;10;10;9;9;9;9;8;7;7;7;7;6;6;6;6;6;6;5;5;5;5;5","BREAST CANCER;CLINICAL PRACTICE;CANCER PATIENTS;MENTAL HEALTH;MEDIAN AGE;CLINICAL TRIALS;CONFIDENCE INTERVAL;ADVERSE EVENTS;LUNG CANCER;PD-L EXPRESSION;CURE PREVALENCE;PALLIATIVE REHABILITATION;PATIENTS TREATED;PREVIOUS CESAREAN;RETROSPECTIVE STUDY;RISK FACTORS;SURVIVAL OS;COLORECTAL CANCER;CONFOCAL MICROSCOPY;HR CI;MEDIAN FOLLOW-UP;SIGNIFICANT DIFFERENCES;CELL CARCINOMA;CELL DEATH;FUNCTIONAL OUTCOME;MAGNETIC RESONANCE;PREGNANT WOMEN;PROGRESSION-FREE SURVIVAL;PSYCHOLOGICAL PAIN;STUDY INCLUDED","35;27;21;17;14;13;13;12;12;12;11;11;11;11;11;11;11;10;10;10;10;10;9;9;9;9;9;9;9;9",3,0.01,14.05,18.5,0,0,0,1,0,0,0,19,0,0,18,0,0,1,7,11.5,3,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,0,0,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,0,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA,NA
